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RESUMO 
 
A investigação em células estaminais embrionárias tem permitido grandes avanços 
na pesquisa em ciências biomédicas. Este é o evidente reflexo de estas serem 
células não especializadas que são capazes de se auto-renovar indefinidamente, e 
assim dar origem a novas células estaminais num estado indiferenciado, mas 
também têm a possibilidade de se diferenciarem em um ou múltiplos tipos de 
células especializadas sob condições definidas ou estímulos intrínsecos e/ou 
extrínsecos. 
Linhas de células estaminais embrionárias de ratinho foram inicialmente derivadas 
e cultivadas há cerca de 30 anos e, desde então, têm sido uma ferramenta 
inestimável na compreensão dos processos de desenvolvimento embrionário dos 
mamíferos, bem como no estabelecimento das bases moleculares da pluripotência 
e da auto-renovação celular. Para além disso, por permitir a criação de 
geneticamente modificados (e.g. knock-outs) através de recombinação homóloga, 
estas são determinantes no estudo da função genética in vivo. Não menos 
importante, os estudos das células estaminais embrionárias de ratinho abriram o 
caminho à investigação das células estaminais embrionárias humanas que, dada a 
sua capacidade de auto-renovação e diferenciação, têm suscitado muito interesse 
pelo seu elevado potencial para uso em terapia celular. As células estaminais 
embrionárias têm sido co-cultivadas geralmente com células de suporte tais como 
fibroblastos embrionários de ratinho. Os fibroblastos embrionários de ratinho 
servem de células de suporte para cultura de células estaminais embrionárias 
desde a derivação das mesmas. Estes fibroblastos continuam a ser ainda hoje os 
mais usados como células de suporte para cultura e manutenção de células 
estaminais de ratinho e humanas, uma vez que proporcionam um substrato que 
aumenta a eficiência de adesão das células estaminais, promove a manutenção da 
sua pluripotência e capacidade de auto-renovação e facilita a sua sobrevivência e 
crescimento. Os fibroblastos embrionários usados para cultura de células 
estaminais produzem uma complexa mistura de fatores de crescimento, citoquinas 
e outros componentes da matriz extracelular tais como o fator inibidor de 
leucemia, proteínas morfogenéticas ósseas, activina, laminina e vitronectina, que 
mantêm as células estaminais embrionárias indiferenciadas e pluripotentes mesmo 
quando cultivadas a longo prazo.  
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Sabe-se que o comportamento das células estaminais embrionárias in vitro é 
fortemente influenciadas pelas condições de cultura. Estudos recentes 
demonstram que os métodos convencionais de cultura de células estaminais não 
reúnem os requisitos mínimos para regular e controlar com rigor a função das 
células estaminais. Além disso, os vários protocolos existentes para cultura de 
células estaminais envolvem o uso de matrizes de origem animal, tais como a 
gelatina e os fibroblastos de ratinho. De modo a ultrapassar esta limitação, vários 
cientistas têm-se empenhado em desenvolver matrizes artificiais no sentido de 
eliminar os componentes de origem animal dos sistemas de cultura de células, 
mas mantendo o controlo da capacidade de auto-renovação e diferenciação das 
células estaminais. O avanço no desenvolvimento de biomateriais tem-se revelado 
uma ferramenta fundamental para a criação de microambientes artificiais que 
visam mimetizar o microambiente in vivo das células estaminais, influenciando e 
controlando a expressão dos genes que definem o destino e as propriedades 
estaminais, ou seja, a auto-renovação ou a diferenciação. No entanto, apesar dos 
grandes avanços que têm ocorrido no desenvolvimento de biomateriais, a maioria 
são dispendiosos e poucos são apropriados para manter as células estaminais 
embrionárias num estado indiferenciado. Por isso, o objetivo principal deste 
trabalho foi o de encontrar ou desenvolver um biomaterial capaz de dar suporte 
ao crescimento de células estaminais embrionárias indiferenciadas, evitando os 
custos de uma série de procedimentos experimentais trabalhosos e morosos da 
cultura paralela de fibroblastos com a cultura de células estaminais, e que fosse 
de fácil manuseamento tal como a gelatina. Visto que o ambiente que envolve as 
células estaminais tem um papel determinante na seleção do destino das mesmas, 
o objetivo deste trabalho consistiu então em otimizar as condições de cultura de 
células estaminais embrionárias de ratinho através da substituição da 
monocamada de fibroblastos ou da gelatina por um suporte artificial que 
mimetizasse a matriz extracelular e que servisse como substrato para adesão 
celular, proliferação e diferenciação. No âmbito deste trabalho desenvolveu-se e 
testou-se a aplicabilidade de um revestimento de goma de semente de alfarroba 
e de uma matriz de nanofibras sintéticas na manutenção da pluripotência e 
capacidade de diferenciação de células estaminais embrionárias de ratinho em 
cultura. 
A estabilidade química e a biocompatibilidade dos biomateriais de origem natural 
tem contribuído para a sua utilização cada vez mais frequente na medicina 
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moderna. A goma de semente de alfarroba é um polímero natural que tem uma 
vasta gama de aplicações desde a indústria alimentar e cosmética, passando 
também pela farmacêutica devido à sua biocompatibilidade e às suas propriedades 
de adesão e de espessante. Nós quisemos testar este composto natural na cultura 
de células estaminais pluripotentes. Numa primeira abordagem, células estaminais 
embrionárias de ratinho foram cultivadas em poliestireno revestido com goma de 
semente de alfarroba e avaliou-se o seu potencial de manutenção da pluripotência 
através da análise da morfologia das colónias, do ensaio da fosfatase alcalina, da 
expressão de marcadores de pluripotência (Nanog, Sox2 e Oct4) e da capacidade 
de diferenciação nos três folhetos embrionários (endoderme, mesoderme e 
ectoderme) após cultura a longo prazo. De acordo com os resultados, as células 
estaminais embrionárias cultivadas em goma de semente de alfarroba 
apresentaram-se sob a forma de colónias regulares, semelhantes às colónias 
obtidas quando as células estaminais foram cultivadas em fibroblastos, o suporte 
standard para a manutenção da pluripotência. As células estaminais embrionárias 
cultivadas em goma de semente de alfarroba mantiveram a sua viabilidade e 
tiveram um crescimento semelhante às células cultivadas em gelatina. Por outro 
lado, as células estaminais embrionárias cultivadas em goma de semente de 
alfarroba apresentaram níveis de expressão de marcadores de pluripotência e de 
atividade da fosfatase alcalina equivalentes e em alguns pontos mais elevados do 
que as células cultivadas em gelatina. Após 30 dias de cultura em goma de 
semente de alfarroba, as células estaminais embrionárias mantiveram a sua 
capacidade de se diferenciar nos três folhetos embrionários. 
Apesar das várias vantagens apresentadas pelos polímeros naturais, a sua 
composição pode variar consoante o lote e o produtor. O principal componente da 
goma de semente de alfarroba é o polímero galactomanano que se encontra no 
endosperma das sementes e funciona como reserva energética. Neste trabalho 
testou-se também a utilização de goma de semente de alfarroba de diferentes 
origens (Roeper e Industrial Farense) e purificada versus não purificada, para 
cultura de células estaminais embrionárias. Em geral, confirmou-se que o 
revestimento do poliestireno tratado para cultura de células com goma de semente 
de alfarroba promove o crescimento de células estaminais embrionárias num 
estado indiferenciado e viável, o que tem potencial para ser um suporte de origem 
vegetal para cultura de células alternativo à gelatina. 
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Tendo em conta que a matriz extracelular nativa é maioritariamente constituída 
por fibras, e que no caso da cultura sobre fibroblastos estas são produzidas pelos 
fibroblastos, desenvolveu-se um suporte de nanofibras poliméricas de poli 
(etilenoglicol-β-metacrilato de trimetilsilício-β-ácido metacrílico), conjugado com 
péptido glicina-arginina-glicina-aspartato-serina. Esta matriz é então resultante da 
conversão de co-polímeros anfifílicos em nanofibras através de um processo de 
organização espontânea (self-assembly). Considerando que um suporte ideal deve 
conter locais que proporcionem a adesão celular, os co-polímeros anfifílicos foram 
desenhados e sintetizados de modo a incorporar uma sequência de péptidos 
termoestáveis que correspondem a uma sequência biológica integrante da matriz 
extracelular. Com o objetivo de determinar o potencial de aplicação futura do 
suporte de nanofibras para cultura de células estaminais, células estaminais 
embrionárias indiferenciadas de ratinho foram cultivadas no suporte de nanofibras 
e em condições convencionais. O potencial de aplicação das nanofibras em 
investigação de células estaminais foi avaliado através da morfologia, proliferação, 
viabilidade, auto-renovação e pluripotência das células estaminais embrionárias 
indiferenciadas de ratinho comparativamente com os resultados obtidos para as 
condições de cultura standard. De acordo com os resultados, as nanofibras 
promoveram o crescimento celular e um aumento da expressão dos genes de 
pluripotência em comparação com as metodologias convencionais de cultura de 
células estaminais. Além disso, as células estaminais embrionárias cultivadas a 
longo prazo em nanofibras conservaram a capacidade de diferenciação. Portanto, 
neste trabalho foi desenvolvido uma nova matriz de nanofibras sintéticas que 
permite a eliminação de matrizes de origem animal e providencia um método 
económico para cultura de células constituído por uma rede de nanofibras. Esta 
matriz de nanofibras possui uma escala semelhante à matriz extracelular nativa 
onde as células podem ser mantidas e manipuladas. 
 
Paralelamente ao estudo da utilização de biomateriais na cultura e manutenção de 
células estaminais, a última parte do meu trabalho foi dedicada ao estudo da 
função da proteína CCBE1. A proteína CCBE1 contém domínios putativos de 
colagénio e de fator de crescimento epidermal (EGF). O gene Ccbe1 foi identificado 
num ensaio de expressão diferencial efetuado para revelar novos genes expressos 
nos percursores cardíacos realizado pelo nosso laboratório e está envolvido em 
processos de linfangiogénese, cardiogénese e carcinogénese. No entanto, apesar 
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de putativamente CCBE1 ser uma proteína secretada, a sua função e mecanismo 
de ação continuam a ser desconhecidos. Dados experimentais publicados e outros 
realizados no nosso laboratório revelaram que o ratinho mutante para o gene 
Ccbe1 morre durante o desenvolvimento embrionário. Outros resultados indicam 
que Ccbe1 é muito expresso em fibroblastos embrionários de ratinho. Por estas 
razões, foram realizados estudos de função de Ccbe1 utilizando culturas primárias 
de fibroblastos embrionários de ratinho como modelo. Realizaram-se ensaios de 
adesão, proliferação, viabilidade e migração. De acordo com os resultados, 
verificou-se que os fibroblastos isolados do ratinho mutante para Ccbe1 a E13.5 
apresentam uma morfologia típica de fibroblastos senescentes, a sua proliferação 
é mais lenta e têm expressão de Bax aumentada, um inibidor de proliferação 
celular. Por outro lado, quando CCBE1 é adicionado a fibroblastos Ccbe1-/-, a sua 
proliferação e viabilidade aumentam.  
O papel de Ccbe1 em migração foi também testado. Os fibroblastos mutantes para 
Ccbe1 apresentaram um carácter mais migratório do que os fibroblastos normais 
e dependente do substrato. Contrariamente, este carácter migratório é reduzido 
quando o ensaio de migração é feito na presença de CCBE1 no meio de cultura. 
Apesar de o mecanismo de ação de Ccbe1 continuar a ser desconhecido, os 
resultados aqui apresentados sugerem que Ccbe1 coordena a adesão celular, 
migração e proliferação, o que sugere que Ccbe1 deverá desempenhar um papel 
fundamental na matriz extracelular. 
 
 
Palavras-chave: Ccbe1, células estaminais embrionárias, cultura de células, 
goma semente alfarroba, nanofibras, suporte de crescimento substituto da 
gelatina 
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ABSTRACT  
 
Self-renewability and the ability to differentiate into various functional cells are 
characteristics of embryonic stem cells (ESCs) that make them attractive for 
applications in biomedical field, namely in restoring the function of damaged 
cells/tissues. In research, ESCs are usually cultured in gelatin or over a monolayer 
of mitotically inactivated mouse embryonic fibroblasts (MEFsi). The latter is the 
gold standard to maintain pluripotent ESCs in culture. A variety of alternative 
technologies have been suggested to control stem cell fate and function, but 
examples of versatile, non-animal derived and inexpensive materials able to 
support pluripotent ESCs are limited. To circumvent this, we aimed to find a 
biomaterial able to support pluripotent ESC cultures that would avoid the laborious 
and time consuming parallel culture of MEFsi and as simple to handle as gelatin. 
There is an increasing interest in regulating stem cells under a specific 
microenvironment using biomaterials as artificial extracellular matrices (ECMs) to 
control their self-renewability and differentiation capacity. In the present work we 
developed and tested the applicability of two biomaterials, one natural and one 
synthetic polymer, to support mouse ESC (mESC) culture. Accordingly, 
undifferentiated mESCs were cultured in coatings of Locust Bean Gum (LGB) and 
of a new synthetic nanofiber (nf) material based on the self-assembly of a triblock 
copolymer, poly (ethyleneglycol-β-trimethylsilyl methacrylate-β-methacrylic acid), 
conjugated with the peptide Glycine-Arginine-Glycine-Aspartate-Serine. According 
to our data, compared to conventional stem cell culture methodologies, ESCs 
grown in LBG and nanofiber coatings maintained their self-renewability and tri-
lineage differentiation capacity even after long term culture.  
In parallel, this work also comprises the functional study of collagen and calcium-
binding EGF domains 1 (Ccbe1) using primary fibroblasts as a tool. It has been 
shown that Ccbe1 is involved in lymphangiogenesis, cardiogenesis and 
carcinogenesis, however, its function and molecular action remains unknown. The 
data presented here suggests that Ccbe1 coordinates cell adhesion, migration and 
proliferation, thus playing a key role in the ECM. 
 
Keywords: Ccbe1, cell culture, embryonic stem cells, gelatin substitute growth 
support, locust bean gum, nanofibers.  
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1.  INTRODUCTION 
 
In 1981, a major breakthrough occurred in science, especially in the field of 
developmental biology, with the isolation of embryonic stem cells from the inner 
cell mass of the blastocyst (Evans and Kaufman, 1981; Martin, 1981). Although 
the research on adult stem cells began about 60 years ago with the discovery of 
stem cells in the bone marrow, the techniques for culturing mouse embryonic stem 
cells were first reported only 30 years ago (Evans and Kaufman, 1981; Martin, 
1981) and versions of these seminal procedures are still used today as standard 
procedures. 
ESCs have capacity to self-renew and to differentiate, theoretically, into all tissues 
types that constitute the living organism. Therefore, stem cells are a potential cell 
source for tissue engineering and cell therapy applications (Gepstein, 2002; Nelson 
et al., 2010; Weiss, 2013; Wollert and Drexler, 2005). Despite that the major 
advances in cell culture techniques occurred since 1981, almost all tissue cells 
have been studied in Petri dishes, multi-well plates or glass slides coated with 
different substrates. However, all of these could differ radically from the three-
dimensional (3D) microenvironment in the body and, consequently, cells isolated 
from tissues of higher organisms frequently modify their metabolism, morphology 
and gene expression profile as an adaptation process to the culture conditions 
(Gelain et al., 2006; Hutmacher et al., 2009; Ouyang et al., 2007; Petersen et al., 
1992; Santos et al., 2012; Von Der Mark et al., 1977). Furthermore, up to date 
the existing two-dimensional (2D) and 3D culture systems formed from animal-
derived biomaterials contain residual growth factors and undefined constituents 
that make it difficult to use them in human regeneration or replacement therapies. 
 
1.1. Cell culture  
1.1.1. Concepts and Historical background 
Tissue culture (a generic term to include organ culture and cell culture) was first 
defined at the beginning of the twentieth century as a method for studying the 
behavior of animal cells free of systemic variations that might arise in vivo both 
during normal homeostasis and under the stress of an experiment (Freshney, 
2005). The culture of cells from such primary explants of tissue dominated the 
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field for more than 50 years, so it is not surprising that the term ‘‘tissue culture’’ 
has remained in use as a generic term despite the fact that most of the evolution 
or expansion in this area in the second half of the twentieth century was made 
possible by the use of dispersed cell cultures (Freshney, 2005). Indeed, the term 
cell culture is applied when the cells are removed from the organ fragments prior 
to, or during cultivation, thus disrupting their normal relationships with 
neighboring cells, are cultured in aseptic laboratory in similar environmental 
conditions to in vivo (Freshney, 2005). Disaggregation of explanted cells or cells 
that were surgically removed from an organism and subsequent plating out of the 
dispersed cells so they can attach, divide and grow, was first demonstrated by 
Rous and was called primary culture (Rous and Jones, 1916). The concept of 
passaging, also known as subculture or splitting cells, which involves transferring 
a small number of cells into a new vessel, become more evident in 1950s with the 
generalization of trypsin use, following procedures described by Dulbecco 
(Dulbecco and Vogt, 1960). 
Although animal cell culture was first successfully undertaken by Ross Harrison in 
1907 with culture of frog nerve cells (Harrison, 1907), it was only until from the 
late 1940’s to early 1950’s that several developments occurred that made cell 
culture widely available as a tool for scientists. Since the 1950s, further 
optimization of the culture conditions consisted on the use of antibiotics in the 
culture media, which facilitated long-term cell line propagation (Perlman, 1979) 
and avoid many of the contamination problems that plagued earlier cell culture 
attempts. The development of the techniques, such as the use of trypsin to remove 
cells from culture vessels was fundamental to obtain continuously growing cell 
lines and colonies of animal cells derived and developed subcultures from a primary 
cell culture. The 1950s were also the years of the development of standardized 
and chemically defined cell culture media, which led ultimately to the development 
of serum-free media (Jayme et al., 1997). Recently, the efforts made to develop 
alternative supports, scaffolds and coatings provide a widespread increase of 
quality and a promising future for laboratories and industries that use cell culture 
as a tool. The stimulus from medical science carried out interest into warm-blooded 
animals. In warm-blooded animals both normal and pathological development are 
closer to that found in humans, which encouraged scientists to perform substantial 
efforts towards the development of in vitro biomimetic environments. The 
accessibility to different tissues, many of which grew well in culture, made the 
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embryonated hen’s egg a favorite choice; but the development of experimental 
animal strains, particularly with genetically pure strains of rodents, brought 
mammals to the forefront as the favorite material. The development of transgenic 
mouse technology, together with the well-established genetic background of the 
mouse, has added further impetus to the selection of this animal as a favorite 
species (Freshney 2005). 
 
 
1.1.2. Cell culture applications  
Cell culture has become one of the major tools used in the life sciences today. 
There are two major advantages in cell culture. One is the control of the 
physiochemical environment (pH, temperature, osmotic pressure, and O2 and CO2 
tension), which can be controlled very precisely, and the physiological conditions 
like the control of hormone and nutrient concentration in the culture medium. The 
other main advantage is the characterization and homogeneity of sample. After 
one or two passages, cultured cell lines tends to assume a homogeneous (or at 
least uniform) constitution, as the cells are randomly mixed at each transfer and 
the selective pressure of the culture conditions tend to produce a homogeneous 
culture of the most vigorous cell type. Hence, at each subculture, replicate samples 
are theoretically identical to each other, and the characteristics of the cell line may 
be perpetuated over several generations (Freshney 2005). In addition, the 
possibility to perform in vitro modeling of in vivo conditions avoids moral and 
ethical questions of animal or human experimentation. Furthermore, in terms of 
costs, scale and mechanization, the cultures may be exposed directly to a reagent 
at a lower and defined concentration, so fewer reagents are required in comparison 
to the use in vivo.  
The fields of research that lend themselves particularly to cell and tissue culture 
are summarized in Fig. 1.1: 
- Intracellular activity, e.g., the replication and transcription of 
deoxyribonucleic acid (DNA), cell cycle, protein synthesis, energy 
metabolism, and drug metabolism; Ribonucleic acid (RNA) flux, the 
translocation of hormone receptor complexes and resultant signal 
transduction processes, and membrane trafficking;  
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- Microenvironmental interaction, e.g., nutrition, infection, cytotoxicity, 
carcinogenesis, drug screening and its metabolism, ligand–receptor 
interactions, therapeutics and diagnostics; 
- Cell–cell interaction, e.g., morphogenesis, paracrine control, cell proliferation 
kinetics, metabolic cooperation, cell adhesion and motility, matrix interaction, 
and organotypic models for medical prostheses and invasion;  
- Genetics, including genome analysis in normal and pathological conditions, 
gene therapy, genetic manipulation, differentiation, prenatal diagnosis and 
genetic counseling;  
- Cell products and secretion, biotechnology, proteomics, bioreactor design, 
product harvesting and downstream processing for production of 
pharmaceutical drugs, vaccines (viruses), recombinant or genetically 
engineered proteins, monoclonal antibodies. 
Despite all the advantages, the cell culture techniques imply a high level of skills 
and understanding on the part of the operator in order to recognize the 
requirements of the system and to diagnose problems as they arise. 
 
 
 
 
 
Figure 1.1: Cell culture applications. Cell culture techniques are used in cell and 
molecular biology research and studies. Some of the important areas where cell culture 
plays an important role are toxicity testing, cancer research, virology, gene therapy, drug 
discovery and tissue constructs.  
CELL-CELL INTERACTION 
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The higher limitations of cell culture is the cost in effort and in materials that goes 
into the production of relatively little amount of cells and the loss of the phenotypic 
characteristics typical of the tissue from which the cells had been isolated 
(dedifferentiation). Furthermore, regarding origin of cells, if differentiated 
properties are lost it is difficult to relate the cultured cells to functional cells in the 
tissue from which they were derived (Freshney 2005). 
Another common problem observed in continuous culture of cell lines is 
chromosomal instability. Even with short-term cultures of untransformed cells, 
heterogeneity in growth rate and the capacity to differentiate within the population 
can produce variability from one passage to the next (Freshney 2005). 
In sum, animal cell culture technique has played and still plays an important role 
in research and in drug discovery, production of antiviral vaccines and ultimately 
help improving the health and quality of life of patients suffering from life 
threatening diseases like cancer or genetic disorders. 
 
 
1.1.3. Embryonic stem cell culture 
At present, a lot of effort has been made to establish and improve the culture of 
stem cells, in particular culture of embryonic stem cells (ESCs), mainly due to its 
enormous potential. Stem cells can differentiate into more than one kind of cell 
depending on whether it originates from an embryo (tissue precursor cells), 
embryonic stem cells, or from an adult organism also called adult stem cells.   
Embryonic stem cell is an unspecialized cell type that is characterized by their 
ability to generate identical copies of itself (in an undifferentiated state) for 
indefinite periods in culture (self-renewal), and their capacity to give rise to mature 
or specialized cells of a variety of cell types (pluripotency; Lanza 2006; Fig. 1.2). 
Mammalian ESCs are isolated exclusively from the inner cell mass (ICM) of 
blastocysts in a 5 and 3.5-day pre-implantation human and mouse embryo, 
respectively (Kaufman et al., 1983; Thomson, 1998). The blastocyst is a structure 
formed during early embryogenesis of mammals, after the formation of the 
morula, but prior to implantation. It possesses an inner cell mass, or embryoblast, 
which subsequently forms the embryo, and an external layer of cells, or 
trophoblast, which later forms the placenta (Fig. 1.2). The first embryonic stem 
cells explored were mouse embryonic stem cells (Evans and Kaufman, 1981). 
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Mouse derived ESC lines have been cultured and maintained in a feeder cell layer 
of mouse embryonic fibroblasts (MEFs) because they provide a complex mixture 
of nutrients and substrata for the long term growth and proliferation of 
undifferentiated pluripotent ESCs. Since mouse ESCs derivation in 1981 mouse 
ESCs continue to be one of the most used in research as its use does not raise as 
many legal and ethical issues like human ESCs (hESCs). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.4. The potential of embryonic stem cells 
The importance of ESCs for living organisms is unquestionable. The inner cell mass 
gives rise to the entire body of the organism, including all of the many specialized 
cell types and organs, such as the heart, lungs, kidney, pancreatic, skin and germ 
cells e.g. sperm or oocytes. Later in adulthood, stem cells function as a sort of 
internal repair system in many tissues, dividing essentially without limit to 
replenish other cells as long as the person or animal is still alive. Stem cells allow 
EMBRYONIC STEM CELL 
INNER CELL MASS 
BLASTOCYST TROPHOBLAST 
Figure 1.2: Differentiation of embryonic stem cells. Embryonic stem cells are 
obtained from the inner cell mass of a blastocyst. When cultured, these cells can
differentiate into many different kinds of cells, representing the three germ layers. Adapted
from (Panno, 2005). 
ZONA PELLUCIDA 
       BLOOD CELLS         NEURONS      PANCREATIC CELLS     MUSCLE         GERM CELLS 
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blood, bone, gametes, epithelia, nervous system, muscle, and myriad other tissues 
to be replenished by fresh cells throughout life. In some adult tissues, such as 
bone marrow, muscle, and brain, discrete populations of adult stem cells that lie 
dormant can be activated at particular life cycle stages or following injury, to 
replace cells that are lost through normal wear and tear, injury, or disease.  
Taking into account their potential, embryonic stem cells are a powerful tool for 
the study of gene function and regulation, the generation of cellular and animal 
models for human diseases, and the investigation of cell differentiation (Kokron et 
al., 1997). Successful derivation of murine ESCs from ICM of mouse blastocysts 
and subsequent development of a precise gene targeting strategy by homologous 
recombination in ESCs has led to the development of highly sophisticated 
techniques for generation of genetically altered animal models (Keskintepe et al., 
2007). Genetically altered mice represent powerful models to dissect and 
understand complex biological processes, as well as to manipulate gene expression 
towards development of therapeutic strategies for a variety of diseases including 
cancer, inflammatory and infectious diseases, and neurogenetic and cardiovascular 
disorders (Huijbers et al., 2011). Initially, scientists were interested in embryonic 
stem cells because they provided an approach to improve our understanding of 
how the body develops from a fertilized egg, the normal embryo development, so 
to study totipotency and the plasticity of cells during embryonic development. 
Nevertheless, it is clear now that as ESC research the understanding of how tissues 
are specialized, maintained and repaired in health and allow us to understand how 
diseases occur and develop, ESCs may be used to treat and cure a wide variety of 
diseases (Fig 1.3 and 1.4). Furthermore, the most serious diseases, such as cancer 
or congenital defects, are the result of problems in the process of stem cell 
differentiation towards more specialized cells. Therefore, as soon as scientists 
understand better normal cell/tissue development, we will be able to understand 
and perhaps prevent or correct the errors the causes of these medical conditions. 
Stem cells are emerging as one of the fundamental foundations in the field of 
tissue biology. The most powerful potential application of stem cells is in the 
growth organ specific cell type(s) and consequent construction of tissues and 
organs for medical therapies as an alternative to the donated organs and tissues. 
This application of stem cells would solves a medical and social problem because 
today the number of people needing a transplant far exceeds the number of organs 
donated for transplantation. The process of replacing or regenerating human cells, 
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tissues or organs to restore or establish normal function, is refereed as 
regenerative medicine (Mason and Dunnill, 2008). Depending on the source of 
cells, regenerative medicine can potentially solve the problem of organ 
transplant rejection if the organ's cells are derived from the patient's own tissue 
or cells. In that field, the induced pluripotent stem cell (iPS) technology recently 
developed by the Nobel laureate Shinya Yamanaka (Takahashi and Yamanaka, 
2006) may allow the generation of cells/organs genetically tailored to a patient, 
thus eliminating the concern of immune rejection. Up to date, there are several 
successful examples of the use of regenerative medicine, such as the injection 
of stem or progenitor cells (cell therapies), the induction of regeneration by 
biologically active molecules administered alone or as a secretion by infused cells 
to stimulate resident adult stem cells (immunomodulation therapy) and 
transplantation of in vitro grown organs and tissues (tissue engineering). 
 
Figure 1.3: The promise of stem cell research. Stem cell research offers a useful tool 
for unravelling the molecular mechanisms that determine the differentiation fate of a 
pluripotent cell and for understanding the gene expression properties and epigenetic 
modifications essential to maintain the pluripotent state. This knowledge may be used to 
generate cells for transplantation therapies, whereby a specific cell population 
compromised by disease is replaced with new and functional cells. Differentiated 
derivatives of human pluripotent cells are also useful as models for understanding the 
biology of disease and developing new drugs, particularly when there is no animal model 
available for the disease to be studied. Adapted from (Yu and Thomson, 2006). 
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The combined use of pluripotent stem cells and regenerative medicine offers the 
possibility of a renewable cell source of replace cells and tissues in order to treat 
numerous diseases, conditions, genetic and degenerative disorders (Fig. 1.4). 
Among them, Parkinson's disease, amyotrophic lateral sclerosis, spinal cord injury, 
multiple sclerosis, age-related functional defects, hematopoietic and immune 
system disorders, heart failures, chronic liver injuries, burns, lung disease, 
diabetes and arthritis can be treated trough stem cell-based therapies and are 
currently being developed (Fig. 1.4.) (Diekman et al., 2012; Hsu et al., 2012; 
Tewarie et al., 2008; Weiss, 2013). The culture of stem cells makes possible the 
production of tissues and cells for transplantation, for example, pancreatic islet 
cells for diabetes, heart muscle cells for heart disease, nerve cells for Parkinson or 
Alzheimer’s disease and hematopoietic stem cells or bone marrow for leukemia or 
other blood disorders and chemotherapy (Fig. 1.4). In general, ESCs can be 
applied in both scientific research and medical fields, such as in discovery science 
(human development, pathobiology, genotype/phenotype and molecular 
mechanisms), diagnostics (regenerative potential, drug toxicology, individualized 
medicine) and therapeutics (congenital or acquired heart disease, regenerative 
biologics, immunity and innate rejuvenation). 
 
 
Figure 1.4: Potential medical applications of stem cells. Diseases and conditions 
where stem cell treatment is promising or emerging. Human model from “Bodies – The 
Exhibition”. 
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The most attention-grabbing breakthroughs in stem cell science involve the 
promise of its use in regenerative medicine (cell and tissue transplantation), as 
well as, application in pre-clinical models for drug development, and as “disease 
in a culture dish” models for testing drug efficacy and mechanistic studies. Other 
significant benefit of stem cell technologies is the possibility to develop in vitro 
models using human-derived stem cells, that hold a great potential for the 
development of biologically relevant models for evaluating the toxicity of 
substances and perform drug screening. Recent progress at incorporating stem 
cell niches into a bioengineered human tissue model is perhaps the most 
interesting development in stem cell field.   
 
 
1.2. Stem cell niche 
The stem cell niche concept was firstly introduced in 1978 (Schofield, 1978) and 
represents the natural microenvironment that surrounds stem cells, i.e. the local 
tissue microenvironment capable of housing and maintaining one or more stem 
cells, which in combination with extrinsic and intrinsic factors, determine the 
behavior and fate of stem cells (Morrison and Spradling, 2008). Until recently, 
niches were a theoretical concept supported by the observation of that 
transplanted stem cells survived and grew only in specific locals. However, such 
structures were recently characterized in diverse tissues of invertebrates and allow 
the establishment of principles that probably coordinate the behavior of niches in 
other organisms. In adult organisms, is thought that the majority of stem cells are 
in a quiescent state, but can be activated by exogenous factors, starting division 
and differentiation and thus contributing to the renewal or repair of tissues or 
organs. Therefore, stem cell niches play a crucial role in maintaining tissue 
homeostasis and tissue repair and regeneration in case of injuries  (Walker et al., 
2009). For instance, neuronal stem cells from central nervous system are located 
in the lateral ventricles in the subventricular zone after embryonic development 
and in the dentate gyrus of the hippocampus in adult brain (Conover and Notti, 
2008). In other cases, the local of stem cells niche can be dynamic, namely the 
localization of cells from hematopoietic system that in steady-state conditions 
reside in bone marrow and occupy facultative niches, distributed in the trabecular 
surface of bone (Morrison and Spradling, 2008). Indeed, hematopoietic stem cells 
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are constantly in circulation from a compartment of bone marrow to other (for 
instance, from femur to tibia). The capacity of activating facultative niches is not 
limited to the hematopoietic system, namely, in adult skin, new hair follicles can 
be formed after injury when nascent follicles arise from epithelial cells outside of 
the hair follicle stem cell niche, which suggests that epidermal cells in the wound 
assume a hair follicle stem cell phenotype (Ito et al., 2007). Furthermore, it was 
also verified that the complexity of spatial organization of ESC in culture, in 
combination with exogenous factors [leukemia inhibitory factor (LIF), fibroblast 
growth factor (FGF) and transforming growth factor beta (TGFβ), supporting cells] 
created niches or heterogeneous microenvironments that influence ESC fate 
(Peerani, 2009). 
In vivo, resident adult stem cells are located in tissue-specific anatomically defined 
clusters called “niches”. The stem cell niche is highly complex and dynamic, 
including both cellular and acellular components, which provides spatial and 
temporal cues to support and coordinate stem cell activities, regulating their cell 
fate (Lund et al., 2009). Extensive studies in numerous laboratories have begun 
to elucidate the critical components of many stem cell niches, which include 
mesenchymal, vascular and inflammatory cell types, diffusible and cell surface-
associated signaling molecules, and physical parameters such as matrix rigidity, 
shear stress, oxygen tension, and temperature (Fig. 1.5). Within the stem cell 
niche, cell fate is thought to be controlled both spatially and temporally, as well as 
through cell-cell and cell-matrix interactions (Nava et al., 2012). The cell-cell and 
cell-ECM interactions not only provide structural support, regulate adhesion and 
produce soluble signals that can control stem cell function, but also provide 
mechanical signals, based on substrate rigidity, which allow stem cells to respond 
to external physical forces (Choi et al., 2011; Sun et al., 2012). In addition, 
acellular or physic elements, such as pH, temperature and shear forces, and 
chemical signals provided by the niche also modulate stem cell behavior in 
response to the external environment (North et al., 2009) (Fig. 1.5). 
In sum, these cellular and acellular components appear to be integrated by stem 
cells to inform their fate decisions, including choices between quiescence or 
proliferation, self-renewal or differentiation, migration or retention, and cell death 
or survival (Wagers, 2012). 
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Figure 1.5: Constituents of a stem cell niche. Stem cell niches are highly complex and 
dynamic, including both cellular and acellular components. In the niche, stem cells are 
exposed to ECM, soluble and immobilized molecules (cytokines, metabolic products), 
support cells, and physical cues (topography, structure, stiffness, static and dynamic 
forces). 
 
 
In vitro, the microenvironment or niche of a cell, comprises the culture substratum, 
i.e. the appropriate culture dish or specifically coated surface, which allow 
attachment and spreading of cells (the contact environment) and the culture 
medium, which represents the diffuse environment. The latter comprises all types 
of soluble molecules – nutrients and salts, hormones and growth factors 
(Gstraunthaler, 2003). Cell-matrix and cell-cell junctions crosstalk, and these two 
junctions cooperatively regulate cell movement, proliferation, adhesion and 
polarization (Sakamoto et al., 2006). 
 
 
 
 
 
 
 
Figure 1.6: Parts of the microenvironment of the mammalian cell regulating its 
behavior in vivo and in vitro. (1) The diffuse environment, which in cell cultures is solely 
provided by the culture medium, (2) the contact environment (cell-matrix adhesion), and 
(3) the junction connections between neighboring cells (cell-cell adhesion). Adapted from 
(Gstraunthaler, 2003). 
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1.3. Biomaterials as structural support for ESC culture 
As mentioned above, the extracellular microenvironment plays a pivotal role in 
controlling stem cell fate responses (Kshitiz et al., 2013). Therefore, to enable 
precise control of the ESC niche it is necessary to control of cell-cell contacts, cell-
ECM interactions, cell-soluble factor interactions as well as mechanical and 
electrical stimuli in a spatiotemporal manner (Khademhosseini et al., 2006b). 
Consequently, identification of appropriate environmental stimuli that support 
cellular proliferation, pluripotency or lineage specific differentiation, is critical for 
the clinical application of the stem cell therapies. 
Even though the first mouse embryonic stem cell lines were derived more than 3 
decades ago and standard protocols for ESC cultivation are widely used today, 
many efforts are being made to mimic the endogenous microenvironment of cells 
in a body. The ultimate goal is to find an approach that is closest to the in vivo 
situation, but where the functional properties of cells can be easily observed and 
manipulated (Gelain et al., 2006). To the researcher, a suitable culture 
environment is one that does more than just allow cells to survive in culture. 
Instead it usually means an environment that at the very least allows cells to 
increase in number by undergoing cell division. Indeed, when conditions are the 
adequate, some cultured cells will express their “wellness” with their environment 
by carrying out important in vivo physiological or biochemical functions, such as 
muscle contraction or the secretion of hormones and enzymes. Therefore, a 
number of engineering approaches such as surface modifications, coatings and 
scaffolds have been applied in an attempt to control the ESC niche (Edalat et al., 
2012). 
ESCs are anchorage-dependent cells and hence they require a good substrate for 
attachment and growth. Feeder cells such as xenogenic MEFsi are commonly used 
and necessary for the in vitro maintenance and growth of many cell types, in 
particular ESCs (Hu et al., 2012; Khademhosseini et al., 2006a) or induced 
pluripotent stem cells. In this approach, MEFsi are a niche-supporting cells 
providing a suitable microenvironment for maintenance and growth of 
undifferentiated ESCs due to their ability to supply growth factors like LIF, activin, 
bone morphogenetic proteins (BMPs), insulin-like growth factor, and cytokines and 
extracellular matrix proteins, such as laminin, fibronectin and vitronectin (Peerani, 
2009). Nevertheless, animal-derived feeder cell-based culture methods can cause 
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unexpected disadvantages such as uncertain data outcomes, xenotransmission of 
unknown pathogens and may impede the establishment of stable culture 
conditions. Consequently, the development of non-cellular niches for defined stem 
cell culture systems has become a priority. Several approaches have been 
developed to control the morphology and function of cultured ESCs by the design 
of the culture surface. In 1987, Prof. David F. Williams and a group of experts 
defined biomaterial as “all substances (other than drugs) designed to become in 
contact with biological systems with the aim to evaluate, treat, raise or replace 
any tissue, organ or function of the organism” (Williams, 1987). Since then, a high 
diversity of biomaterials have been developed for tissue engineering and to serve 
as support to a stem cell niche in vitro. These materials function as platforms for 
cell attachment, migration, proliferation and differentiation.  
 
 
 
 
 
 
 
 
 
 
Biomaterials can present a variety of structures depending on their composition 
and processing methods. In general, the modification of culture surfaces comprises 
chemical modifications, biofunctionalization and geometric or topographic 
modifications (Fig. 1.7) (Mashayekhan and Miyazaki, 2011). 
Concerning the chemical modifications, treated plastics are the most commonly 
used substrates. Plasma-modified tissue culture polystyrene (TCPS) is widely used 
in cell culture for an ample range of different cell types (Biazar et al., 2011; Sasai 
et al., 2009). On the other hand, Salgado et al proposed a new concept of 
miniaturized device for combinatorial screening of chemical composition and 
cytocompatibility of biomaterials. For that, they demonstrated that polystyrene 
(PS) can be used to produce superhydrophobic surfaces and further UV/ozone 
irradiation modify the wettability of such substrates up to the superhydrophilic 
regime, using hollow photomasks to generate spot regions in which biomaterials 
SURFACE
COATING
FUNCTIONALIZATION /
CHEMICAL MODIFICATION
TOPOGRAPHIC MODIFICATION
Figure 1.7: Surface modifications as a general approach for controlling ESC fate.
The growth surface can be improved by chemical modifications, immobilization of
bioactive molecules or attachment factors, coating with an attractive matrix regarding
the cells under study and by introducing three-dimensionality to cell culture. 
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can be then dispensed and tested (Salgado and Oliveiraz, 2012). Furthermore, 
hydrophobic surfaces were also used for enhanced differentiation of embryonic 
stem cell-derived embryoid bodies (Valamehr et al., 2008). On the other hand, 
immobilization of bioactive molecules or attachment factors, such as collagen, 
gelatin, fibronectin and laminin, can be used depending on the main purpose of 
the culture as substrate coatings to improve growth and function of normal cells. 
These biomolecules can be simply adsorbed onto the material’s surface or 
covalently linked via chemical groups previously created on the surface.  
Biomaterials from animal sources like gelatin, collagen gels, 
polyglycosaminoglycans and MatrigelTM are examples of surfaces widely used for 
stem cell culture that, besides the good results in terms of cell growth, cannot be 
used for transplantation therapies because of the possibility of containing residual 
undefined components or impurities and consequently promote immunity 
responses (Greenlee et al., 2005; Mallon et al., 2006). In addition, despite that 
animal-derived biomaterials present multiple ligands which enhances surface 
functionality, they do not completely mimic the highly complex embryonic stem 
cell niche. In most cases, the immobilization or adsorption of a coating on the 
vessel growth area is not enough to create a suitable ESC culture 
microenvironment. In vivo, topographical structures such as grooves and ridges at 
the nano and microscale level are present, such as in the fibrous ECM proteins 
(Fig. 1.8) and the rough mineralized bone, that are difficult to reproduce in vitro. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: An overview of the macromolecular organization of the extracellular 
matrix. ECM is a highly dynamic and complex structure that surrounds and supports cells. 
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Structural ECM proteins consist primarily of the collagen and elastin families of 
proteins. Collagen fibers strengthen and organize the matrix; elastin fibers provide 
flexibility and resilience. Nonstructural ECM proteins, such as fibronectin, laminin, 
and tenascin have an adhesive or integral role; these proteins allow for cell attachment 
and form crosslinks within the matrix gel. Finally, numerous proteoglycans and heparan 
sulfate-containing proteins form the hydrated, gel-like mixture that stabilizes the matrix 
within its aqueous environment. Adapted from (Campbell and Reece, 2005). 
 
  
Many efforts have been made in the last decade to engineer substrate materials’ 
topography to promote stem cell responses, at both the cell and tissue levels (Park 
et al., 2007). Numerous methods can be used to fabricate or engineer materials, 
however the most widely used techniques are those that allow the development of 
nanofibrous systems, tubes or meshes, which have the potential to provide 
enhanced cell adhesion by virtue of the similarity of their 3D architecture to natural 
ECM. Currently, there are several techniques available for the synthesis of 
nanofibers: electrospinning, melt-blow, self-assembly, injection molding, template 
synthesis and phase separation. Of these techniques, electrospinning, followed by 
self-assembly, are the most widely studied techniques and has also demonstrated 
the most promising results in terms of tissue engineering applications (Vasita and 
Katti, 2006). Accordingly, the results reported in Alam Nur-E-Kamal et al study 
constitute the first demonstration that a 3D nanofibrillar surface composed of 
electrospun polyamide nanofibers (Ultra-Web®) can promote the proliferation and 
self-renewal of mESCs. The data highlight the role of dimensionality in maintaining 
stemness in proliferating mESCs and suggest that nanofibers may provide an 
important new tool for promoting stem cell proliferation for applications in 
regenerative medicine (Nur-E-Kamal et al., 2006). In another report, Anli Ouyang 
et al concluded that the smaller-pore polyethylene terephthalate fibrous matrix 
produced by electrospinning technique is favorable for growing and maintaining 
undifferentiated ESCs (Ouyang et al., 2007). Another easy and versatile technique 
to produce fibers (and other structures) is by self-assembly of block copolymers. 
Self-assembly is a “bottom up” approach, that refers to the spontaneous 
association of numerous individual entities into a coherent organization and well-
defined structures to maximize the benefit of the individual parts without external 
instruction; it is reversible, and can be controlled by the proper design of the 
components, the environment, and the driving force (Pelesko, 2007). A block 
copolymer is a polymer derived from more than one species of monomer and is 
formed when the different monomers cluster together giving rise to 'blocks' of 
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repeating units. Because of the block architecture, the copolymers can self-
assemble into a variety of different morphologies (Fig. 1.9). Variation of block 
length allows the adjustment of the typology and size of these structures on a 
scale between 1 nm  and 10 µm (Förster and Plantenberg, 2002). 
Figure 1.9: Block copolymer microstructure formed in bulk and solutions by self-
assembly. Self-organization of block copolymers give rise to structures with different 
shapes, such as spherical micelles, cylindrical micelles, vesicles and simple lamellae. 
Adapted from (Förster and Plantenberg, 2002). 
 
 
Several factors have to be considered when designing the appropriated cell or 
tissue culture support, i.e. fabrication cost and easiness, porosity, biocompatibility, 
cytotoxicity, fluid transport for the exchange of gases and nutrients, biochemical 
and mechanical properties and biodegradability, depending on the intended degree 
of cell-materials interaction. A wide range of biomaterials have been developed for 
different cell and tissue culture applications. These biomaterials can be divided into 
three major classes: polymers (natural or synthetic), metals and ceramics (Bhat 
and Kumar, 2012). 
 
 
1.4. Natural biomaterials for ESC culture 
For several decades, ECM from natural sources has served as an important tool for 
biologists. In fact, the development of natural biomaterials has existed for 
centuries and natural polymers are considered the first biodegradable biomaterials 
used clinically (Ige et al., 2012). Biopolymers or natural polymers are an attractive  
class of polymers since they are derived from natural sources, relatively easily 
available and cheap and can be chemically modified. Natural polymers can be 
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classified as proteins, polysaccharides or polynucleotides. Proteins and 
polysaccharides play several roles in vivo and thus make such materials attractive 
for cell or tissue engineering applications. Additionally, due to their natural origin, 
usually these polymers presented components containing sites for cellular 
adhesion and tend to be biocompatible.  
The use of natural products as a biomaterial is currently undergoing a resurgence 
in the biomedical field and biopolymers have received particular attention as tissue 
engineering substrates for both 2D and 3D cell culture (Jana et al., 2011). 
Furthermore, natural polymers are widely used because they inherently possess 
adhesive ligands and their cellular origin, similarities with the ECM and their 
biological activity properties promote cellular adhesion, interaction and further 
improvement of cell’ performance in biological system. For this same reason, 
natural polymers can be disadvantageous in isolating certain cell responses. Other 
limitations of natural polymers include the lot-to-lot variability in molecular 
structure depending on the source and producer, as well as the need to ensure the 
purity of the polymer in case of replacement therapies to avoid immunogenic 
response.  
 
1.4.1. Protein-based biomaterials 
One of the main functions of proteins is to provide structure to tissues and this 
property suggests that protein-based biomaterials would be suitable for tissue 
engineering applications involving stem cell differentiation and transplantation. 
Protein-based biomaterials such as collagen, elastin, gelatin and fibrin are widely 
used as cell culture coatings or matrices as they make up much of the body’s 
native ECM (Sell et al., 2010). 
 
1.4.1.1. Gelatin and Matrigel® 
Gelatin and Matrigel®, commonly used as support of ESC culture (Greenlee et al., 
2005), are heterogenous materials composed of complex protein mixtures. Gelatin 
is an animal-derived material produced by partial hydrolysis of collagen extracted 
from boiled bones, connective tissues and organs of animals, and this poses 
problems for use in cell replacement therapies (Gorgieva and Kokol, 2011). On the 
other hand, Matrigel® matrix is a reconstituted basement membrane preparation 
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that is extracted from the Engelbreth-Holm-Swarm mouse sarcoma, a tumor rich 
in ECM proteins. This material, once isolated, is approximately 60% laminin, 30% 
collagen IV, and 8% entactin, but also contains uncharacterized number of growth 
factors that varies substantially between batches (Hughes et al., 2010). Therefore, 
these biomaterials have limited applications for cell or tissue replacement 
therapies due to viability and to the immunogenic response that can occur 
following implantation associated with their animal-derived source.  
 
1.4.1.2. Fibrin and Collagen 
Fibrin and collagen are two major components of ECM microenvironment 
commonly used as biopolymers in tissue engineering due to their availability, 
scaffolding function, and bioactive qualities (Beier et al., 2009; Couet et al., 2007). 
Fibrin biopolymer has a structural role and is a biochemical stimulant of the wound 
healing response (Janmey et al., 2009). On the other hand, collagen is 
characterized by a high stiffness and tensile strength that imparts resistance to 
tensile and shear loads in soft tissues (Viguet-Carrin et al., 2006). Therefore 
collagen, fibrin or collagen-fibrin composites are used clinically in drug delivery 
(Nishimura et al., 2013) and as a surgical sealant (Moench et al., 2010), as well 
as supportive materials for cell culture (Lee et al., 2010), skin (Han et al., 2010) 
and vascular tissue engineering (Cummings et al., 2004). An advantage of using 
solubilized collagen and fibrin in tissue engineering is that they can be molded and 
reconstituted into essentially any desired geometry, however some authors alerted 
that mechanic properties of collagen-fibrin gels may not be plastic enough to mimic 
some tissues (Lai et al., 2012). 
 
1.4.2. Polysaccharide-based biomaterials 
Polysaccharides, polymeric carbohydrate molecules composed of long chains 
of monosaccharide units bound by glycosidic bonds, are extensively used in recent 
years in biomedical and pharmaceutical applications. Polysaccharides represent 
one of the most abundant industrial raw materials. Their sustainability and intrinsic 
properties such as biodegradability and biodegradability, make them an interesting 
subject of intensive research. In addition, polysaccharides have interesting 
physical properties (film-forming, gelling and thickening properties) that allow 
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their use in different applications and its processing in different forms such as 
beads, films, capsules and fibers (Rinaudo, 2008). Some of the most commonly 
used polysaccharide-based scaffolds and coatings used for stem cell culture and 
differentiation include agarose, alginate, hyaluronan, starch, carrageenans, guar 
and xanthan gum and chitosan.  
 
1.4.2.1. Agarose and Alginate 
Agarose, which is isolated from red algae and seaweed, is commonly used as a 
medium for cell culture in the form of agar and as a platform for motility (Mousseau 
et al., 2007) or chemotactic invasion assays (Wiggins and Rappoport, 2010). One 
of the attractive properties of agarose is that its stiffness can be altered, allowing 
for tuning of the mechanical properties of the scaffold. Therefore, agarose scaffolds 
have been used to culture eukaryotic cells (Gordeev et al., 2012), in combination 
with mesenchymal stem cells for differentiation in chondrocytes (Schmitt et al., 
2012) or with induced pluripotent stem cells (iPS) for cartilage defect repair 
(Diekman et al., 2012). Furthermore, Sigma Life Science developed the 3D Petri 
Dish®, composed of agarose, which maximizes cell-to-cell interactions. It 
comprises a broad selection of micro-molds used to form applicable culture formats 
for the creation of spheroids, gliomaspheres, hepatospheres, chondrospheres, 
osteospheres, cell aggregates, neurospheres, cardiospheres and embryoid bodies.  
Alginate is one of the most studied and applied polysaccharidic polymers in tissue 
engineering and drug delivery field, mainly due to its pH-sensitive property.  In 
general, alginate is modified or combined with other polymers to form hydrogel 
matrices, microspheres or micelles beads (H. Liu et al., 2008) and used for 
cartilage (Dobratz et al., 2009), bone (Suárez-González et al., 2010) and vascular 
tissue engineering (Lee et al., 2003), and also to obtain platforms for toxicology 
screenings (Lan and Starly, 2011). AlgiMatrixTM is an animal-free product and a 
ready-to-use sponge that allows cells to invade the pores and secrete endogenous 
ECM components that support in vivo-like morphologies, structures and behaviors. 
AlgiMatrixTM provides formation of vascularized embryoid bodies (EBs) (Gerecht-
Nir et al., 2004) and is applicable for development of cardiac co-cultures (Dar et 
al., 2002) (Fig. 1.10). 
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1.4.2.2. Starch  
Starch, which is the major dietary source of carbohydrates, is used in medicine 
based on its adhesive, thickening, gelling, swelling and film-forming properties, as 
well as its ready availability, low cost and controlled quality. Starch chemical 
structure can be variable concerning its origin. Most starches are composed of two 
kinds of polysaccharides, a linear α-(1→4) linked glucan, called amylose, and an 
α-(1→4) linked glucan with 4.2 to 5.9% α-(1→6) branch linkages, called 
amylopectin (Fig 1.11 A). Starch is mainly used in pharmaceutical applications as 
excipient, tablet disintegrant, hydrogel, microcapsules, nanoparticles and a few 
reports describe the use of starch as a biomaterial for bone-tissue engineering 
(Salgado et al., 2004) or for culture of fibroblasts (Reddy and Yang, 2009) (Fig. 
1.11 A, B).  
 
  
 
 
 
 
Figure 1.11: Starch chemical structure and culture of fibroblasts and osteoblasts 
in starch-derived supports. A. Chemical structure of a segment of amylose (simple or 
C  
 
 
 
D   
 
A  
 
 
 
B   
 
Figure 1.10: Cell culture in agarose and alginate. A-B. MicroTissues® 3D Petri 
Dish® micro-mold for spheroids. A. Autoclavable precision micro-mold to cast 3D Petri Dish 
for forming larger spheroids. B. Human mesenchymal stem cells seeded on the 3D Petri
Dish used to form large EBs or spheroids. C. Scanning electron microscopy (SEM)  of 
cardiac cells morphology within alginate scaffolds at day 3 postseeding (Dar et al., 2002). 
D.  SEM of LF120 alginate scaffolds seeded with hESCs and cultured for 1 month with hEBs
developed mainly within the confining scaffold pores (Gerecht-Nir et al., 2004). 
 
 
   A                               B                                   C 
General Introduction 
24 
 
unbranched starch) adapted from (Robyt, 2008). B. SEM images showing the attachment 
of mouse fibroblasts on the starch acetate fibers, 5 days after seeding (Reddy and Yang, 
2009). C. SEM of starch-based scaffolds showing human osteoblast-like cells colonizing the 
inner regions of the scaffolds and collagen fibril deposition, indicating the possible 
deposition of bone extracellular matrix (Salgado et al., 2004) 
 
 
1.4.2.3. Chitosan 
Chitosan is an animal derived linear polysaccharide, composed of glucosamine and 
N-acetyl glucosamine units linked by β (1–4) glycosidic bonds (Fig. 1.12 A). 
Chitosan, the fully or partially deacetylated form of chitin, has also attracted much 
attention in tissue engineering and drug delivery research fields with a wide variety 
of applications ranging from skin (Hilmi et al., 2013), bone (B Malafaya et al., 
2005), cartilage (Yang et al., 2011) and vascular grafts (Qiu et al., 2009) to fibrous 
substrates for fibroblasts (Nie et al., 2012), mesenchymal stem cells (Yang et al., 
2011), adipose tissue derived-stem cells (B Malafaya et al., 2005), osteoblasts and 
chondrocytes (Lahiji et al., 2000), cardiomyocytes (Karp et al., 2006)  and 
neuronal (Wang et al., 2009) cell culture (Fig. 1.12 B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12. Chitosan chemical structures and its applications in cell culture. A. 
Chemical structure of chitosan. B. SEM microphotographs showing the morphology of cells 
isolated from adipose tissue seeded on chitosan particle agglomerated scaffolds and 
cultured for 2 weeks under chondrogenic conditions (B Malafaya et al., 2005). C. The 
scanning electron micrograph of Schwann cells cultured on the oriented chitosan nanofiber 
mesh sheet. (Wang et al., 2009) D. SEM microphotographs of mesenchymal stem cells 
attached on PLCL/chitosan scaffold taken 16h postseeding (Yang et al., 2011). E. SEM 
micrograph of human dermal fibroblasts covering the pores of chitosan at day 14 (Hilmi et 
al., 2013). 
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1.4.2.4. Hyaluronan 
Hyaluronan, also known as hyaluronic acid (HA), is a polymer of disaccharides 
composed of D-glucuronic acid and D-N-acetylglucosamine, linked via alternating 
β-1,4 and β-1,3 glycosidic bonds (Fig. 1.13 A). HA is one of the major components 
of the extracellular matrix; it is present in connective tissue, in the synovial fluid 
of articular joints and in the vitreous humor of the eye. HA is important in many 
biological processes such as tissue hydration, cell differentiation, cell behavior and 
tissue repair. HA contains sites for cell adhesion and its upregulation during 
embryogenesis, suggest its suitability as a scaffold material for the culture of ESCs 
(Gerecht et al., 2007; Ramírez et al., 2011). Other approaches have combined HA 
derivated scaffolds with keratinocytes, fibroblasts, and endothelial cells for 
engineering skin (Tonello et al., 2005). HA has been also used for adipose tissue 
engineering (Halbleib et al., 2003) and for cartilage (Lee et al., 2012) and bone 
regeneration (Kim et al., 2007). Hyaluronan is available for several applications, 
such as, for lubrication and mechanical support for the joints in osteoarthritis 
(Hyalgan® and Hyalubrix®), as well as, culture media for in vitro fertilization 
(EmbryoGlue® from Vitrolife, USA) 
 
     
 
 
 
 
 
 
Figure 1.13: Chemical structure and application of hyaluronan. A. Chemical 
structure of hyaluronan. B. Distribution of human adipocyte precursor cells inoculated in a 
Hyaffs® scaffold for 36 days (Halbleib et al., 2003). 
 
 
1.4.2.5. Xanthan, Gelan and Locust bean gum 
Xanthan gum, a microbial desiccation-resistant polysaccharide prepared 
commercially by fermentation of Xanthomonas campestris, was firstly used as a 
solidifying agent for plant tissue culture media (Jain and Babbar, 2006). Nowadays, 
A                                   B                                           
General Introduction 
26 
 
xanthan gum has been successfully used in fabrication of matrices with uniform 
drug release characteristics and also carboxymethyl xanthan gum polysaccharide 
has been investigated as an artificial matrix for the encapsulation of chondrocytic 
cells (Mendes et al., 2012). On the other hand, gellan gum, a polysaccharide 
manufactured by microbial fermentation of the Sphingomonas paucimobilis 
microorganism, was used primarily as a gelling agent, alternative to agar, in 
microbiological and plant tissue culture (Jain et al., 2005). Nowadays, gellan gum 
has been presented as a biomaterial for culture of mammalian cells in hydrogel 
systems (Smith et al., 2007) and for cartilage tissue engineering (Oliveira et al., 
2010). 
Locust bean gum, or LBG, is a galactomannan extracted from the seeds of the 
carob tree, and displays a number of appealing characteristics for 
biopharmaceutical applications, among which its high adhesiveness and gelling 
capacity. LBG was the first galactomannan used both industrially (paper, textile, 
pharmaceutical, cosmetic and other industries) and in food products (ice cream 
and other preparations). LBG is widely used in drug delivery systems (Manjanna 
et al., 2013) and in biopharmaceutical applications (Dionísio and Grenha, 2012), 
however its potential use in ESC culture remained unexplored. 
 
In sum, natural polymers offer the advantage of being very similar, often identical, 
to macromolecular substances present in the human body. Therefore, the 
biological environment is prepared to recognize and interact with natural polymers 
favorably in use in pharmaceutical, cell and tissue engineering applications (Table 
1.1). Despite the wide variety of natural polymers commonly used for culture of 
stem cells for tissue engineering applications few are applicable or tested for 
culture of ESCs. 
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Table 1.1: Summary of natural biomaterials and their applications in cell and tissue 
engineering applications. A, animal; V, vegetal; B, bacterial; S, seaweed 
 
 
Origin 
 
Type of 
material 
 
Cultured cells and (Future) 
applications 
 
 
References 
   
Protein-based biomaterials 
 
 
 
A 
Fibrin 
 
Culture of mesenchymal cells 
(vascular tissue engineering) 
 
Cell migration and invasion assays 
 
 
(O’Cearbhaill et al., 
2010) 
 
(Doillon et al., 2004) 
Collagen 
 
Culture vascular smooth muscle 
cells 
 
Culture of dermal fibroblasts 
(skin engineering) 
 
Cell invasion assays 
 
 
(Cummings et al., 
2004) 
 
(Hu et al., 2010) 
 
 
(Kikuchi et al., 2011) 
 
Fibrin-
Collagen 
 
Culture of Vascular smooth 
muscle cells (vascular 
engineering) 
 
Culture of Myoblasts (engineering 
of skeletal muscle tissue) 
 
Neuronal stem cell culture 
 
(Hong and Stegemann, 
2008) 
 
 
(Beier et al., 2009) 
 
 
(Lee et al., 2010) 
 
Gelatin 
 
Mouse and human ESC culture 
 
(Li et al., 2009) 
 
Matrigel 
(laminin, 
collagen 
IV,entactin) 
 
Mouse and human ESC culture 
 
 
 
Cell motility and invasion assays 
 
 
Cardiac tissue engineering 
 
(Greenlee et al., 2005; 
McElroy and Pera, 
2008) 
 
(Hulkower and Herber, 
2011) 
 
(Li and Guan, 2011; 
Zhou et al., 2013) 
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Table 1.1 (Cont.): Summary of natural biomaterials and their applications in cell and 
tissue engineering applications. A, animal; V, vegetal; B, bacterial; S, seaweed 
 
 
Origin 
 
Type of 
material 
 
Cultured cells and (Future) 
applications 
 
 
References 
 
Polysaccharide-based biomaterials 
 
S Agarose 
 
Culture of eukaryotic cells 
(HeLa, HEK293, H1299 and SC-
1) 
 
Differentiation of mesenchymal 
cells in chrondrocytes and repair 
of cartilage defects 
 
Cell motility and invasion assays 
 
 
(Diekman et al., 2012; 
Gordeev et al., 2012) 
 
 
(Schmitt et al., 2012) 
 
 
 
(Mousseau et al., 2007; 
Wiggins and Rappoport, 
2010) 
 
S, B Alginate 
 
Platform for drug screening 
 
Growing of stem cell spheroid 
culture (embryoid bodies) and 
cardiac co-cultures 
 
(Lan and Starly, 2011) 
 
(Dar et al., 2002; 
Gerecht-Nir et al., 
2004) 
 
V Starch 
 
Drug delivery  
 
 
Culture of fibroblasts 
 
 
Bone tissue engineering 
 
(Santander-Ortega et 
al., 2010) 
 
(Reddy and Yang, 
2009) 
 
(Salgado et al., 2004) 
 
A Chitosan 
 
Cell and tissue culture 
 
 
 
 
 
 
 
Drug delivery 
 
(B Malafaya et al., 
2005; Hilmi et al., 
2013; Karp et al., 
2006; Lahiji et al., 
2000; Nie et al., 2012; 
Qiu et al., 2009; Wang 
et al., 2009) 
 
(Hu et al., 2013) 
 
B Xanthan gum 
 
Drug delivery 
 
 
 
(Mendes et al., 2012) 
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Table 1.1 (Cont.): Summary of natural biomaterials and their applications in cell and 
tissue engineering applications. A, animal; V, vegetal; B, bacterial; S, seaweed 
 
 
Origin 
 
Type of 
material 
 
Cultured cells and (Future) 
applications 
 
 
References 
 
Polysaccharide-based biomaterials 
 
A 
Hyaluronan 
(Glycosmin
oglycan) 
 
ESC culture 
 
 
Mesenchymal and endothelial cell 
culture for skin, adipose, cartilage 
and  bone engineering 
 
(Gerecht et al., 2007; 
Ramírez et al., 2011) 
 
(Halbleib et al., 2003; 
Kim et al., 2007; Lee et 
al., 2012; Tonello et al., 
2005) 
 
 
B Gellan gum 
 
Culture of mammalian cells in 
hydrogel 
 
Cartilage engineering 
 
 
(Smith et al., 2007) 
 
 
(Oliveira et al., 2010) 
 
V Locust bean gum 
 
Drug delivery 
 
 
Biopharmaceutical applications 
 
(Manjanna et al., 2013) 
 
 
(Dionísio and Grenha, 
2012) 
 
 
 
 
1.5. Synthetic biomaterials for ESC culture 
The development of synthetic gels has rapidly advanced during the past decade, 
and has been motivated by the desire to provide better control over the materials 
and their biological properties (Baker and Chen, 2012). Synthetic biomaterials 
offer many advantages, including reproducibility due to their defined chemical 
composition and the ability to control the mechanical properties, degradation rate, 
and shape independently. Synthetic biomaterials include polymer-, peptide- and 
ceramic-based biomaterials (Willerth et al., 2008). Polymer- and peptide-based 
biomaterials are the most commonly used in cell culture. 
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1.5.1. Synthetic peptides 
An example of a peptide-based biomaterial applied in cell culture was presented in 
Klim et al; a substrate of heparin-binding peptide GKKQRFRHRNRKG derived from 
vitronectin, which is recognized by cell-surface glycans, supported long-term 
propagation of multiple hESCs in fully defined conditions (Klim et al., 2010). In 
another study, Kolhar et al demonstrated that both RGD and cyclic RGD (CRGDC) 
can support the culture of hESCs, with CRGDC increasing the adhesion of the ESCs 
over the linear RGD peptide (Kolhar et al., 2010). The use of a self-assembled 
layer of RGD was also reported in Yea et al in a fabrication of a mouse ESC chip 
(Yea et al., 2008). 
 
1.5.2. Synthetic polymers  
Synthetic polymer-based biomaterials represent the largest class of biomaterials 
(Bhat and Kumar, 2012). Synthetic polymers typically possess a structural 
backbone, cell-binding ligands, and a ‘cell-friendly’ crosslinking mechanism. In 
general, synthetic polymers are attractive because they can be fabricated into 
various shapes and are easier to design and manipulate to obtain a desired pore, 
morphologic features and chemical functional groups. Furthermore, the 
geometrical and specific mechanical modifications of synthetic polymers make 
them more suitable to use as a support for ESC culture and further differentiation. 
For instance, a moldable polymer is easily adapted to acquire the specifications of 
the tissue where it will be implanted. Moreover, the possibility of incorporation of 
synthetic polymers with specific degradation is advantageous over the natural 
polymeric systems as e.g. in the scope of drug delivery applications where control 
of release rate is mandatory. However, several synthetic materials are unattractive 
for cell adhesion. In those cases, polymers can be chemically modified or easily 
designed to incorporate specific proteins or ligands such as fibronectin or RGD 
peptides to coat and promote stem cell adhesion and spreading (Bellis, 2011). On 
the other hand, there are still some issues concerning the biocompatibility of 
synthetic polymers and its suitability for transplantation in vivo, as well as whether 
or not the material and its byproducts resultant of degradation can trigger an 
immune response. 
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A wide variety of synthetic polymers has been explored to produce nanofibers and 
hydrogels for culture and tissue engineering. Among the numerous synthetic 
polymers, the most commonly used polymer supports for culture of ESCs are poly 
(lactic-co-glycolic acid) (PLGA) and poly (ethylene glycol) (PEG). Other polymers, 
such as poly (2-hydroxyethyl methacrylate) (pHEMA) and poly (ε-caprolactone) 
(PCL) have been also explored as a coating for ESC culture.   
 
1.5.2.1. Poly (lactic-co-glycolic acid) 
Poly (lactic-co-glycolic acid), or PLGA, has been approved by the American agency 
for public health Food and Drug Administration (FDA), and one of the most 
commonly used polymers to fabricate nanofibers for bone (Chen et al., 2013; 
Curran et al., 2013) and cartilage (Uematsu et al., 2005) tissue engineering and 
controlled drug delivery (Kirby et al., 2011) due its biocompatibility and the ability 
to modulate the degradation rate. In the presence of cells, PLGA scaffolds degrade 
in to their monomers, which are natural metabolites but that can have negative 
effects due to their acidic nature. PLGA scaffolds have been used for engineering 
a wide range of tissues. Several studies have been conducted using orderly PLGA 
fibers to manipulate adhesion (Salamian et al., 2013) and orientation of fibroblasts 
(Hwang et al., 2009) and endothelial cells (Hsueh et al., 2009) for further 
application in recreation of striated tissues, such as cardiac muscle. 
PLGA has also been used to develop in vitro models that mimic in vivo conditions. 
One of those systems consisted in porous PLGA microsphere that was used both 
as a cancer cell culture substrate to expand cells and as a cancer cell 
transplantation vehicle for tumor construction in mice. This 3D tumor model that 
mimics the in vivo environment is ideal for screening anticancer drugs and their 
formulations, and presented an alternative for animal models developing tumors 
(Kang and Bae, 2009). In other study, porous PLGA was also used to produce 
sponges to grow hepatic cells (Hep3B cells) (Zhu et al., 2008). Study of the 
disorders of nervous system is another area where PLGA scaffolds seeded with 
stem cells can be used as a model to study them and develop further possible 
therapies. In a preclinical test, PLGA scaffolds were designed to mimic the spinal 
cord and its culture with murine neural stem cells produced an increase in 
functional recovery after traumatic spinal cord injury (Teng et al., 2002). An 
additional study demonstrated that hESCs seeded inside of PLGA scaffolds could 
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be directed to differentiate into neurons when treated with the appropriate cues 
(Levenberg et al., 2003). PLGA has also been demonstrated to be a suitable 
scaffold to culture Schwann cells and differentiate neuronal stem cells for further 
transplantation of functional neural tissue in spinal cord injury (Xiong et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Structure and cellular applications of PLGA. A. Structure of poly(lactic-
co-glycolic acid), x= number of units of lactic acid; y= number of units of glycolic acid. B. 
Cell morphology of mouse L929 fibroblasts on PLGA fibers shows different orientations with 
respect to the long axis of fibers (Hwang et al., 2009). C. SEM micrographs of cross-section 
of porous PLGA microsphere (Kang and Bae, 2009). D.  H&E staining of MCF-7 cells cultured 
on porous PLGA microsphere in spinner flask for 5 days and (Kang and Bae, 2009). E. SEM 
images of Hep3B cells grown on the PLGA sponges after 1 week of culture (Zhu et al., 
2008).  F.  Inner PLGA-derived scaffolds seeded with NSCs. (Teng et al., 2002) G.  SEM of 
PLGA scaffolds without and with differentiating hESCs (Levenberg et al., 2003)  
 
 
1.5.2.2. Poly(ethylene glycol) 
Poly(ethylene glycol), PEG, with high molecular weight versions being referred to 
as poly (ethylene oxide) (PEO), is a commonly used polymer for biomaterial 
applications because they can be chemically modified to contain bioactive 
molecules. PEG has been used as a support tool in cell and tissue culture in various 
shapes, e.g. as coating and as a 3D structure. Sugiura et al reported the 
 B                               C                D                     
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development of dynamically controlled 3D micropatterned cellular co-cultures of 
mESCs and human hepatocellular carcinoma cells, within photocurable and 
chemically degradable PEG-hydrogels, to study a range of cell-culture applications 
related to cell differentiation, tissue engineering and regenerative medicine 
(Sugiura et al., 2013). On the other hand, the PEG-microwell array system 
developed for stem cell culture is a potentially versatile tool for mESC 
differentiation studies and high-throughput stem cell experimentation as it 
demonstrated an improved degree of homogeneity of the resulting aggregate 
populations, therefore establishing a robust protocol for eliciting high EB formation 
efficiencies (Moeller et al., 2008). Furthermore, 3D PEG-based hydrogel matrix 
niche can be used to support expansion and self-renewal of multiple hESC lines 
(Jang et al., 2013). Moreover, in combination with stem cells, PEG-based matrices 
have been evaluated for their suitability as potential replacement for bone, 
cartilage, nerve, liver and vasculature tissue. In one study, a nanostructured array 
of a PEG hydrogel was developed to use as a cell culture platform to guide the 
growth of primary rat cardiomyocytes for potential tissue engineering applications 
(D. H. Kim et al. 2006). Furthermore, the synthesis of polyethylene glycol 
dimethacrylate (PEGdma) from PEG allows the formation of a 3D nanofibrous 
matrix that directs rat mesenchymal stem cell differentiation to vascular cells 
(endothelial and muscle cells) (Wingate et al., 2012). Moreover, PEG scaffolds 
have been investigated in combination with human mesenchymal stem cells for 
adipose tissue engineering and with mouse embryonic liver cells to generate 
hepatocytes (Underhill et al., 2007) for further liver tissue engineering, showing 
the versatility of such scaffolds. 
 
 
 
 
 
 
 
 
 
Figure 1.15: Structure and cellular applications of PEG. A. Chemical structure of 
poly(ethylene glycol). B. Dynamic 3D micropatterned co-culture of mESCs (green) and 
A 
 B                      C              D                        E                 
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HepG2 (red) cells in the photocurable PEG and chemically degradable alginate hydrogel 
(Sugiura et al., 2013). C. EBs grown in microwell array for EB culture until they were 
constrained by the size of the well, yielding a homogeneous culture (Moeller et al., 2008). 
D. Co-culture of mouse embryonic liver cells and fibroblasts encapsulated in RGDS-PEG 
hydrogel randomly and in highly defined architecture and cellular organization (E.) 
(Underhill et al., 2007). 
  
 
1.5.2.3. Polycaprolactone 
Polycaprolactone (PCL) has been used extensively in the biomaterials field and in 
a large range of implants, devices and drug-delivery devices since the 1970s, due 
to its easy manufacturing process and manipulation of its rheological and 
viscoelastic properties (Woodruff and Hutmacher, 2010). Indeed, PCL drew 
attention due to its versatile properties, including tailorable degradation kinetics 
and mechanical properties, ease of shaping and manufacture enabling appropriate 
pore sizes conducive to tissue in-growth, and the controlled delivery of drugs 
contained within their matrix. In addition, functional groups can also be added to 
render the polymer more hydrophilic, adhesive, or biocompatible enabling 
favorable cell responses. An extensive amount of research has been conducted 
using PCL matrices for cell culture and in vitro models applications. Namely, PCL 
nanofiber scaffolds revealed to be suitable for culture, attachment and proliferation 
of rat parenchymal hepatocytes (Lubasová et al., 2010) and kidney epithelial cells 
(Ghasemi-Mobarakeh, 2008). In work done by the Meiners’ lab, fibroblasts, normal 
rat kidney cells and breast epithelial cells were seeded on a PCL nanofibrillar 
matrix. Fibroblasts and normal rat kidney cells displayed the morphology and 
characteristics of their counterparts in vivo and, interestingly, breast epithelial cells 
underwent morphogenesis to form multicellular spheroids containing lumens, 
highlighting the considerable value of PCL scaffold for applications in cell-based 
therapies and studies of cell/tissue function and pathology (Schindler et al., 2005). 
In another study, biofunctionalized PCL scaffold was used to create a 3D 
pharmacokinetic cancer model using a prostate cancer cell line (Hartman et al., 
2010). Several companies develop and commercialize now PCL nanofibers for cell 
culture. These include tissue culture plates with 3D PCL nanofiber scaffold inserts 
from Biotek and CELLTREAT Scientific Products, and there are also aligned or 
randomly oriented PCL nanofibers integrated into standard multi-well cell culture 
dishes for high-throughput cell culture, cancer research, stem cell, and 
regenerative medicine from Nanofiber Solutions™.  
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Scaffold-based tissue engineering aims to promote the repair and/or regeneration 
of tissues through the incorporation of cells and/or biomolecules within a 3D 
scaffold system which can be maintained in vitro culture conditions until 
implantation. So, after established that PCL supports cell attachment, migration, 
growth and differentiation in in vitro models, several studies proceed with the 
implantation of PCL scaffolds containing differentiated cells, to repair defects and 
guide tissue development into a mature and healthy state, using different animal 
models (Martinez-Diaz et al., 2010; Sawyer et al., 2009). 
 
 
  
 
 
 
Figure 1.16: Chemical structure and applications of PCL. A. Chemical structure of 
polycaprolactone (Gunatillake and Adhikari, 2003) B. Structures made from PCL: 
nanospheres (a,b), nanofibers (c,d), foams (e,f), knitted textiles (g,h,i). Selective laser 
sintered scaffold (j-o). Fused deposition modeled scaffolds (p–u). Adapted from (Woodruff 
and Hutmacher, 2010). C. kidney epithelial cells on the electrospun nanofibrous after 7 
days of culture (Ghasemi-Mobarakeh, 2008). D. Confocal sections of a multicellular 
spheroid composed of T47D breast epithelial cells grown on nanofibers. Note the lumen 
extending through the spheroid (Schindler et al., 2005). 
 
 
1.5.2.4. Poly (2-hydroxyethyl methacrylate) 
Poly (2-hydroxyethyl methacrylate), PHEMA, a polymer that forms a hydrogel in 
water, was developed by Drahoslav Lim and Otto Wichterle and patented in 1953 
(Wichterle and Lím, 1960). PHEMA has been used in many biomedical devices since 
the twentieth century and is probably one of the best known biomaterial used 
A 
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today to transplant undifferentiated ESCs or their differentiated derivatives and 
repair an injured part of the organ or tissue (Kopecek, 2009). However, HEMA 
hydroxyl groups often prevent adhesion and spreading of cells, making PHEMA 
poorly recognized by osteoblasts and adherent cells. Therefore, the polymer has 
been modified by blending with hydrophobic materials, such as poly(methyl 
methacrylate) or with natural substrates normally present in the ECM such as 
collagen, to improve cell attachment and proliferation. An extensive amount of 
research has been conducted using PHEMA-based slabs, coatings and hydrogels to 
grow undifferentiated mouse and human ESCs in 2D systems (Horák et al., 2004; 
Kroupová et al., 2006) and to culture neuronal cells in 3D (Shepherd and Parker, 
2011). 
 
 
 
 
 
 
 
Figure 1.17: Chemical structure and applications of PHEMA. A. Chemical structure of 
poly (2-hydroxyethyl methacrylate). B. Compact colonies of mESCs cultivated for 4 days on 
the surface of P(HEMA-co-EDMA) slab in transmitting light (Horák et al., 2004). C. Confocal 
images of primary rat hippocampal cells distributed within pHEMA scaffold processes actin 
(green) nuclei (red) (Shepherd and Parker, 2011) 
 
The development of PHEMA solved a critical piece of the puzzle in tissue 
engineering approaches, which was to find a suitable polymeric material for 
seeding cells and for subsequent growth of tissues. The mechanic and thermo-
responsive properties of Poly(N-isopropylacrylamide) (PIPAAm) and PHEMA allows 
fabrication of functional tissue constructs from designed three-dimensional 
structure of cells using layered method of cultured cells and rapid recovery of cell 
sheets. Therefore, the biological functions and viability of recovered cell sheets is 
maintained, thus allowing practical assembly of tissue structures (Tang et al., 
2012). In fact, the grafting of PHEMA and PIPAAm onto cell culture surface enables 
rapid cell sheet recovery (Kim et al., 2013). 
 
  A                                              B                                      C     
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1.5.2.5. Co-polymers 
In cell and tissue culture, the use of co-polymeric materials is frequent. In fact, 
the development of copolymers improve the properties of scaffolds or coatings 
increasing the number and type of applications (Table 1.2). Therefore, several 
authors combined the use of PLGA, PEG, PCL, poly(lactic acid) (PLLA) and 
methacrylate monomers to form biomaterials. The use PEG-PCL of is one of the 
most frequent combinations of copolymers. Fibrous hydrogels of PEG and PCL have 
been used for vascular applications (Crowder et al., 2012), to culture human 
neuroblastoma cells (Han et al., 2012) and dermal fibroblasts (Grafahrend et al., 
2008). On the other hand, PLGA-PCL blends have been used for culture of 
osteoblastic cells (Lucchesi and Barbanti, 2010) and human adipose stem cells for 
further use in small-caliber vascular grafts (Diban et al., 2013). Several 
copolymeric compounds such as poly(lactic acid)–PEG (PLLA-PEG) and PLLA-PCL 
have been used as a biomimetic ECM for culture of cardiomyocytes (Zong et al., 
2005) and culture of periosteal tissue (Kouya et al., 2013), respectively. In another 
work, Anderson et al identified a combinatorial library of biomaterials formed from 
acrylate and methacrylate monomers that support appropriate cellular 
attachment, proliferation and differentiation of hESC (Anderson et al., 2004) 
 
 
Table 1.2: Summary of the synthetic biomaterials most common used and their 
applications in cell and tissue engineering applications. 
 
 
Type of 
material 
 
Cultured cells and (Future) 
applications 
 
 
References 
 
Synthetic peptides 
 
 
 
Culture of mouse and human ESCs 
 
(Yea et al., 2008) 
(Klim et al., 2010) 
(Kolhar et al., 2010) 
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Table 1.2 (Cont.): Summary of the synthetic biomaterials most common used and their 
applications in cell and tissue engineering applications. 
 
 
Type of 
material 
 
Cultured cells and (Future) 
applications 
 
 
References 
 
Synthetic polymers 
 
PLGA 
 
Cartilage and bone tissue 
engineering 
 
 
Drug delivery  
 
 
Neural stem cell culture and 
differentiation 
 
 
Culture of fibroblasts and 
endothelial cells (recreation of 
striated muscles) 
 
 
Porous microsphere model to 
study developing tumors  
 
Culture of hepatic cells in sponges 
 
 
(Uematsu et al., 2005) 
(Chen et al., 2013; 
Curran et al., 2013) 
 
(Kirby et al., 2011) 
 
 
(Levenberg et al., 2003; 
Teng et al., 2002; Xiong 
et al., 2012) 
 
(Hsueh et al., 2009; 
Hwang et al., 2009; 
Salamian et al., 2013) 
 
 
(Kang and Bae, 2009) 
 
 
(Zhu et al., 2008) 
 
PEG 
 
 
Co-culture of mESCs and human 
hepatocellular carcinoma cells to 
study cell differentiation 
 
Microwell array for EB culture  
 
Expansion and self-renewal of 
multiple hESC lines  
 
Nanopatterned culture of rat 
primary cardiomyocytes  
 
Rat mesenchymal stem cell 
differentiation to vascular cells 
(endothelial and muscle cells)  
 
Mouse embryonic liver cells to 
generate hepatocytes  
 
 
(Sugiura et al., 2013) 
 
 
 
(Moeller et al., 2008) 
 
(Jang et al., 2013) 
 
 
(D. H. Kim et al. 2006) 
 
  
(Wingate et al., 2012) 
 
 
 
 (Underhill et al., 2007) 
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Table 1.2 (Cont.): Summary of the synthetic biomaterials most common used and their 
applications in cell and tissue engineering applications. 
 
 
Type of 
material 
 
Cultured cells and (Future) 
applications 
 
 
References 
 
Synthetic polymers 
 
PCL 
 
 
Rat parenchymal hepatocytes   
kidney epithelial cells  
 
 
Culture of  prostate cancer cell line 
(3D pharmacokinetic cancer 
model) 
 
Cartilage and bone repair animal 
models 
 
  
 
(Lubasová et al., 2010) 
(Ghasemi-Mobarakeh, 
2008) 
 
(Hartman et al., 2010) 
 
 
 
(Martinez-Diaz et al., 
2010; Sawyer et al., 
2009). 
 
 
PLLA 
 
Culture of cardiomyocytes  
 
Culture of periosteal tissue (bone 
regeneration) 
 
Human umbilical vein endothelial 
cells 
 
 
(Zong et al., 2005) 
 
(Kouya et al., 2013) 
 
 
(Can et al., 2011) 
PGA 
 
Culture of human smooth muscle 
cells and vascular-derived cells 
(vascular tissue engineering) 
 
 
(Brugmans et al., 2013) 
(Hajiali et al., 2011) 
PMMA 
 
Culture of human stromal cells 
 
Cell culture chip 
 
Culture of Human osteosarcoma 
cells (bone regeneration) 
 
 
(Patel et al., 2006) 
 
(Petronis et al., 2006) 
 
(Son et al., 2013) 
 
PHEMA 
 
 
Culture of undifferentiated mouse 
and human ESCs  
 
Culture of neuronal cells 
 
(Horák et al., 2004; 
Kroupová et al., 2006) 
 
(Shepherd and Parker, 
2011) 
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In 1987, a group of experts defined the word biomaterial as “a non-viable material 
used in a medical device, intended to interact with biological systems” (European 
Society of Biomaterials Conference, 1987) and since then, the field has advanced 
considerably resulting in the development of implantable scaffolds that consist 
entirely of specific biomaterials. A wide range of biomaterials have been developed 
for different applications and current knowledge of using biomaterials in 
combination with stem cells has increased. Natural or synthetic biomaterials 
comprise advantages and drawbacks that can be easily overcome by taking 
advantage of composite compounds. Indeed, there are several biomaterials 
available that could be adapted or directly used depending on the application, 
either for culture and expansion of undifferentiated stem cells or for directed 
differentiation of stem cells into mature phenotypes. Here, we will explore the use 
of natural and synthetic polymers to support the culture and maintenance of 
pluripotent mouse ESCs. 
 
 
1.6. Collagen and calcium binding EGF domains 1   
State of the art  
Collagen and calcium binding epidermal growth factor domains 1 (Ccbe1) is a still 
poorly characterized gene, whose function is thought to be related to ECM 
remodeling and migration because its domains are found in several of the ECM 
proteins.  Ccbe1 gene has been identified in several vertebrate systems. In chick, 
a differential screening Affymetrix GeneChip® Chicken Genome arrays conducted 
in our laboratory identified Ccbe1 as one of the upregulated genes present in the 
heart/hemangioblast precursors (Bento et al., 2011) and might be responsible for 
alterations in cell migration events during chick heart development. In a zebrafish 
genetic screening, Ccbe1 was found to be indispensable for embryonic 
lymphangiogenesis and venous sprouting (Hogan et al., 2009). In mice, Ccbe1 null 
mutants die in utero with malformations such as severe edema and Ccbe1 has also 
shown to be essential for budding and/or migration of lymphatic endothelial cells 
(LECs), maintenance of their proliferation and subsequently for lymphatic 
vasculature formation (Bos et al., 2011). Bos and collaborators reported Ccbe1 as 
a factor critically required for budding and migration of Prox1+ and Lyve-1+ LECs 
(fate-specified LECs) from the cardinal vein to form the lymph sacs and give rise 
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to the lymphatic vasculature (Bos et al., 2011). However, accordingly to the 
presented results, the observation of less migration seemed to be related to 
absence of signaling or absence of a required number or pool of cells to migrate, 
as LEC numbers are reduced in mutants, and not due to less ability of cells to 
initiate migration. Indeed, the results indicated an overall reduction in the number 
of Lyve-1+ and Lyve-1+ LECs between E10.5 and E12.0 in Ccbe1-/- embryos, 
resulting in a primary defect before the formation of lymph sacs. Furthermore, the 
authors revealed that CCBE1 has little lymphangiogenic effect on its own, but 
dramatically enhances the lymphangiogenic effect of vascular endothelial growth 
factor-C (VEGF-C), an inducer of lymphangiogenesis and a growth factor active in 
stimulation of endothelial cell growth and proliferation, in vivo. Those results 
suggest that in the absence of VEGF-C interaction, Ccbe1 seems to be essential 
but not sufficient for lymphangiogenesis. In that study, it is also hypothesized  
whether CCBE1 might be part of the extracellular ECM, as suggested by the CCBE1 
domain structure (Bos et al., 2011). Furthermore, CCBE1 mutations in human lead 
to clinical manifestations of severe lymphedema or Hennekam syndrome, a 
disorder characterized by abnormal lymphatic system and mild to moderate levels 
of growth and mental retardation (Alders et al., 2013; Connell et al., 2012; Marchiò 
et al., 2013). Moreover,  gene expression analyses using a high-throughput 
systematic multiplex qPCR revealed that CCBE1 was downregulated in the majority 
of clinical cases of breast cancer and CCBE1 also modulates cell migration and 
survival in human ovarian cancer cells (Barton et al., 2010; Yamamoto and 
Yamamoto, 2007). 
The function of Ccbe1 is however still contradictory and poorly understood. While 
the importance of Ccbe1 for the development of the lymphatic system appears to 
be unquestionable (Bos et al., 2011; Hägerling et al., 2013),  unlike other 
lymphangiogenesis associated genes, CCBE1 is not expressed in endothelial cells, 
but is spatially and temporally expressed along the migration routes of lymphatic 
endothelial cells and may be a guidance molecule involved in lymphangioblast 
budding and migration (Hogan et al., 2009). On the other hand, CCBE1 has also 
been reported to be highly down-regulated in primary breast carcinomas as 
compared with matched normal breast tissue (Yamamoto and Yamamoto, 2007). 
Furthermore, it was shown that CCBE1 is highly expressed in normal ovary, as 
compared with other tissue types (Shyamsundar et al., 2005), but is low expressed 
in ovarian cancer cell lines and primary carcinomas (Barton et al., 2010). In 
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Barton’s study, qPCR analysis of 78 primary ovarian carcinomas revealed that 
CCBE1 was significantly down-regulated in ovarian cancers of all histological 
subtypes as compared with normal ovarian surface epithelium. In addition, CCBE1 
was frequently down-regulated in ovarian and breast cancer cell lines as compared 
with normal ovarian and breast epithelial cell lines. These data indicated that 
CCBE1 may be a tumor metastasis suppressor gene. Indeed,  CCBE1 
overexpression in breast cancer cells inhibited cell migration (Barton et al., 2010). 
Therefore, loss-of-function of CCBE1 in ovarian cancer context confers migratory 
and survival advantage to cancer cells. 
As in Bos et al study mentioned above (Bos et al., 2011), the work conducted by 
Barton also hypothesized that the structural motifs of CCBE1, including the 
presence of collagen repeats and an Asp/Asn hydroxylation motif, together with 
its expression in the surface epithelium and stroma of the ovary, are indicative of 
a function in the cross-talk between the surface epithelial cells and the ECM 
affecting cellular migration (Barton et al., 2010). 
Recently, another work suggests an additional role for CCBE1 outside the 
lymphatic vasculature. The study reveals that loss of CCBE1 in mice results in 
severe mid-gestation anemia, likely due to reduced fetal liver erythropoiesis. Zou 
and co-workers have identified CCBE1 as a required secreted factor that plays an 
unexpected and critical role in fetal erythropoiesis, process by which red blood 
cells (erythrocytes) are produced. Like the well-characterized secreted factors 
erythropoietin and stem cell factor, CCBE1 functions cell non-autonomously to 
promote erythroid survival, maturation and proliferation. Fetal liver erythroid 
precursors of Ccbe1 null mice exhibit reduced proliferation and increased 
apoptosis. As such, fetal livers were normal or mildly reduced in size in Ccbe1-/- 
embryos at E12.5 and markedly smaller and pale by E14.5 and E16.5. In addition, 
the number of hematocrit in E15.5 Ccbe1-/- embryos was severely reduced 
compared with that of heterozygous littermates. Furthermore, staining for 
phospho-histone H3 revealed reduced numbers of proliferating cells in Ccbe1-/- 
fetal liver and staining for activated caspase 3 confirmed an increased number of 
apoptotic cells. Those findings identify a primary and specific defect in definitive 
erythropoiesis within the Ccbe1-/- fetal liver as the cause of anemia. Thus, secreted 
CCBE1 by non-hematopoietic cells is required to maintain a unique and specific 
erythropoietic environment which support erythroblastic island formation 
specifically within the fetal liver erythroid niche.  
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Despite all the controversy that rose about the function of Ccbe1, according to the 
literature Ccbe1 seems to be involved in lymphangiogenesis and venous sprouting, 
cardiogenesis and (anti-) carcinogenesis events. Ccbe1 is thought to act as a 
modulator of cell migration, specification, proliferation and ECM remodeling, but 
its function remains mostly uncharacterized. 
 
 
1.7. Specific aims 
Basic and clinical research carried out during the last few years on embryonic stem 
cells has constituted a revolution in regenerative medicine and cancer therapies 
by providing the possibility of generating multiple therapeutically useful cell types. 
However, much work remains to be performed in the laboratory and in the clinic 
to understand how to use these cells for cell-based therapies to treat disease. One 
of the important issues to overcome is related to the culture of cells in a support 
suitable for further cell-based therapies, thus a support which does not induce 
immune response. Therefore, in order to use ESCs in those applications, they must 
be cultured in animal-free derived matrices. Several authors have been searching 
and developing synthetic and natural alternative supports that could be used to 
maintain ESC pluripotency, enabling a subsequent application in basic stem cell 
biology and regenerative medicine. However, so far the feeder-dependent and 
gelatin-based cultures are still standard protocols to culture pluripotent mouse 
ESCs. 
 
In the present work, Chapter III and IV refers to the application of natural and 
synthetic polymeric coatings in stem cell research. The main goal was to develop 
new supporting biomaterials that could be used both to grow pluripotent stem cell 
and allow their differentiation. Ideally, the supports should lead to production of 
high quality of undifferentiated pluripotent stem cells; provide better control of cell 
proliferation and differentiation; build a realistic micro-environment where the 
functional properties of stem cells can be observed and manipulated; and be 
cheap, easy to use and time-efficient for stem cell research. Taking this into 
consideration, in Chapter III and IV, a set of successive experiments were 
performed to characterize the selected natural and synthetic matrices and to 
validate their suitability in mouse ESC cultures. In Chapter III - Locust Bean Gum 
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as an alternative polymeric coating for embryonic stem cell culture and in Chapter 
III.I - Comparative study of LBG from different sources, it was explored the 
potential use of LBG, a natural vegetal-derived polysaccharide, in pluripotent 
mouse ESC culture. In Chapter IV - Novel triblock copolymer nanofiber system as 
an alternative support for embryonic stem cells growth and pluripotency, is 
reported the synthesis of poly(ethyleneglycol-β-trimethylsilyl methacrylate-β-
methacrylic acid)–glycine–arginine–glycine–aspartate–serine (PEG–PTMSMA–
PMAA–GRGDS)-based nanofibers and the capability of this new artificial nanofiber 
network to support pluripotent mouse ESC culture. 
 
According to literature and data from our lab suggest that Ccbe1 modulates cell 
migration and survival. However, the function and the mechanism whereby Ccbe1 
modulates both proliferation and migration is unknown. 
In Chapter V, Characterization of Ccbe1 mutant MEFs – Ccbe1 and its effect in 
proliferation and migration, we took advantage that conventional Ccbe1 mutant 
mice existent in our animal facility and of the primary cell culture approach, as 
they provide effective tools to investigate the basic principles of in vivo mammalian 
development. Ccbe1 is highly expressed in mouse embryonic fibroblasts so, here, 
we aimed to explore the autonomous proliferative capacity of Ccbe1+/+ and Ccbe1-
/- primary MEFs in culture.  Also, to test it’s role in fibroblasts for stem cell 
differentiation support.  The analysis of cell morphology, adhesion, proliferation 
and cell cycle was complemented with an apoptosis assay. With those assays we 
aimed to clarify if Ccbe1 has a role in cell survival. Furthermore, we also intended 
to evaluate the motility properties of Ccbe1-/- MEFs, using different matrices that 
may interact with CCBE1. The study of Ccbe1 role in proliferation and migration of 
primary mouse embryonic fibroblasts was complemented with the rescue of 
Ccbe1+/+ phenotype by introducing CCBE1 in the culture system.
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2. MATERIALS AND METHODS 
 
2.1. Cell Culture 
Handling of the cells, medium preparation and other techniques that require 
aseptic conditions were performed in a laminar flow cabinet (Hera safe Heraerus) 
after irradiation for 15 minutes (min) with ultraviolet (UV)  light. Mammalian cells 
were cultured in an humidified incubator (Hera cell 150 Heraerus) at 37 degrees 
Celsius (ºC) with 5% of CO2 in 95% air and media and culture solutions were pre-
warmed to 37 ºC in a water bath prior to use. Microscopic examination of cell 
growth was preformed frequently by using an inverted light microscope (Leica). 
 
2.1.1. Isolation of primary mouse embryonic fibroblasts 
Embryos to isolate MEFs were collected from pregnant female mice at embryonic 
day 13.5 to 14.5. Briefly, the pregnant females were sacrificed by CO2 inhalation 
and the ventral surface was swabbed liberally with 70% alcohol and placenta was 
dissected out following the protocol described elsewhere (Freshney, 2006) and 
transferred to a clean dish with fresh phosphate buffered saline (PBS). In case of 
the Ccbe1 mutant embryos, each individual embryo with its involving placenta was 
handled separately. Internal organs, head and blood system cells were removed 
from the free membranes and placenta. The remainder was then transferred to 
another fresh Petri dish. Next, in a laminar flow hood, the remaining of the 
embryos, consisting of the carcass, was washed five times with PBS, in five Petri 
dishes. Subsequently, the carcasses were transferred to sterile 10 cm plates with 
15 ml of 0.05% of Trypsin / 0.53 mM ethylenediaminetetraacetic acid (EDTA) 
(Gibco) where it was finely cut with a razor blade. The resulting suspension was 
resuspended and homogenized by pipetting up and down six to seven times to 
help breaking up the tissue and then the plate was placed in the incubator for 15 
min. After that, 5 ml of Trypsin/EDTA was added to the plate and again pippeted 
up and down followed by a 10 min incubation in the incubator. The digested tissue 
was dissociated, homogenized and next the cellular suspension was passed 
through a 100 µm cell strainer of nylon to remove the large pieces of undigested 
tissue and the cells collected in another plate. The cell strainer was rinsed with 5 
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ml of PBS and the permeated was placed in the same plate. The collected cellular 
suspension was transferred to a 50 ml falcon and centrifuged at 200 x g (times 
gravity) for 8 min at room temperature (RT). The supernatant was discarded and 
the cell pellet resuspended in MEFs culture medium (described in 2.1.2). The cells 
were platted to obtain the cellular content of one embryos by one 75 cm2 T-flask 
and incubated at 37 ºC with 5% CO2. The medium was changed after six hours 
and after one day. When a confluence of 70% was achieved, MEFs were 
subcultured and at passage 1 cells were ready for cryopreservation at about 1 
million cells per vial.   
 
2.1.2. Culture of Mouse Embryonic Fibroblasts 
MEFs were cultured in tissue culture plate with 10 ml of growth medium consisting 
of Dulbecco’s modified eagle medium (DMEM) Glutamax with D-glucose and 
without sodium pyruvate (Gibco) supplemented with 10% volume per volume 
(v/v) of heat inactivated fetal bovine serum (FBS; Sigma), 2 mM of L-glutamine 
(Gibco), 0.1 mM mercaptoethanol (Gibco), Penicillin (100 U/ml) / Streptomycin 
(100 µg/ml) (Gibco). Medium was changed every two days. 
MEFs were split 1:3 or 1:5 (maximum) as soon as they became 70% confluent. 
For passage, cells were washed with 5 ml of PBS two times and trypsinized with 2 
ml of trypsin/EDTA followed by 8 min incubation at 37 ºC. The trypsin-EDTA was 
inactivated by adding 5 ml of MEFs medium. The suspension was pipetted up and 
down to ensure a single-cell suspension and collected in a falcon for centrifugation 
at 200 x g for 8 min at RT. The cell pellet was resuspended in fresh MEFs medium 
and the cells were then plated in a 100 mm dish and incubated at 37 ºC with 5% 
CO2. 
 
2.1.3. Preparation of MEF feeder layers 
When a confluence of 90% was reached or when MEFs forms a good feeder mesh 
for ESC culture, 1.5 µg/ml mitomycin C (Sigma) was added in the medium and 
cells were incubated for 2 hours (h) at 37 ºC. Then, cells were washed 3 times 
with 10 ml of PBS to completely remove the mitomycin, and then trypsinized with 
2 ml of trypsin/EDTA for 8 min in the incubator. MEFs medium was added to stop 
the trypsinization, and the cells were then centrifuged at 200 x g for 8 minutes. 
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The cell pellet was resuspended in 1 ml of fresh MEFs medium and the number of 
inactivated MEFs was counted. Finally, the cells were frozen or replated to make 
the feeder layer. About 1x106 of inactivated MEFs were used to cover the bottom 
of a 100 mm plate and approximately 4x105 cells per well in a six well plate. 
 
2.1.5. Traditional Mouse Embryonic Stem Cell Culture 
E14GPF8 mESCs, that constitutively express green fluorescent protein (GFP), were 
kindly provided by Dr. Tristan Rodriguez.  E14GPF8 mESCs were thawed and grown 
on 0.1% of gelatin (w/v) or on top of MEFsi at 37ºC and 5 % CO2 in a 10 cm 
diameter - plate with 10 ml of a growth medium consisting of Glasgow Minimum 
Essential Medium (GMEM) without pyruvate and glutamine (Gibco) supplemented 
with 10% (v/v) of ES screened and defined FBS (HyClone), 2 mM L-glutamine 
(Gibco), 1 mM sodium pyruvate (Gibco), 50 µM β-mercaptoethanol (Gibco), 100 
U/ml Penicillin and 100 µg/ml Streptomycin (Gibco), 0.1mM non-essential 
aminoacids (Gibco) and 1000 U/ml of LIF (ESGRO®, Millipore). mESCs were 
subcultured every 2 to 3 days through incubation of 0.05 % trypsin/EDTA solution 
for 5 min and the culture medium was replaced daily. 
 
2.1.4. Total and Viable cell count 
Cells were washed with PBS and incubated with trypsin/EDTA at 37ºC and 5% CO2. 
The cellular suspension was resuspended in growth medium, centrifuged and 
ressuspended in 50 to 1000 µl of medium depending on the predicted cellular 
concentration. One volume of 0.4% of trypan blue solution (w/v; Sigma) was 
added to the suspension and incubated for 1 to 2 min. The suspension was 
homogenized again and 10 µl of the mixture was introduced on a hemocytometer 
or Improved Neubauer chamber (VWR). Cells were counted using an inverted light 
microscope. The number of cells were counted in at least five 1 mm2 squares of 
one chamber and determined the average number of cells per square. If a 
minimum of 20-50 cells per 1 mm2 square could not be counted, the cells were 
centrifuged, resuspended and counted again. While viable cell do not absorb the 
dye, dead or non-viable cells absorb the dye and, hence viable cells are colorless 
and non-viable cells are stained blue. To estimate the number of cells of original 
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suspension the following formula was used: Nº of cells = Nº of cells counted x 104 
x Cell suspension volume (ml) x Dilution factor 
Cells were also counted by flow cytometry and the viability determined using 
propidium iodide (PI). For flow cytometry, the maintenance medium was removed, 
cells were washed with PBS and trypsinized. Cells were collected to a flow 
cytometry tube (BD Biosciences) and incubated with PI (5 µg/ml; Sigma). The cell 
suspensions were analyzed by flow cytometry upon excitation with the red laser 
(488 nm) being the emission signals measured in the FL2 channel (585/42 nm). 
Data was analyzed with BD CellQuestTM Pro software (BD Biosciences). Viability 
ratio was obtained as the ratio between the number of viable cells and total number 
of cells. Cell proliferation was calculated as the ratio between viable cells and initial 
cell number. 
In case of cell passaging, population doubling (PD) per passage was calculated as 
log(nf/n0)/log2, where n0 is the initial and nf the final number of cells at each 
passage. Cumulative population doubling (CPD) at each passage was calculated 
by adding population doubling per passage. When n0 was greater than nf, the 
population doubling was defined as 0. 
 
2.1.6. Subculture of Mouse Embryonic Stem Cells 
mESCs were routinely split 1:5 every 2 to 3 days or when 60 % confluence had 
been achieved. Culture medium was aspirated off and cells were rinsed twice with 
5 ml of PBS, 2 ml of 0.05% trypsin/EDTA were added and incubated for 5 min at 
37 ºC and 5% CO2. 5 ml of pre-warmed ES cells medium were added to stop 
trypsinization and suspension was pipetted up and down to achieve a single-cell 
suspension. The suspension was transferred to a 15 ml centrifuge tube, centrifuged 
at 200g for 5 minutes, and the pellet carefully resuspended in fresh ESC medium 
and plated. 
 
2.2. Polymeric coatings 
2.2.1. Purification of LBG  
1 L of deionized water was heated until it reached 85ºC, then, 5 g of LBG were 
added gradually to avoid formation of clusters, and stirred for 1h. After letting the 
solution cool down to RT, it was centrifuged at 22 000 x g for 1h at 20ºC. The 
Materials and Methods 
51 
 
supernatant was precipitated by pouring into an equal amount of ethanol, gently 
stirring with a glass rod. The precipitate formed was transferred to a new beaker 
and washed with fresh ethanol. Then, vacuum filtration was used to remove the 
excess ethanol by compressing the precipitate against the walls of the Buckner 
funnel. Finally, the precipitate was cut in small pieces and residues of ethanol were 
removed by drying at 30 ºC for 3 days in a vacuum oven. 
 
2.2.2 Characterization of natural polymeric coatings by Scanning Electron 
Microscopy (SEM) 
Natural polymer coatings were characterized using a field emission scanning 
electron microscope (FE-SEM; FESEM Ultra Plus, Zeiss, Germany) at 3 kV of 
voltage and a secondary electron (SE) detector. In brief, solutions of natural 
polymers were incubated in TCPS coverslips o.n., then the excess of solution was 
removed and the remaining coating analyzed. The coverslips were placed onto 
metal plates and a 5 nm thickness iridium film was sputter-coated on the samples 
(Q150T S/E/ES Sample Preparation System, Quorum Technologies) before 
visualization.  
 
2.2.3. Synthesis and characterization of nanofibers 
2.2.3.1. Materials and instruments 
All reagents and solvents for synthesis were reagent grade and were used without 
further purification, unless stated otherwise. Trimethylsilyl methacrylate (TMSMA) 
(Sigma-Aldrich) and methacrylic acid (MAA) (Fluka) were distilled at low pressure 
in a Büchi Glass Oven B-585 micro distiller before use. Azobisisobutyronitrile 
(AIBN) (Fluka) was recrystallized from methanol and dried under vacuum at RT. 
GRGDS (Sigma) was dissolved in miliQ water to a concentration of 5 mg/mL. 
Polymer isolation and identification was performed as described above. 
 
2.2.3.2. Polymer synthesis 
PEG-PTMSMA-PMAA was obtained from the diblock copolymer poly(ethyleneglycol-
β-trimethylsilylmethacrylate) (PEG-PTMSMA), which synthesis is described 
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elsewhere (Mouffouk et al., 2011). In short, to synthetize PEG-PTMSMA-PMAA, to 
1.83 g of PEG-PTMSMA dissolved in 5 mL of tetrahydrofuran (THF), 1.8 mL (106 
eq) of methacrylic acid and 0.033 g of AIBN were added. After three freeze-pump-
thaw cycles, the mixture was incubated in an oil bath at 60 ºC, under stirring, for 
24 h. The flask was then cooled down to RT and 20 mL of THF added to dilute the 
mixture, which had become very viscous, and its content precipitated by pouring 
into diethyl ether. The polymer was separated from the supernatant by 
centrifugation at 15344 x g for 10 min followed by decantation. This procedure 
was repeated once more, providing a white solid that was vacuum dried, at 40 ºC 
overnight, yielding 3.5 g (96%). 1H NMR  (CD3OD): 0.06 [(s), (CH3)3Si], 0.10 [s, 
(CH3)3Si], 1.09 (s, CH3C–C=O), 1.19 (s, CH3C–C=O), 1.86 (s, CH2C–C=O), 1.99 
(s, CH2C–C=O), 3.35 [s, CH3O–(CH2CH2O)n], 3.64 [s, (CH2CH2O)n], 3.72 [s, 
(CH2CH2O)n]. DPn (NMR) = 94. IR (KBr): 1706 [(C=O)], 1255 [(Si(CH3)3], 1181 
and 846 [(Si(CH3)3] cm−1. Gel permeation chromatography (GPC) analysis 
revealed a monomodal molecular weight distribution; elution time (te) = 16.00 
min. 
 
2.2.3.3. Polymeric fiber formation and bioconjugation with the peptides 
Twenty mg of the polymer were added to 1 mL of miliQ water containing Pen/Strep 
(100 U/mL) and sonicated for 30 min. The solution became opaque white as the 
polymer dissolves and self-assembled into nanostructures that were confirmed by 
Cryo-TEM. Then, 15 µL of GRGDS peptide were added to the previous solution 
(corresponding to a 1:10 peptide/polymer molar ratio), and the resulting solution 
sonicated for an additional 5 min. 
 
2.2.3.4. Cryo-Transmission Electron Microscopy (TEM)  
The structure of the self-assembled nanofibers was observed on a Fei Titan Krios™ 
Cryo-Transmission Electron Microscope (TEM). Nanofibers were suspended in a 
fluid staining medium (1% uranyl acetate) and applied to a standard pre-treated 
support film. Then, the specimen grid was blotted with filter paper to remove 
excess fluid and rapidly plunged into liquid ethane that had been cooled to liquid 
nitrogen temperature (freezing rate on the order of 1.000.000 K/sec) to prevent 
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the formation of ice crystals. Images were recorded under low electron dose 
conditions (10 – 25 e-/Å2). 
2.3. Stem cell culture in natural and synthetic polymeric coatings 
2.3.1. Preparation of polymeric coatings and mESC culture 
LBG has limited solubility in water and, hence, LBG solutions were prepared by 
dissolving the powder (Roeper, Germany) in sterile milliQ water and stirring for 2h 
at 60 ºC. LBG amount was adjusted to obtain a final concentration of 0.1% weight 
per volume (w/v). The solution was then transferred to a tube, sonicated o.n. at 
60-70 ºC and filtered using a 0.45 µm pore size syringe filter. A 0.1% (w/v) 
solution of gelatin type B (Sigma, Switzerland) was also prepared in sterile milliQ 
water. The polymeric nanofiber solutions were prepared as described above 
(2.2.3.3. Polymeric fiber formation and bioconjugation with the peptides). 
Polymeric nanofiber and LBG solutions (LBG from Roeper, LBG from Industrial 
Farense, purified LBG) were placed into 6-well culture plate to cover the entire 
growth area, which allowed the nanofibers to form a mesh and adsorb to TCPS 
surface and the polymers to adsorb to the TCPS surface. Upon 12 h incubation at 
4ºC, in case of using nanofibers the wells were sterilized for 30 minutes in UV light. 
Subsequently, the excess of nanofibers and natural polymers solution was 
removed and mESCs resuspended in growth medium were seeded directly onto 
polymer covered wells, in triplicate and at an approximate density of 20 000 
cells/well. Half of the medium was changed every day.  
 
2.3.2. Alkaline Phosphatase assay 
The pluripotency of ESCs was tested by an Alkaline Phosphatase (ALP) staining, 
using an Alkaline Phosphatase staining kit (86R; Sigma) according to the 
manufacturer’s instructions. In brief, the cells were fixed with the 
citrate:acetone:formaldehyde solution for 2 min, washed twice with water,  stained 
with the ALP staining solution for 30 min and counterstained with Hematoxylin for 
2 min. The morphology of the colonies and ALP positive cells were observed in an 
inverted light microscope (Leica DMIL) and photographed by the coupled digital 
camera (Leica DC 500).  
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2.3.3. Differentiation potential in vitro 
Differentiation potential of ESCs cultured on nanofibers and in natural polymers 
over multiple passages was compared to cultures under standard conditions. 
Determination of the differentiation potential was assayed by the quantification of 
the expression of gene markers from the three primary germ layers in EBs 
collected at day 10 of differentiation. To do so, undifferentiated ESCs were seeded 
and passaged every 3 days at the same cell density for 10 passages. At day 30, 
correspondent to day 0 of differentiation, cells were resuspended in differentiation 
medium, which consists of growth medium with 15% (v/v) FBS and without LIF 
supplementation, and a three-dimensional environment consisting of embryoid 
bodies (EBs) was created to induce spontaneously differentiation of 
undifferentiated ESCs (Fig. 2.1). For that, cells were dissociated in ESC culture 
differentiation medium and drops of 20 μl of ESC suspension (22 cells/µl) plated 
onto the base of a bacteriological Petri dish. Cells were placed in hanging droplets 
by inverting the base of a Petri dish. After 48 hour incubation, mESC differentiation 
medium was added so that the cells were cultured in suspension for 4 days. The 
EBs were then plated on 0.1% gelatin coated 6-well plates at day 6 and cultured 
up to day 10 of differentiation. Culture medium was replaced every two days. 
 
 
 
 
 
 
 
Figure 2.1:  Schematic representation of the hanging droplet method used to 
induce differentiation of mESCs. A. Undifferentiated ESCs in culture. B. ESCs were 
dissociated and drops of 20 μl of ESC suspension (440 cells) were plated onto the base of 
a Petri dish (day 0). Cells were placed in hanging droplets by inverting the base of a Petri 
dish into the lid containing 2 ml of PBS. C. After 48 h incubation (days 1 to 2), the cells 
were cultured in suspension for a further 4 days. D. EBs were then plated and cultured up 
to day 10 of differentiation. Adapted from (Pandur 2005). 
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2.4. Characterization of Ccbe1 mutant MEFs 
2.4.1. Mice 
The Ccbe1 mutant mice used in the present work were ordered from “The Mutant 
Mouse Regional Resource Center” (MMRRC) at the University of California, in which 
coding exon 1 and exon 2 of the Ccbe1 gene was targeted (NCBI accession 
AK028377.1) by homologous recombination (Bos et al., 2011; Tang et al., 2010). 
MEFs derived from wild type (Ccbe1+/+) and Ccbe1 mutant (Ccbe1-/-) embryos 
were used in the following methods at passage 0 to 3. 
 
2.4.2. Cell Adhesion and Spreading  
Ccbe1+/+ and Ccbe1-/- MEFs at passage 0 were seeded sparsely in a 6-well plate at 
a density of 100 000 cells per well (10 400 cells/cm2) previously marked with 
horizontal and vertical reference lines. Cell adhesion was evaluated at 0, 20, 40, 
80 and 240 min (4h) by microscopy and photography. After 4 h, the detached cells 
were washed with PBS and the adherent cells were collected and counted. In 
addition, 130 000 MEFs at passage 1 were plated in wells of a 6-well plate (13 500 
cells/cm2) and cultured for 48h to reach confluence. Then, cells were washed with 
PBS and the adhesive capacity was determined by incubating the cells with 0.01% 
of trypsin for 0, 1, 2, 3, 5 and 8 min and monitored by microscopy and 
photography. 
 
2.4.3. Proliferation and viability of Ccbe1 KO mouse embryonic fibroblasts 
2.4.3.1. Cell proliferation 
MEFs were isolated separately from littermate embryos at 13.5 and 14.25 days of 
gestation. After 24 to 48h, adherent fibroblasts were collected, some were used 
for genotyping and the majority was split once before the proliferation assay. 
Subsequently, Ccbe1+/+ and Ccbe1-/- primary MEFs were plated at a density of 144 
000 cells per well of a 6-well plate (15 000 cells/cm2), in technical triplicate, and 
subcultured or passaged every 3 days at the same cell density, in parallel and 
under identical cell culture conditions. The medium was changed 24h after seeding 
to remove cell debris. Passage 0 corresponds to the seeding day.  
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2.4.3.2. Cell cycle analyses by Bromodeoxyuridine labeling assay  
The bromodeoxyuridine (BrdU) labeling assay started with the seeding of 80 000 
Ccbe1+/+ and Ccbe1-/- primary mouse embryonic fibroblasts per well, in triplicate, 
in a 6-well plate. Cells were cultured for 24 h and incubated with 10 µM of BrdU 
(BrdU Labeling and Detection Kit I - Roche) diluted in growth medium in last 14 h 
before flow cytometry acquisition. After BrdU incubation, BrdU labeling medium 
was aspirated and MEFs were washed twice with PBS to eliminate unincorporated 
BrdU. MEFs were then trypsinized and centrifuged at 300 x g in flow cytometry 
round-bottom tubes (BD Biosciences) for 5 min at 20 ºC. The pellet was 
resuspended and fixed and permeabilized by incubating with Cytofix/Cytoperm 
solution (BD Cytofix/Cytoperm™ Kit) for 15 min at RT. 3 ml of PBS were added to 
wash fixative solution and tubes were centrifuged for 5 min at 300 x g and 20 ºC. 
After fixation, MEFs were incubated with anti-BrdU working solution (mouse 
monoclonal antibody clone BMG 6H8 IgG1 containing nucleases, Roche) for 30 min 
at 37ºC / 5% CO2, washed with PBS, followed by incubation in anti-mouse-Ig-
fluorescein working solution (sheep Ig, Roche) for further 30 min at 37ºC / 5% 
CO2. The BrdU antibody and the anti-mouse antibody were diluted at a ratio of 
1:10 in incubation buffer and PBS respectively (Roche), according to the 
manufacturer’s instructions. Finally, cells were washed with PBS and stained with 
7-aminoactinomycin D (7-AAD; 1 µg/ml of 7-AAD; Biolegend). Nuclear uptake of 
BrdU and 7-AAD was quantitated on a cell analyzer cytometer (BD FACSCalibur™ 
cell analyzer, BD Biosciences) and analyzed with BD CellQuestTM Pro software (BD 
Biosciences). For BrdU evaluation by flow cytometry, was used excitation with the 
red laser (488 nm) and detection in the FL1 channel (green, 530/30 nm) and 7-
AAD was excited by 488 nm laser light and detected in the FL 3 channel (>670 
nm). 
 
2.4.3.3. Cell Proliferation Dye eFluor® 670 
Cultured Ccbe1+/+ and Ccbe1-/- MEFs were trypsinized followed by two washes with 
PBS to remove any serum. Cells were resuspended in 1 ml of PBS at RT and 
counted. 1 ml of a 10 µM solution of Cell Proliferation Dye eFluor® 670 
(eBioscience) in PBS (at RT) was added drop by drop to the cell suspension and 
incubated for 10 min at 37 ºC in the dark. The labeling was stopped by adding 10 
ml of cold growth medium and incubation on ice for 5 min. Finally, labeled Ccbe1+/+ 
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and Ccbe1-/- MEFs were washed 3 times with 5 ml of growth medium and seeded 
at a density of 140 000 cells per plate of a 6 cm diameter culture plates (5 000 
cells/cm2). A portion of non-labeled and eFluor® 670 labeled MEFs was acquired 
on a cell analyzer cytometer (BD FACSCalibur™ cell analyzer, BD Biosciences) to 
define the population of undivided cells corresponding to day 0. Flow cytometry 
was carried out upon excitation with the red laser (633 nm) being the emission 
signals measured in the FL4 channel (661/16 nm). The fluorescence intensity of 
the dye was measured along the time of culture, at day 2, 4 and 7 by flow 
cytometry and data analysed using the BD FACSDivaTM software (version 6.1.3, 
BD Biosciences). The growth medium was changed at day 1, 3 and 5. 
 
2.4.3.4. Apoptosis assay 
Ccbe1+/+ and Ccbe1−/− MEFs were seeded at a density of approximately 200 000 
cells per plate of a 6 cm diameter culture plate (7 000 cells/cm2) and cultured for 
48h in growth medium (10% FBS) and in starvation medium (2% FBS) to induce 
cell stress. Then, cells were detached from culture plates and collected to a flow 
cytometry tube and incubated PI (5 µg/ml, Sigma) immediately before FACS 
acquisition by BD FACSCalibur™ cell analyzer. Flow cytometry was carried out 
upon excitation with the red laser (488 nm) being the emission signals measured 
in the FL2 channel (585/42 nm). Data was analyzed with BD CellQuestTM Pro 
software (BD Biosciences). 
 
2.4.4. Immunofluorescence for Cleaved Caspase3  
100 000 Ccbe1+/+ and Ccbe1−/− MEFs at passage 3 were seeded per well of a 6-
well plate in TCPS coverslips and cultured for 24 h. Then, the culture medium was 
removed, the coverslips rinsed with PBS and fixed with 1% paraformaldehyde 
(Sigma) for 30 min followed by 30 min of  permeabilization with 1% Triton-X100 
at RT. The samples were incubated in blocking solution (3 g Glycine, 800 g Bovine 
Serum Albumin, 80 g sodium azide, 400 ml PBS) for 30 min at 37 ºC. Cells were 
incubated with rabbit polyclonal anti-cleaved caspase 3 antibody (1:200; R&D 
Systems) in blocking solution o.n. at 4 ºC. Next, the cells were washed 3 times for 
5 min with PBS, followed by incubation with goat anti-rabbit Alexa 594 (1:1000; 
Sigma) for 1h at 37 ºC in dark. Cells were then washed 3 times with PBS and 
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coverslips were mounted with Mowiol-DAPI (4′,6-diamidino-2-phenylindole) and 
sealed. Images were captured using Axio Imager Z2 Fluorescence microscope 
(Zeiss).  
 
2.4.5. Wound-induced migration assay 
0.1% gelatin (Sigma), 10 µg/ml of fibronectin (Sigma) and vitronectin (Invitrogen) 
solutions were incubated o.n. at 4 ºC in a 6-well plate previously marked with an 
horizontal reference line. Ccbe1+/+ and Ccbe1-/- MEFs were mitotically inactivated 
with mitomycin C incubation for 2 h and then seeded into the pre-coated 6-well 
culture plates at a concentration of 500 000 cells/well, in triplicate, and cultured 
in growth medium for 24 h. The confluent monolayers of cells were “wounded” by 
scraping the bottom of the dish with a plastic P1000 pipette tip. Three wounds per 
well were done perpendicularly to the reference line (Fig. 2.2 A). Cellular debris 
were removed by washing with 1 ml PBS and the growth medium was added. In 
the wound-healing assay using antibodies to block specific subtypes of integrins, 
cells were seeded on gelatin, scratches were performed and MEFs were incubated 
with growth medium supplemented with antibodies against β1-integrin (1:100; 
Santa Cruz) and β4-integrin (1:100; Abcam) and with 10 µg/ml of CCBE1 protein. 
The migration of the cells was monitored by microscopy and photography at 0, 6, 
12 and 24 h time points. 10 measurements were performed per picture at 0 and 
6h using ImageJ 1.45 Software (Fig. 2.2 B). The pictures were captured using the 
10x objective of Leica DM IL microscope, in which, 1 mm was correspondent to 
944 pixels. 
 
Figure 2.2: Representation of wound-induced migration assay. A. Schematic 
representation of one well from a 6-well plate during the migration assay. Pictures were 
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taken under and above the guideline at 5 time points (0, 6, 12, 16 and 24h). B. 
Representative picture of length measurements using ImageJ Software. 
 
2.5. DNA extraction from MEFs and mouse tissues 
A small portion of tail or head of the embryos was cut and mixed with 375 µl of 
lysis buffer [50 mM Tris-HCl pH 8, 100 mM EDTA, 100 mM NaCl, 1% sodium 
dodecyl sulfate (SDS), 0.5 mg/ml Proteinase K] for 1h at on ThermoMixer Compact 
(Eppendorf) at full speed [1400 revolutions per minute (rpm)] until reaching 
complete digestion of the tissue. To pellet the proteins, 125 µl of saturated NaCl 
(6M) was added, the suspension was vortexed until tissue or cells particulates were 
dissolved and centrifuged at 16.1 x g for 10 min. The 475 µl of the supernatant 
(containing the DNA) was then transferred into a new 1.5 ml centrifuge tube and 
375 μl of isopropanol was added and mixed 1 to 2 min on an eppendorf mixer at 
750 rpm. The solution was centrifuged at 16.1 x g for 2 min at 4 ºC. Then, the 
DNA pellet was washed with 375 μl of 70% ethanol by inverting the tube several 
times. The solution was centrifuged one more time at 16.1 x g for 5 min at 4 ºC. 
The pellet was allowed to dry at RT. Finally, the DNA was dissolved in 50 μl 
nuclease free H2O though incubation at 37 ºC for 15 min on an ThermoMixer 
Compact (Eppendorf) at 800 rpm and stored at 4 ºC.  
 
2.6. RNA extraction 
The RNA isolation was performed using TRI Reagent (Sigma) and was basically 
constituted by four steps: homogenization, phase separation, RNA precipitation 
and wash. The RNA was extracted after cells counting. The cellular suspension was 
centrifuged at 200 x g and 4 ºC and the pellet was collected to an RNAse free tube. 
The tube was quickly placed in ice and 1000 µl of TRI reagent was added with the 
objective of homogenizing the pellet and incubated at -80ºC o.n. After that, 200 
µl of chloroform (Merck) was added to the homogenized and shaken vigorously. 
The resultant homogenized is centrifuged for 10 min at 16.1 x g and 4 ºC. 
Following centrifugation, three phases (pink, white and colorless) were visible 
within the tube. The colorless upper aqueous phase is thoroughly collected 
(avoiding transfer any interface) into a new tube containing 200 µl of chloroform 
and mixed. The mixture was centrifuged again and upper phase was collected to 
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a tube where 250 µl of isopropanol were previously added. The tube is mixed well 
by hand and placed at -20 ºC for 1 h or o.n., depending on the initial amount of 
cells. After RNA precipitation, the sample is centrifuged for 15 min at 16.1 x g and 
4 ºC, the supernatant was removed and the pellet is carefully washed twice with 
1000 µl of 75% ethanol and centrifuged for 5 min at 16.1 x g and 4 ºC. 
Subsequently, the supernatant was discharged and the pellet was left to dry for 
few minutes at RT. Finally, the pellet was dissolved in 20 µl of nuclease free H2O 
and stored at -80 ºC. 
 
2.7. Reverse Transcription PCR 
The Reverse Transcription was performed using First strand cDNA synthesis kit in 
which the complementary DNA (cDNA) was synthesized from a volume equivalent 
to 0.5 or 1 µg of RNA sample, RiboLock RNase Inhibitor, Reaction Buffer, dNTP 
Mix, Oligo(dT)18 Primer, RevertAidTM M-MuLV Reverse Transcriptase and water 
nuclease-free up to 20 µl, following the manufacturer’s instructions (RevertAid 
First Strand cDNA Synthesis Kit, Thermo Scientific). Non-template controls (NTC) 
containing no RNA and non-enzyme controls (NEC) were included. For quantitative 
PCR, cDNA was diluted at a ratio of 1:10. The resultant cDNA was stored at – 20ºC 
or at -80 ºC for longer storage.  
 
2.8. Semi-quantitative PCR 
The PCR mix was prepared with Dream Taq buffer (1x, Thermo Scientific), 
deoxyribonucleotides (dNTPs; 0.2 µM, Sigma), primer reverse (1.25 µM, Sigma), 
primer forward (1.25 µM, Sigma), Dream Taq Polymerase (0.06 U/µl, Thermo 
Scientific), 1 µl of each DNA sample and filled with nuclease free water to reach a 
total volume of 25 µl. In Table 1 there is a brief descript about the different primers 
and the PCR program.  
 
2.9. Quantitative PCR  
Quantitative PCR (qPCR) was performed using the Sso Fast Eva Green Supermix 
(Bio-Rad) on a CFX96 Real-Time PCR Detection System (Bio-Rad). Table 1 contains 
a brief description of the primers and qPCR programs used. The performance of 
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each qPCR reaction was determined using the standard curve, which consisted of 
a series of 10-fold dilutions of a positive control sample of cDNA. cDNA bands were 
cut from the gel and placed in 1.5 ml centrifuge tube. DNA was extracted with the 
GeneJETTM Gel Extraction Kit (Fermentas) according to manufacturer’s 
instructions.  
Reactions that performed efficiency upper than 90%, Pearson correlation 
coefficient close to 1 and melting curve without non-specific amplification were 
considered acceptable for current application. The relative level of expression of 
each target gene was calculated using ddCq method (Bustin, 2000). Co-culture of 
ESCs and MEFSi, cells cultured in gelatin or Ccbe1+/+ MEFs were used as control 
and gene expression was normalized to glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh), TATA binding protein (Tbp) or phosphoglycerate kinase 
1 (Pgk1) expression, depending on the experiment. Data were analyzed with Bio-
Rad CFX Manager software. 
 
2.10. Statistical analysis 
Unless otherwise specified, results are expressed as mean ± standard deviation 
(SD). Data were statistically analyzed using One-way analysis of variance test 
(ANOVA) to test for significant differences between the experimental conditions 
and t-student for pairwise comparison, using Sigma Stat software. Differences 
were considered significant for p<0.05.
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Table 2.1: Primer sequences, product size and program used for semi-quantitative and 
qRT gene expression analysis. αMhc, α-myosin heavy chain; αSma, α-smooth muscle actin; 
Afp, α-fetoprotein; Bax, BCL2-associated X protein; Bcl2, B cell leukemia/lymphoma 2; 
Col1α1, collagen type I α1; cTnT, cardiac troponin - T; Mmp2, matrix metallopeptidase 2; 
uPa, urokinase-type plasminogen activator.  
 
Gene name Forward sequence (5’–3’) Reverse sequence (5’–3’) 
Ta 
(ºC) 
Amplicon 
size (bp) 
Gapdh GGGAAGCCCATCACCATCTTC AGAGGGGCCATCCACAGTCT 59 356 
Tbp ACAGGAGCCAAGAGTGAAGAAC GGAGAACAATTCTGGGTTTGA 56 244 
Pgk1 ATGGATGAGGTGGTGAAAGC CAGTGCTCACATGGCTGACT 59 118 
Nanog AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 61 353 
Oct4 AGTATGAGGCTACAGGGACA CAAAGCTCCAGGTTCTCTTG 58 251 
Sox2 CGAGATAAACATGGCAATCAAATG AACGTTTGCCTTAAACAAGACCAC 56 236 
Col1α1 GCAGACGGGAGTTTCTCCTC TCAAGCATACCTCGGGTTTC 61 247 
β1-integrin AATGTGTTCAGTGCAGAGCC TTGGGATGATGTCGGGA 53 261 
βIII-
tubulin 
CCTGGAACCATGGACAGTGTT CAGCACCACTCTGACCAAAGA 55 85 
Sox1 CCAAGAGACTGCGCGCGCTG GGGTGCGCCGGGTGTGCGTG 60 362 
Nestin AGGCTGAGAACTCTCGCTTGC GGTGCTGGTCCTCTGGTATCC 58 111 
Hand1 CCAGTTACATCGCCTACTTG CCTGGTCTCACTGGTTTAGT 56 240 
αSma ATCGTCCACCGCAAATGC AAGGAACTGGAGGCGCTG 56 89 
Afp ATGTATGCCCCAGCCATTCTGTCC GAGATAAGCCTTCAGGTTTGACGC 60 442 
Gata4 GAAAACGGAAGCCCAAGAACC TGCTGTGCCCATAGTGAGATGAC 60 163 
Isl1 CCTGTGTGTTGGTTGCGGCA GGGCACGCATCACGAAGTCG 61 242 
Nkx2.5 CCACTCTCTGCTACCCACCT CCAGGTTCAGGATGTCTTTGA 60 107 
cTnT GGAAATCCAAGATCACTGCCTCC GGGCACTGAGGGACAGACCA 60 168 
αMhc GATGGCACAGAAGATGCTGA CTGCCCCTTGGTGACATACT 59 120 
Ccbe1 GACACACGTGGACCTACCGAG CCGTGCACTGCTGTTCACAGG 59 222 
Ccbe1 WT GGGGGCCGAGAAGAAGC GAAGCACGTGGTGAGCTCG 57 652 
Ccbe1 KO GCAGCGCATCGCCTTCTATC CACCCACAATCCAATCCGC 57 385 
Mmp2 GGCTGGAACACTCTCAGGAC CGATGCCATCAAAGACAATG 59 213 
uPa TTACTGCAGGAACCCTGACAACCA TGCTAAGAGAGCAGTCATGCACCA 59 104 
Bax ATGCGTCCACCAAGAAGCTGAG CCCCAGTTGAAGTTGCCATCAG 60 166 
Bcl2 GTCCCGCCTCTTCACCTTTCAG GATTCTGGTGTTTCCCCGTTGG 60 148 
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3.1. ABSTRACT  
Pluripotent embryonic stem cells (ESCs) have self-renewal capacity and the 
potential to differentiate into any cellular type depending on specific cues 
(pluripotency) and, therefore, have become a vibrant research area in the 
biomedical field. ESCs are usually cultured in gelatin or on top of a monolayer of 
feeder cells such as mitotically inactivated mouse embryonic fibroblasts (MEFsi). 
The latter is the gold standard support to maintain the ESCs in the pluripotent 
state. Examples of versatile, non-animal derived and inexpensive materials that 
are able to support pluripotent ESCs are limited. Therefore, our aim was to find a 
biomaterial able to support ESC growth in a pluripotent state avoiding laborious 
and time consuming parallel culture of MEFsi and as simple to handle as gelatin. 
Many of the new biomaterials used to develop stem cell microenvironments are 
using natural polymers adsorbed or covalently attached to the surface to improve 
the biocompatibility of synthetic polymers. Locust beam gum (LBG) is a natural, 
edible polymer, which has a wide range of potential applications in different fields, 
such as food and pharmaceutical industry, due to its biocompatibility, 
adhesiveness and thickening properties. The present work brings a natural system 
based on the use of LBG as a coating for ESC culture. Undifferentiated mouse ESCs 
were cultured on commercially available LBG to evaluate its potential in 
maintaining pluripotent ESCs. In terms of morphology, ESC colonies in LBG 
presented the regular dome shape with bright borders, similar to the colonies 
obtained in co-cultures with MEFsi and characteristic of pluripotent ESC colonies. 
In short-term cultures, ESC proliferation in LBG coating was similar to ESC cultured 
in gelatin and the cells maintained their viability. The activity of alkaline 
phosphatase and Nanog, Sox2 and Oct4 expression of mouse ESCs cultured in LBG 
were comparable or in some cases higher than in ESCs cultured in gelatin. An in 
vitro differentiation assay revealed that mouse ESCs cultured in LBG preserve their 
tri-lineage differentiation capacity. In conclusion, our data indicate that LBG 
coating promotes mouse ESC growth in an undifferentiated state demonstrating to 
be a viable, non-animal derived alternative to gelatin to support pluripotent mouse 
ESCs in culture. 
 
Keywords: embryonic stem cell culture, locust bean gum, natural polymers; 
gelatin substitute growth support, pluripotency. 
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3.2. INTRODUCTION 
The large potential of ESCs for clinical applications, replacement therapies or tissue 
engineering is evidenced by their ability to self-renew and to differentiate into 
many cellular types (Evans and Kaufman, 1981). General practices of ESC growth 
usually rely on their culture on a feeder layer of mitotically inactivated primary 
mouse embryonic fibroblast to maintain them in a pluripotent state (Lanza et al., 
2009). However, maintaining a parallel culture of MEFsi to the ESC culture is 
laborious and time-consuming, and certain procedures require additional steps for 
the separation of both cells. Therefore, many researchers culture ESCs in tissue 
culture polystyrene vessels coated with gelatin or Matrigel®, which are animal-
derived protein solutions. 
Gelatin, a translucent and colorless substance derived from collagen, is a cheap 
coating that has been vastly used to culture mouse ESC. As gelatin is an animal-
derived material produced by partial hydrolysis of collagen extracted from the 
boiled bones, connective tissues and organs of animals (Gorgieva and Kokol, 
2011), it poses problems for use in cell replacement therapies.  
Nevertheless, in order to use ESCs in the aforementioned applications, they must 
be cultured in animal-free derived matrices. For that reason, several authors have 
been developing synthetic and natural alternative supports that could be used to 
maintain ESC pluripotency, enabling a subsequent application in basic stem cell 
biology and regenerative medicine (Jia et al., 2013; Kaivosoja et al., 2012; Meade 
et al., 2013; Perestrelo et al., 2013). Non-animal derived materials are less prone 
to induce problems for cell replacement therapies, namely immunogenic reactions, 
which is a clear advantage. Synthetic polymers are easily incorporated into a wide 
variety of materials, making their application very frequent. Nevertheless, 
replacing these polymers by natural counterparts is a parallel and cheaper 
approach, which further evidences high biocompatibility potential. Indeed, natural 
polymers are frequently used in nanocomposites or as coatings to improve the 
biocompatibility of metal implants, being highly recommended to make the bridge 
between synthetic devices and human tissue (Hauser et al., 2010). 
Polysaccharides are the most common polymers in nature, consisting of 
monosaccharides bound together through glycosidic bonds (de Jong and van de 
Velde, 2007). The most abundant polysaccharides include starch, cellulose, chitin, 
glycogen, galactomannans and carrageenans  (de Jong and van de Velde, 2007; 
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Jana et al., 2011). Among the galactomannans, Locust Bean Gum (LBG) is 
obtained from the seeds of the carob tree (Ceratonia siliqua) where it normally 
acts as storage carbohydrate during germination. LBG has a mannose backbone 
with single side chain galactose units in a mannose/galactose ratio of 
approximately 4:1 (Fig. 3.1 A). LBG is commercially available and is widely applied 
in different areas, from food to pharmaceutical industry, due to its gelling and 
thickening properties (Dionísio and Grenha, 2012). Additionally, it is also used as 
stabilizer and emulsifier. In this work a new application of LBG is described. The 
development of a LBG coating and its application in ESC culture as a support for 
undifferentiated and pluripotent mouse ESC growth is reported. 
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3.3. RESULTS 
 
3.3.1. LBG solution forms an organized and patterned coating  
 
To characterize the topography of the LBG coating, TCPS plates coated with the 
polymer were visualized by SEM. As described in the methodology section, the LBG 
coating was achieved by overnight incubation of LBG aqueous solution with the 
plates. SEM microphotographs revealed that the LBG coating induces a rough 
striated topography in a relatively well-organized pattern (Fig. 3.1 B).  
TCPS (negative control) and gelatin coating were also characterized by SEM and 
revealed a completely smooth surface (data shown in Supplementary Study). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
       A                                               
Figure 3.1: Chemical and morphological structure of LBG. A. Chemical 
structure of locust bean gum showing a linear polysaccharide (1-4)-β-linked 
backbone of mannose units with single (1-6)-α-D-galactose units attached. Adapted 
from (Dionísio and Grenha, 2012) B. SEM morphology of LBG coating. The polymeric 
film forms a striated and rough mesh. 
3 µm 
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3.3.2. LBG coating promotes ESC proliferation 
To assess the ability of commercially available LBG to promote ESC adhesion, 
growth and self-renewal, undifferentiated mouse ESCs were cultured for 3 
passages (9 days) in LBG coating or using standard conditions, such as in gelatin 
coating, on top of MEFsi and in the negative control TCPS. According to our data, 
the proliferation at days 3 and 6 of culture was significantly higher in ESCs cultured 
in LBG (12.71- and 11.18-fold) than in gelatin (10.37- and 9.27-fold) or TCPS 
(8.44- and 7.27-fold) (Fig. 3.2 A). After 9 days in culture, however, there were no 
significant differences in cell growth between ESCs grown in gelatin or LBG 
coatings, but ESCs cultured in LBG still presented significantly higher proliferation 
than ESCs cultured in TCPS, 10.93- and 8.25–fold respectively (Fig. 3.2 A). As 
expected, while ESCs cultured in TCPS had the lowest proliferation at all passages, 
the highest proliferating rate was observed in ESCs cultured on top of MEFsi, the 
gold standard support to growth ESCs (Fig. 3.2 A). These results suggest that in 
short-term culture, ESC proliferation in LBG coating was at least equivalent and 
for the first two passages higher than ESCs grown in gelatin.  
Next, we evaluated cell viability by incubating ESCs with trypan blue, a dye which 
is taken up by dead cells but excluded from viable ones. The assay was performed 
at 3 and 9 days of culture and the percentage of viable cells was determined. As 
evidenced in Fig. 3.2 B, LBG coating maintains ESC viability more efficiently than 
gelatin, in the latter the percentage of viable ESCs being only approximately 89%. 
These data indicate that LBG coating is a suitable matrix to support proliferation 
and viability of ESCs in culture.  
The culture conditions may play an important role in determining cell shape. 
Indeed, many cell cultures are capable of exhibiting multiple morphologies 
depending on the growth surface (Chen et al., 2012; Ji et al., 2012; D.-H. Kim et 
al., 2010; Solon et al., 2007). Morphologically, colonies in LBG presented a round, 
regular and well-defined dome-shape typical of pluripotent colonies (Fig. 3.2 C: a, 
a’), similar to the colonies obtained in cultures in MEFsi (Fig. 3.2 C: b, b’), even 
after 9 days of culture. In contrast, ESCs cultured in gelatin or TCPS are 
disorganized presenting a flat and irregular shape of the colonies, and with 
individual cells that develop cytoplasmic extensions which are characteristic of 
differentiated cells (Fig. 3.2 C: c, c’, d, d’). Therefore, simple morphological 
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analysis indicates that ESCs grown in LBG form colonies with the shape of 
pluripotent ESC colonies. 
 
 
Figure 3.2:  Cell morphology, proliferation and viability. A. Cell proliferation tests 
performed during 3, 6 and 9 days of mouse ESC culture. Cell growth (fold) is presented as 
the ratio between viable cells and initial cell number. B. Cell viability results obtained at 
day 3 and 9 of culture. Viability is expressed in percentage of the ratio between the number 
of viable cells and total number of cells. (*) significantly different cell number in LBG 
(p<0.05) compared to gelatin. (#) significantly different cell number in LBG compared to 
negative control value (TCPS) (p<0.05). Data presented as mean + SD from three 
independent experiments performed in technical triplicates (n=9) C. Representative 
contrast phase images of E14GFP8 mouse ESCs at day 3 (a-d) and day 9 (a’-d’) of culture 
in a. 0.1% LBG, b. MEFsi, c. 0.1% Gelatin and d. TCPS. Magnification is 100x. 
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3.3.3. LBG coating supports self-renewability of ESCs 
To evaluate the pluripotency when ESCs endure long-term subculture on LBG 
coating, undifferentiated mouse ESCs were seeded at the same density and 
passaged every 3 days during 30 days. Thereafter, ESCs pluripotency was 
determined through alkaline phosphatase (ALP) activity assay at passage 3 (day 
9), and qPCR analysis to determine the expression of pluripotency markers at 
passage 3 and 10 (day 30). The expression of ALP, a marker of undifferentiated, 
pluripotent and capable of long-term self-renewal ESCs (Lanza et al., 2009; Martí 
et al., 2013), is commonly used to discriminate between pluripotent and 
differentiated cells.  This can be easily assessed with a staining due to the capacity 
of this enzyme to change the conformation of a colorimetric reagent from a soluble 
to a precipitated state (Martí et al., 2013).  
As depicted in Fig. 3.3 A, at passage 3 there were no significant differences in the 
expression of Oct4 and Sox2 between ESCs cultured in LBG, gelatin or MEFsi. In 
contrast, it is observed that the expression of Nanog, which encodes for 
a transcription factor critically involved in self-renewal of ESCs, was only similar in 
ESCs cultured in LBG (0.92-fold) and in MEFsi (1.01-fold), and significantly higher 
than ESCs cultured in gelatin (0.44-fold) or in TCPS (0.57-fold). Furthermore, ALP 
stainings at passage 3 revealed that ESCs cultured in gelatin or in TCPS showed 
more differentiated ALP-negative ESCs (white arrows) than those cultured in LBG 
(Fig. 3.3 C: a-d). In fact, all the colonies in LBG were, similarly to ESCs cultured 
in MEFsi, ALP-positive (red arrow) and exibited regular shape (Fig. 3.3 C: a, b). At 
passage 10, the differences in the expression of pluripotency markers among 
culture conditions became more evident. Nanog expression in ESCs cultured in 
LBG (0.98-fold) was comparable to ESCs cultured in MEFsi or in gelatin, 1- and 
0.77-fold, respectively, and significantly higher than ESCs cultured in TCPS (0.46-
fold) (Fig. 3.3 B). Furthermore, even though Sox2 expression in ESCs cultured in 
LBG (1.13-fold) and in MEFsi (1-fold) was similar, Sox2 expression in ESCs 
cultured in gelatin or in TCPS was significantly lower, 0.51- and 0.39-fold, 
respectively. (Fig. 3.3 B). The more evident differences were observed in the 
expression of Oct4, the pivotal regulator of pluripotency (Shi and Jin, 2010), in 
ESCs grown in LBG coating. Oct4 expression in ESCs cultured in LBG (1.97-fold) 
was approximately the double of the expression in MEFsi (1-fold) or in gelatin (1-
fold) or in TCPS (0.84-fold) (Fig. 3.3 B).  
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At passage 10, the morphology of the ESCs colonies cultured in LBG coating was 
comparable to the morphology of ESCs cultured in MEFsi, resembling the typical 
dome-shape pluripotent colonies (Fig. 3.3 C: a, b). In contrast, ESCs cultured in 
gelatin or in TCPS presented a fibroblast-like morphology, with colonies that clearly 
lost their discreet borders, suggesting ESC differentiation (Fig. 3.3 C: a’-d’). Taken 
together, these data suggest that, unlike ESCs cultured in gelatin coating or TCPS, 
ESCs cultured in LBG coating efficiently maintain their pluripotency even during 
long-term culture.  
 
 
 
Figure 3.3: Preservation of ESCs Pluripotency. Analysis of stem cell markers 
expression, Nanog, Oct4 and Sox2, at passage 3 (A.) and at passage 10 (B.) of cells 
cultured on LBG and in standard conditions. (*) significantly different expression levels in 
LBG compared to gelatin. (#) significantly expression levels in LBG compared to TCPS. (§) 
significantly expression levels in LBG compared to gelatin, TCPS and MEFsi. Data are 
presented as mean + standard error of mean, representative of two independent 
experiments performed in technical triplicates (n=6) C. Representative pictures of mouse 
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ESCs cultured on natural polymers at passage 3 stained for ALP assay (a-d). ESCs 
morphology at passage 10 (a’-d’), cultured in a. 0.1% LBG, b. MEFsi, c. 0.1% Gelatin and 
d. TCPS. Magnification is 100x. White arrow indicates differentiated cells and red arrows 
point pluripotent colonies. 
 
 
3.3.4. ESCs grown on LBG coating maintain their in vitro tri-lineage 
differentiation capacity  
The expression of pluripotency markers is not sufficient to determine if ESCs are 
pluripotent. Only the simultaneous presence of pluripotency markers and the 
demonstration that the ESCs are able to differentiate into cells from all three germ 
layers define them as truly pluripotent (Martí et al., 2013). On the other hand, it 
is important to evaluate this tri-lineage differentiation capacity upon long-term 
culture to evaluate if long exposure to the coating leads to the accumulation of 
cytotoxic effects and to alterations in cell behavior (Klim et al., 2010). Therefore, 
the differentiation capacity was assessed after long-term culture of ESCs in LBG 
coating or in standard conditions mentioned earlier, by in vitro differentiation of 
ESCs through embryoid body (EB) formation. Briefly, undifferentiated mouse ESCs 
were passaged every 3 days at the same cell density for 10 passages in LBG 
coating or in control conditions. At day 30, spontaneous differentiation of mouse 
ESCs was induced by forcing ESCs to aggregate and form three dimensional 
aggregates, known as EBs. ESCs were allowed to differentiate for 10 days. 
Subsequently, at day 10 of differentiation, the EBs were collected for RNA isolation 
and the differentiation evaluated by quantitative analyses of the expression of 
gene markers of the three germ layer. Morphological analysis indicates that the 
cells migrated or extend outwards from the EBs and displayed either epithelial- or 
mesenchymal-like morphologies. Cells were organized in multilayers and 
presented beating foci, thus confirming that the ESCs were differentiated (Fig. 3.4 
A). In the case of ESCs cultured in LBG coating, the EBs also gave rise to more 
complex structures, such as fibrous and more organized structures (Fig. 3.4 A). 
Quantitative analysis revealed that the ESCs cultured in LBG coating or in MEFsi 
presented higher expression of differentiation markers than ESCs cultured in TCPS 
or in gelatin. Indeed, the expression of the endoderm marker Afp was significantly 
higher in ESCs cultured in LBG than in gelatin, MEFsi or TCPS. Nonetheless, no 
significant differences were found in the expression of the endoderm and 
mesoderm marker Gata4 among the culture conditions (Fig. 3.4 B). In addition, 
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the expression of the mesoderm marker Hand1 was similar between all the culture 
conditions, and the expression of another mesoderm marker αSma was 
significantly higher in ESCs cultured in LBG than in gelatin, MEFsi or TCPS (Fig. 3.4 
C). Regarding the differentiation in ectoderm lineages, expression of both βIII-
Tubulin and Nestin in ESCs cultured in LBG was identical to ESCs cultured in MEFsi 
and significantly higher than ESCs cultured in gelatin or TCPS (Fig. 3.4 D). These 
data indicate that ESCs cultured in LBG coating retain their tri-lineage 
differentiation capacity even after long-term culture. In addition, increased 
expression of some of these marker genes in ESCs cultured in LBG when compared 
to ESCs cultured gelatin or TCPS suggests that ESCs cultured in LBG coating retain 
their pluripotency much more efficiently than ESCs cultured in gelatin or TCPS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: In vitro trilineage differentiation. ESCs cultured on LBG coating for 30 
days were induce to differentiate through hanging drops method. A. Morphology of EBs at 
day 10 of differentiation. B-D. Levels of gene expression of germ layer markers of EBs 
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collected after 10 days of differentiation. B. Afp and Gata4 are expressed in endoderm and 
mesoderm. C. Hand1 and αSma mark mesoderm. D. βIII-Tubulin and Nestin are 
ectodermal marker genes. The relative gene expression was normalized to Gapdh and Tbp 
and to MEFsi control. (*) significantly different expression levels in LBG compared to 
gelatin. (#) significantly different expression levels in LBG compared to TCPS. (§) 
significantly different expression levels in LBG compared to gelatin, TCPS and MEFsi. Data 
are presented as mean + standard error of mean, representative of two independent 
experiments, performed in technical triplicates (n=6).  
 
 
As a whole, these data indicate that natural polymer LBG coating is a suitable 
support to maintain pluripotent mouse ESCs in culture, even better than the 
animal-derived gelatin. 
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3.4. DISCUSSION 
 
The polysaccharide LBG, which is commonly used due to its biocompatibility, 
adhesive and thickening properties, revealed to be able to form a coating with 
rough topography. The formation of such a ridged pattern could be attributed to 
the properties of the LBG solution as it is known that, when dissolved, LBG adopts 
a disordered fluctuating random coiled conformation (Lundin and Hermansson, 
1995). Interestingly, our data suggest that when undifferentiated mouse ESCs 
were cultured in LBG coating and in standard culture conditions, the proliferation 
rates were proportional to the roughness of growth surface. Rough surfaces have 
higher contact area which increases the availability of integrin binding sites or cell-
matrix adhesion spots, thus promoting integrin assembly into focal contacts and 
further cell adhesion (Park et al., 2007). Indeed, according to our data, at passage 
1 the total cell number increased in cultures from TCPS to gelatin, which are 
smooth surfaces, followed by LBG and MEFsi that are rough surfaces. Furthermore, 
the same was observed at passage 2 and 3. This suggests that the rough 
topography of the LBG coating is able to promote ESCs growth more efficiently 
than the smoother surfaces provided by TCPS or gelatin coating.  
On the other hand, cell viability assessment showed that 100% of ESCs cultured 
in LBG coating were viable, while the culture in gelatin only provided 89% viability. 
According to I.S. EN ISO 10993-5:2009 a material is considered cytotoxic if cell 
viability becomes lower than 70% (Europeam Commitee for Standardization, 
2009). Even though 89% of cell viability is acceptable, the accumulation of 
unviable cells along the time of culture in gelatin may become problematic, 
especially if it leads to the activation of mechanisms that change the fate of the 
ESCs (Ardehali et al., 2011). In sum, these data indicate that in short-term culture 
LBG coating is better than that of gelatin to support ESC proliferation and viability.  
A biomaterial is considered suitable for culture of pluripotent ESCs when, besides 
supporting growth and viability, it has the capacity to maintain the ESCs 
undifferentiated and their tri-lineage differentiation capacity. Pluripotent cells 
growing as EBs are able to differentiate spontaneously to cell types of all three 
germ layers (Martin and Evans, 1975; Ying et al., 2008). Our data demonstrated 
that EBs composed of ESCs grown in long-term culture in LBG coating gave rise to 
differentiated heterogeneous populations of cells exhibiting different morphologies 
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and tissue-like structures. Furthermore, gene expression analysis revealed the 
presence of derivatives of all three primary germ layers, confirming that ESCs 
grown in LBG coating efficiently maintain their tri-lineage differentiation capacity, 
even upon long-term culture. On the other hand, the colonies of ESCs grown for 
long-term in LBG coating, used for the spontaneous differentiation in EBs, were 
compact with the shape of undifferentiated pluripotent ESC colonies. According to 
the results of ALP staining and, unlike ESCs cultured in TCPS or gelatin coating, all 
the ESCs cultured in LBG coating and on top of MEFsi were ALP-positive. This 
indicates that while LBG coating is able to maintain the ESCs in their pluripotent 
state, ESCs grown gelatin and TCPS are able to differentiate, thus losing their 
pluripotency. In fact, there is a general agreement that topography has an 
important role in cell adhesion, growth and pluripotency (Blin et al., 2010; 
McNamara et al., 2010; Qi et al., 2013). Furthermore, gene expression analysis of 
pluripotency markers after 3 or 10 consecutive passages was comparable or higher 
in ESCs cultured in LBG than ESCs cultured in gelatin or in MEFsi. The differences 
in the expression of pluripotency markers were more evident at passage 10 
highlighting the importance of making long-term assays for the validation of a 
material for ESC culture. The obtained results suggest that LBG coating is able to 
support pluripotent ESCs in culture and that, possibly, LBG is more suitable than 
gelatin as a coating for stem cell research applications. Besides from being an 
animal-derived material, gelatin may also, as shown here, introduce potential 
variability into the cell culture system. Furthermore, when the ESCs are cultured 
in gelatin, part of the population is differentiated during the culture, which is 
consistent with previous reports (Ramírez et al., 2011). Some authors are so 
critical of the usage of gelatin that they use it as a negative control, considering it 
is not the ideal substrate to maintain pluripotent ESCs (Ramírez et al., 2011; Yue 
et al., 2012). The alternative proposed here, the LBG coating, is even more 
economic than gelatin and is a vegetal-derived polymer. The combination of price, 
origin, topography, adhesive and gelling properties, makes LBG a perfect 
candidate to substitute gelatin coating. Indeed, LGB coating seems to be able to 
overcome one of the biggest challenges for culture defined matrices, which is long-
term pluripotent undifferentiated stem cell propagation. 
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3.1.1.  ABSTRACT 
 
Biopolymers (or natural polymers) are an attractive class of biodegradable 
polymers since they are derived from natural sources, easily available, cheap and 
can be modified using suitable reagents. There are several advantages and 
disadvantages of using natural polymers instead of synthetic polymers, being the 
main advantage the high levels of biocompatibility and the principal disadvantage 
the possible batch-to-batch and manufacturer-to-manufacturer variation. In fact, 
LBG, our biomaterial of interest, is a galactomannan, obtained from endosperm of 
the seeds of the carob tree, in which it acts as a carbohydrate reserve during 
germination.  
The purpose of the present chapter is to validate the use of LBG instead of gelatin 
for embryonic stem cell culture research, even when LBG is obtained from different 
sources and with different purification levels. In general, the results showed no 
significant differences between LBG from Roeper, Industrial Farense and purified 
LBG from Industrial Farense, but still similar or potentially better than gelatin. 
These data confirms the application potential of LBG for pluripotent ESC culture. 
 
 
Keywords: batch-to-batch and manufacturer-to-manufacturer variation, 
biopolymers, embryonic stem cell culture, locust bean gum, gelatin substitute 
growth support. 
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3.1.2.  INTRODUCTION 
 
Featuring different physicochemical properties, galactomannans are a versatile 
material used for many applications: they are excellent stiffeners and stabilizers 
of emulsions, and the absence of toxicity allows their use in the textile, 
pharmaceutical, biomedical, cosmetic and food industries (Vipul D Prajapati et al., 
2013). 
Our galactomannan of interest, LBG, consists of galactose and mannose in the 
ratio 1:4 and derived from the endosperm (gum) of carob seeds (Dionísio and 
Grenha, 2012). Despite the advantage of deriving LBG from a natural source, 
plant-based materials display variations in their properties according to the type 
of culture, growth conditions, collecting season, method of extraction, purification 
process and manufacturing practices (Beneke et al., 2009). In fact, in the case of 
LBG the ratio of galactose to mannose is approximately 1:4, but it differs 
depending on the age of the plant, growth conditions of the plant during production 
and the method of extraction of the polysaccharide (Dionísio and Grenha, 2012). 
In addition, as most of the galactomannans used in pharmaceutical technology and 
cosmetics, which are usually unpurified gums (Üner and Altinkurt, 2004),  LBG can 
contain impurities. These include husk, germ, residual amounts of ethanol or 
isopropanol and microbiological contaminations that can affect the protein and ash 
content, which may affect cells cultured in the presence of LBG. In terms of 
composition, usually the commercial samples of LBG contain approximately 5–
12% moisture, 1.7–5% acid-soluble ash, 0.4–1.0% ash, and 3–7% protein (Vipul 
D. Prajapati et al., 2013). In our perspective, the variations of LBG concerning the 
batch, producer and possible impurities were sufficient to motivate an additional 
study to determine whether LBG from different sources and purified versus non 
purified are equally able to replace gelatin in mouse ESC culture. 
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3.1.3.  RESULTS 
In the present study we used LBG from Roeper and Industrial Farense (LBG I. F.), 
and purified LBG from Industrial Farense (LBG I.F.P.), to support pluripotent 
mouse ESCs in culture. 
 
3.1.3.1. Characterization of LBG 
3.1.3.1.1. Chemical composition 
LBG is a high molecular weight branched galactomannan polysaccharide consisting 
more in detail of a linear chain of (1→4)-linked β-D-mannopyranosyl units with 
evenly spaced (1→6)-linked α-D-galactopyranosyl residues as side chains. In 
general, it presents a molecular weight range of 50 to 1000 kDa (Dakia et al., 
2008). 
LBG from Roeper has origin in Spain, Italy and Turkey, and is commercialized as 
a white to yellowish-white colored powder containing galactomannan (75% 
minimum), water (14% maximum), protein (7% maximum) and ash (1.2% 
maximum). The LBG that was kindly given by Industrial Farense, was provided 
without quality or analysis datasheet. The latter LBG was purified by heating 
followed by precipitation, filtration and drying. It was assumed that samples of 
clarified or purified LBG should contain approximately 3–10% moisture, 0.1–3% 
acid-soluble matter, 0.1–1% ash, and 0.1–0.7% protein (Dakia et al., 2008). 
 
3.1.3.1.2. Topographic characterization of LBG coating 
We started by characterizing the coatings used for ESC culture by FE-SEM. To do 
that, LBG and gelatin aqueous solutions were incubated overnight in TCPS 
coverslips. The next day, the excess of solution that was not adsorbed to TCPS 
surface was removed and samples were processed for FE-SEM. 
FE-SEM micrographs revealed that the LBG coating from Roeper acquires a 
relatively organized striated topography (Fig. 3.5 A). The coating disposition 
acquired for LBG from Industrial Farense (LBG I.F.) was also rough, but presented 
a somewhat different pattern when compared to LBG from Roeper (Fig. 3.5 B, C). 
Both purified and non-purified coatings generated using LBG from Industrial 
Farense, form a rough and porous coating (Fig. 3.5 B, C). Therefore, no apparent 
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differences were found between purified and non-purified LBG from the same 
supplier (Fig. 3.5 B, C). In contrast, the gelatin coating and negative control TCPS 
exhibited an almost smooth surface (Fig. 3.5 D, E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: FE-SEM photographs of coatings prepared for ESC culture. A. 0.1% of 
LBG from Roeper. B. 0.1% of LBG from Industrial Farense. C. 0.1% of purified LBG from 
Industrial Farense. D. 0.1% of gelatin E. TCPS. LBG forms a rough film. 
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3.1.3.2. Cell Proliferation 
 
In order to evaluate the ability of LBG to support cell adhesion and growth, 
undifferentiated mouse ESCs were cultured in 0.1% of non-purified LBG from 
Roeper and from Industrial Farense, 0.1% of purified LBG from Industrial Farense, 
0.1% of gelatin and in negative control TCPS for 3 passages (9 days). According 
to the analysis of cell morphology at passage 1 and 3, colonies of ESCs cultured in 
LBG displayed a round, regular and dome-shape characteristic of pluripotent 
colonies (Fig. 3.6 A-C, A’-C’). In contrast, the majority of ESCs cultured in gelatin 
or TCPS showed cytoplasmic extensions suggesting spontaneous differentiation 
(Fig. 3.6 C: D, D’, E, E’). In ESC culture, a heterogeneous cell population or 
changes in cell morphology can be a first indication that culture is entering in 
differentiation (Roccio et al., 2013). Furthermore, at the morphological level, there 
were no evident differences between ESCs cultured in LBG from Roeper or from 
Industrial Farense, purified or non-purified. This indicates that LBG seems to be 
able to support pluripotent ESC colonies independently of the supplier. 
Analysis of the proliferation at day 3 showed that LBG from Roper was able to 
promote better ESCs proliferation than gelatin (Fig. 3.7 A). At day 6 and 9, 
however no significant differences were found in cell growth between ESCs 
cultured in LBG coatings or in gelatin. In addition, at days 3, 6 and 9, ESCs cultured 
in commercial LBG from Roeper proliferated significantly more than ESCs cultured 
in commercial LBG from Industrial Farense (Fig. 3.7 A). Furthermore, no significant 
differences were observed in proliferation of ESCs cultured in purified versus non-
purified LBG from Industrial Farense (Fig. 3.7 A). This suggests that the 
purification step does not favor the proliferation of ESCs in LBG. 
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Figure 3.6: Cell Morphology. Representative contrast phase images of E14GFP8 mouse
ESCs at day 3 (A-E) and day 9 (A’-E’) of culture in A. 0.1% of LBG from Roeper. B. 0.1% 
of LBG from Industrial Farense. C. 0.1% of purified LBG from Industrial Farense. D. 0.1% 
of gelatin E. TCPS. Magnification is 100x. 
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In addition to cell proliferation, cell viability was also tested by incubating the ESCs 
with trypan blue, at day 3 and day 9 of culture, and counting the number of death 
versus viable cells. According to our data, no significant differences in the viability 
of ESCs cultured in LBG coatings or in gelatin at day 3, but at day 9 ESCs cultured 
in LBG from Roeper seemed to present better viability than ESCs cultured in gelatin 
(Fig. 3.7 B). At day 3, the percentage of viable ESCs cultured in LBG from Roeper 
was significantly higher than in ESCs cultured in non-purified LBG from Industrial 
Farense (Fig. 3.7 B). At day 9, however the viability was similar among all the 
ESCs cultured in the different types of LBG coatings. Furthermore, at day 3 and 9, 
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Figure 3.7: Cell proliferation and viability assays. A. ESCs were cultured for 9 days. 
Cell growth (fold) is presented as the ratio between cells and initial cell number.  B. Cell 
viability results obtained at day 3 and 9 of culture were determined by trypan blue 
incubation. Cell viability is represented as percentage of viable cells to the total number of
cells. (*) significantly different compared to gelatin (p<0.05).  Data presented as mean + 
SD from one independent experiment performed in technical triplicates (n=3). 
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there were no significant differences in cell viability between ESCs cultured in 
purified and non-purified LBG from Industrial Farense, indicating that the 
purification procedure did not influence the ability of LBG to support ESC viability 
(Fig. 3.7 B). Even though LBG from Roper seemed to support the viability of ESCs 
more efficiently than LBG from Industrial Farense, all LBG coatings proved to be 
suitable to replace gelatin, as ESC proliferation and viability in LBG coatings was 
equivalent or higher than ESCs grown in gelatin. 
 
 
3.1.3.3. Analysis of stem cell markers 
As previously mentioned, long-term support of pluripotent ESCs in culture is an 
important issue to validate the use of a material for ESC culture. With this in mind, 
we examined whether LBG coating could support mouse E14GFP8 ESCs self-
renewal for 3 and 10 passages. Pluripotency was assessed through the analysis of 
alkaline phosphatase activity and Nanog, Oct4 and Sox2 expression at passage 3. 
According to our data, there were no significant differences in the expression of 
Nanog, Oct4, Sox2 between ESCs cultured in LBG from Roeper or in gelatin (Fig. 
3.8 A). Furthermore, there were no significant differences in the expression of 
pluripotency markers between LBG from Roeper and non-purified LBG from 
Industrial Farense (Fig. 3.8 A). Nonetheless, the expression of Nanog and Sox2 in 
ESCs cultured in purified LBG from Industrial Farense was significantly higher than 
in ESCs cultured in gelatin (Fig. 3.8 A). These two genes were also significantly 
higher in purified LBG when compared to non-purified LBG from Industrial Farense 
and, hence, the purification of LBG seems to be beneficial for the maintenance of 
ESC pluripotency (Fig. 3.8 A). In addition, all the colonies grown in LBG from 
Roeper, purified and non-purified LBG from Industrial Farense were ALP-positive 
and exibited regular shape typical of plutipotent colonies (Fig. 3.8 B: a-c). On the 
other hand, analysis of the activity of ALP at passage 3 revealed that ESCs cultured 
in gelatin or in TCPS presented more differentiated ALP-negative ESCs than ESCs 
cultured in LBG (Fig. 3.8 B). 
At passage 10, even though the expression of pluripotency markers of ESCs 
cultured in LBG coatings was, in some cases, equivalent to ESCs cultured in gelatin 
(Fig. 3.9 A), the ESCs cultured in LBG from Roeper, purified and non-purified LBG 
from Industrial Farense coatings grew as compact colonies characteristic of 
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undifferentiated pluripotent stem cells (Fig. 3.9 B: a-c). In contrast, ESCs cultured 
in gelatin or in TCPS presented some cells with a fibroblast-like morphology, with 
colonies that clearly lost their well-defined borders, suggesting ESC differentiation 
(Fig. 3.9 B: d, e). Taken together, these data suggest that ESCs cultured in LBG 
coatings from different producers, purified or non-purified are, at least, equally 
efficient as gelatin in maintaining pluripotency upon long-term culture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Pluripotency evaluation at passage 3. A. Analysis of expression of Nanog, 
Oct4 and Sox2 pluripotency markers and representative pictures of mouse ESCs stained 
for ALP activity (B.) of ESCs cultured in a. 0.1% of LBG from Roeper, b. 0.1% of LBG from 
Industrial Farense, c. 0.1% of purified LBG from Industrial Farense, d. 0.1% of gelatin, e.
TCPS for 9 days. Magnification is 100x. (*) significantly different in LBG compared to 
gelatin (p<0.05).  Data presented as mean + SD from one independent experiment 
performed in technical triplicates (n=3). 
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Figure 3.9: Pluripotency and morphology of ESCs at passage 10. A. Expression of 
Nanog, Oct4 and Sox2 pluripotency markers and representative phase contrast pictures
of ESCs (B.) cultured in a. 0.1% of LBG from Roeper, b. 0.1% of LBG from Industrial
Farense, c. 0.1% of purified LBG from Industrial Farense, d. 0.1% of gelatin, e. TCPS for 
30 days. Magnification is 100x. (*) significantly different compared to gelatin (p<0.05). 
Data presented as mean + SD from one experiment performed in technical triplicates
(n=3). 
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3.1.3.4. In vitro differentiation of ESCs 
As mentioned earlier, pluripotent cells have the ability to differentiate into cell 
types of all organs and tissues of a living organism, so it is fundamental that ESCs 
cultured in vitro retain this feature. To study early stages of differentiation, ESCs 
are normally differentiated into three-dimensional structures called embryoid 
bodies (EBs). The potential of differentiation of ESCs cultured on the different LBG 
coating was tested by differentiating ESCs in EBs after enduring 10 passages in 
LBG, gelatin or TCPS. At day 5 of differentiation EBs were plated onto an adherent 
surface. ESCs were differentiated for 10 days. At the end of differentiation, it was 
possible to observe elongated cell projections emanating out from EBs. In addition, 
all EBs differentiated into heterogeneous populations of cells displaying 
morphological evidences of endothelial cells, fibroblasts and other cell types, and 
were organized resembling tissue-like structures (Fig. 3.10 A). This suggests that 
cells cultured for a long term in LBG retain their tri-lineage differentiation capacity 
(Fig. 3.10 A). Indeed, the differentiation was confirmed by quantitative analysis of 
markers of ectoderm (βIII-Tubulin and Sox1), endoderm (Afp, Gata4) and 
mesoderm (Gata4, Hand1, and αSma). According to qPCR data, ESCs cultured in 
LBG coatings obtained higher or comparable expression of markers of all three 
primary germ layers than ESCs cultured in TCPS or in gelatin. As expected, the 
lowest expression of differentiation markers was obtained for ESCs cultured for 
long-term in TCPS, indicating that the ESCs cultured in these conditions lost at 
least in part the capacity to differentiate in all three primary germ layers. The 
endoderm and mesoderm markers Afp and Gata4 were similarly expressed in ESCs 
cultured in LBG from Roeper, in LBG from Industrial Farense, purified or non-
purified, or in gelatin (Fig. 3.10 B). In addition, the expression of the mesoderm 
marker Hand1 was similar between all the culture conditions, but the expression 
of another mesoderm marker, αSma, was significantly higher in ESCs cultured in 
LBG from Roeper and purified LBG from Industrial Farense LBG than in gelatin (Fig. 
3.10 C). The expression of Hand1 and αSma in ESCs cultured in LBG from Roeper 
and LBG from Industrial Farense were equivalent (Fig. 3.10 B). Regarding the 
differentiation into ectodermal lineages, expression of both βIII-Tubulin and Nestin 
in ESCs cultured in LBG from Roeper was identical to ESCs cultured in LBG from 
Industrial Farense, purified or non-purified, but significantly higher than ESCs 
cultured in gelatin (Fig. 3.10 D).  
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In global, these data shows that ESCs cultured in LBG coatings retain their tri-
lineage differentiation capacity even after long-term culture. Furthermore, 
increased expression of some of the genes from the different germ layers in ESCs 
cultured in LBG indicates that they retain the pluripotency much more efficiently 
than ESCs cultured in gelatin or TCPS. 
Figure 3.10. In vitro tri-lineage differentiation. A. Morphology of EBs at day 10 of 
differentiation. B-D. Levels of gene expression of germ layer markers of EBs collected
after 10 days of differentiation. B. Afp and Gata4 are expressed in endoderm and 
mesoderm. C. Hand1 and αSma mark mesoderm. D. βIII-Tubulin and Nestin are 
ectodermal marker genes. The relative gene expression was normalized to Gapdh and Tbp
and to Gelatin control. (*) significantly different expression levels compared to gelatin. 
Data are presented as mean + standard error of mean, representative of two independent
experiments, performed in triplicate (n=6). 
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3.1.4.  DISCUSSION 
LBG or E410 is one of the three major galactomannans of commercial importance 
in food and non-food industries, but its application in research is almost 
unexplored. In the previous chapter, we demonstrated the ability of LBG to support 
mouse ESC culture. The possibility remained, however, that the properties of this 
plant-based material could be affected by the geographic location of the source of 
the plants, collecting season or manufacturer. Therefore, the aim of the present 
chapter was to validate the generic use of LBG in ESC culture. 
According to our data, the topography of LBG coatings from Roeper and from 
Industrial Farense was somewhat different. Nevertheless both LBG coatings gave 
rise to a slightly rough surface, contrasting to the smooth gelatin coating. The 
topography of purified and non-purified LBG from Industrial Farense was similar, 
suggesting that the purification process does not affect the ability of LBG to give 
rise to slightly rough and porous films. ESCs are anchorage-dependent cells and 
normally function better if they are grown on a permeable or porous surface (Ryan, 
2008). Indeed, it is known that ESCs  encounter and respond to topography in vivo 
at length scales ranging from the nano- to microscale (Dolatshahi-Pirouz et al., 
2011; Hatano et al., 2013; Leclerc et al., 2013). In addition, there is a general 
agreement that topography has an important role in cell adhesion, growth and 
pluripotency (Blin et al., 2010; McNamara et al., 2010; Qi et al., 2013). Therefore, 
the topography acquired by LBG coating probably brings an asset to the ESC in 
vitro cell culture systems making it resembling closer the in vivo situation. In 
general, according to our results, when ESCs were cultured in LBG coatings for a 
short-term culture, no significant differences were found in cell growth between 
ESCs cultured in LBG coatings or in gelatin, and also between ESCs cultured in 
purified or non-purified LBG. This suggests that all LBG coatings were suitable to 
grow ESCs, independently of the producer and additional purification step. Analysis 
of the tri-lineage differentiation capacity by quantifying the expression of 
pluripotency markers showed that ESCs cultured in purified or non-purified LBG 
coatings from different producers, were able to maintain their pluripotency upon 
long-term culture. LBG coatings allowed maintenance of pluripotency similarly, if 
not even more efficiently than ESCs cultured in gelatin. Accordingly and as 
presented in the previous chapter, in contrast to ESCs grown in gelatin, all ESCs 
grown in LBG for 3 or 10 passages were ALP positive and organized in compact 
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colonies with well-defined borders. This is consistent with the ESCs cultured for a 
long-term in LBG coatings retaining much more efficiently their tri-lineage 
differentiation capacity than ESCs cultured in gelatin.  
Natural gums, such as LBG, are natural polymers commercially available, which 
mainly consist of carbohydrates sometimes with small amounts of proteins and 
minerals. Therefore, depending on the application, a purification step could be 
required to purify natural products from water solutions. For example, in the 
formulation of nanoparticles for drug-delivery, the impurities may alter the 
physico-chemical and release characteristics of nanoparticle system, so the 
purification of the natural polymers prior to nanoparticles formulation is highly 
recommended (Dalwadi et al., 2005). In addition, sometimes the purification is 
required to ensure the purity of the protein or polysaccharide before implantation 
to avoid activating an immune response (Willerth et al., 2008). In the present 
comparative study, one of the main aims was to test whether the ash and protein 
content affects the pluripotency of ESCs in culture or if the ESCs respond mainly 
to galactomannan, the major component of LBG. The purified LBG has higher 
galactomannans content and no longer contains the cell wall structures or 
materials (Kawamura, 2008). According to ESC proliferation, viability, pluripotency 
and differentiation data, ESC response to purified or non-purified LBG was almost 
equivalent, with the exception of the pluripotency maintenance at passage 3, in 
which the purification of LBG revealed to be beneficial. Taking together, the fact 
that the results using the purified gum match those obtained with the commercial 
one, indicates that protein and ash impurities did not have any deleterious effect 
on the ESCs. Furthermore, since ESC response among the different LBG coatings 
was equivalent the observed results may be attributed to the galactomannan.  
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4.1. ABSTRACT 
 
Conventionally, embryonic stem cells (ESCs) are cultured on gelatin or over a 
mitotically inactivated monolayer of mouse embryonic fibroblasts (MEFsi). 
Considering the lack of versatile, non-animal-derived and inexpensive materials 
for that purpose, we aimed to find a biomaterial able to support ESC growth in a 
pluripotent state that avoids the need for laborious and time-consuming MEFsi 
culture in parallel with mouse ESC (mESC) culture. Undifferentiated mESCs were 
cultured in a new nanofiber material designed for ESC culture, which is based on 
the self-assembly of a triblock copolymer, poly(ethyleneglycol-β-trimethylsilyl 
methacrylate-β-methacrylic acid), conjugated with the peptide glycine–arginine–
glycine–aspartate–serine, to evaluate its potential application in ESC research. 
The morphology, proliferation, viability, pluripotency and differentiation potential 
of ESCs were assessed. Compared to conventional stem cell culture 
methodologies, the nanofibers promoted a higher increase in ESCs number, 
enhanced pluripotency and were able to support differentiation after long-term 
culture.  
This newly developed synthetic system allows the elimination of animal-derived 
matrices and provides an economic method of ESC culture, made of a complex 
network of nanofibers in a scale similar to native extracellular matrices, where the 
functional properties of the cells can be observed and manipulated. 
 
 
Keywords: embryonic stem cells, embryonic stem cell culture, gelatin substitute, 
growth support, pluripotency, polymeric nanofibers 
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4.2.  INTRODUCTION  
Stem cell research has grown from unexplored to becoming an important field in 
biomedical sciences today.  ESCs have theoretically two unique abilities, an 
unlimited self-renewal capacity and multilineage differentiation potential 
(pluripotency; Evans and Kaufman 1981). Indeed, a deeper understanding of the 
basic biology of stem cells holds the key to unlock new hopes to various so-far 
incurable human diseases (Silva et al., 2012).  
Even though the first mouse ESC lines were derived three decades ago (Evans and 
Kaufman 1981) and standard protocols for ESC derivation and maintenance are 
widely used today, the technical difficulties of these protocols still pose a challenge 
for many investigators attempting to produce pluripotent ESCs at high quality 
levels. The gold standard supportive material for in vitro mESC culture is MEFsi, 
which allows mESCs to continue proliferating without differentiating (E. Michalska, 
2007). Besides the immunity problems and batch-to-batch variation, the use of 
MEFsi as a support for ESC culture is a laborious and time-consuming process. 
MEFs are primary cells and stop dividing after a couple of passages and hence they 
need to be isolated freshly from time to time, and one week is required to reach 
the correct confluency to perform ESC culture (E. Michalska, 2007). Concerning 
that, many efforts are being made to avoid the use of MEFs without losing ESC 
pluripotency through replacing the supportive MEFsi by synthetic systems. The 
major challenge is to find a cheap, defined, user-friendly and feeder-free condition 
that properly mimics the ESC niche, in order to obtain high quality undifferentiated 
ESCs. Many efforts have been made to closely mimic the real microenvironment 
of cells. So far, a wide range of approaches have been explored, including the use 
of the new 2i defined medium (Ying et al., 2008), coating with proteins (Heng et 
al., 2012) and peptides (Klim et al., 2010), carbon nanotubes (Lizundia et al., 
2012), hydrogels (Geckil et al., 2010), a diversity of natural and synthetic scaffolds 
from different sources (Li et al., 2010) and nanofibers (nfs; Nur-E-Kamal et al., 
2006). Nanofibers have exciting geometry properties that have drawn much 
attention recently, particularly in the field of ESCs and tissue engineering. Special 
properties of nanofibers, such as the ability of mimicking the arrangement of fibers 
and fibrils of the ECM makes them suitable for a wide range of biomedical 
applications that are improved when combined with ESCs (Kanani and Bahrami, 
2010).  
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Here, we report the synthesis of poly(ethyleneglycol-β-trimethylsilyl methacrylate-
β-methacrylic acid)-Glycine-Arginine-Glycine-Aspartate-Serine (PEG-PTMSMA-
PMAA-GRGDS) - based nanofibers and the capability of this new artificial nanofiber 
network to support mouse ESC culture.  
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4.3. RESULTS 
4.3.1. Synthesis and characterization of nanofibers 
The mechanism of PEG-PTMSMA-PMAA-GRGDS nanofiber formation involves three 
phases: first, the self-assembly of the amphiphilic copolymer into vesicles; second, 
conversion of polymeric vesicles into nanofibers via a stacking process; and third, 
incorporation of GRGDS into the nanofibers surface by electrostatic interaction 
(Fig. 4.1 A).  
 
 
Figure 4.1: Synthesis and characterization of nanofibers. A. Synthetic approach to 
PEG–PTMSMA–PMAA and nanofibers formation: self-assembly of the amphiphilic co-
polymer into vesicles, conversion into nanofibers via stacking, and GRGDS incorporation. 
A 
B 
Chapter IV – Nanofibers for ESC culture 
103 
B. Cryo-TEM images of polymeric nanofibers by negatively staining with 1% uranyl acetate. 
These nanofibers are predisposed to form a mesh. 
 
 
 
PEG-PTMSMA-PMAA was synthesized by reversible addition-fragmentation chain 
transfer (RAFT) polymerization (Chiefari et al., 1998) from the diblock copolymer 
-(O-ethylxanthate)--methyl PEG-PTMSMA as macro-chain transfer agent 
(macro-CTA) and methacrylic acid (MAA). A monomer:macro-CTA ratio of 106:1 
and AIBN (1 mol% of the monomer), as radical initiator were used (Fig. 4.1 A). 
The polymer was characterized by 1H NMR spectroscopy triple-detection GPC, 
FTIR, and MALDI-TOF. A DPn value of 94 was inferred from the NMR peak area at 
3.64-3.72 ppm (CH2 in PEG) and those at 1.09-1.19 ppm (CH3 in TMSMA and MAA) 
and 0.06-0.10 ppm [(CH3)3Si in TMSMA]. GPC analysis reveals a monomodal 
molecular weight distribution. The presence of TMSMA units was patent on both 
the FTIR and NMR spectra as evidenced by the bands at 1255, 1181 and 846 cm-
1 { and [Si(CH3)3], respectively} and the singlets at 0.06 and 0.10 ppm 
[(CH3)3Si]. On the MALDI-TOF spectrum, interpeak distances corresponding to the 
masses of the three repeating units (44 for EG, 86 for MAA, and 158 for TMSMA) 
were observed. 
Self-assembly of the polymer into nanofibers was achieved by means of its 
solubilization in an aqueous medium through sonication. The synthetic nanofibers 
were observed by Cryo-TEM and found to be 1-2 µm long and approximately 30 
nm diameter (Fig. 4.1 B). 
 
4.3.2. Cell adhesion 
Analysis of the expression of β1-Integrin revealed that culture of undifferentiated 
ESCs in 10 and 100 µg/ml  of nanofibers for 13 days results in a significantly higher 
expression of β1-Integrin (1.32- and 1.55-fold, respectively) when compared to 
gelatin and MEFsi (1.10 and 1, respectively) (Fig. 4.2 A). Furthermore, ESCs 
cultured in 100 µg/ml of nanofibers presented significantly higher expression levels 
of Collagen type I alpha 1 (Col1α1; 0.12-fold) than standard polystyrene culture 
plates and gelatin (0.08- and 0.09-fold, respectively) (Fig. 4.2 B). Furthermore, 
previous experiments already revealed the importance of GRGDS bioconjugation 
with PEG-PTMSMA-PMAA nanofibers in ESCs adhesion and growth (Fig. 4.3). These 
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data suggest that nanofibers bioconjugated with GRGDS are able to improve cell 
adhesion by inducing the expression of adhesion molecules that will allow the 
reorganization of the microenvironment and incorporation in a fiber-based matrix.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Cell Adhesion. Expression of endogenous ECM proteins and adhesion 
proteins in ESCs grown for four subcultures on PEG-PTMSMA-PMAA-GRGDS nanofibers and 
under standard conditions.  A. Adhesion marker, levels of β1-integrin gene expression; (*) 
significantly different expression levels between nanofibers, MEFsi and gelatin (p<0.05). 
B. Endogenous ECM protein marker, levels of  Col1α1 gene expression; (#) significantly 
different expression levels between nanofibers and gelatin and tissue culture polystyrene 
plates (TCPS) (p<0.05). The relative expression was normalized to Gapdh and to MEFsi 
control. 
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Figure 4.3: Cell proliferation test performed at day 3 of ESC culture in untreated 
polystyrene (PS), MEFsi, 0.1% of gelatin, 5 µM of GRGDS, PEG-PTMSMA-PMAA nanofibers 
and PEG-PTMSMA-PMAA nanofibers bioconjugated with 5 µM GRGDS. (***) statistically 
differences among the group (p<0.001). Data presented as mean + SD for n=6. 
 
 
4.3.3. Cell Proliferation 
As a first approach to evaluating the capacity of the nanofibers to sustain 
pluripotent ESCs cultures, we tested whether the nanofibers were able to support 
mESCs adhesion and growth. Undifferentiated E14GFP8 ESCs were cultured for 3 
and 5 days on different concentrations of PEG-PTMSMA-PMAA-GRGDS nanofibers 
and compared to cultures in MEFsi, gelatin and TCPS used as control conditions. 
The morphology, viability and the proliferation of the cells were assessed. 
Morphological analysis of mESCs cultured for 5 days on nanofibers (Fig. 4.4 A’, B’, 
C’) showed that colonies were tightly-packed, dome-shaped and presented clear 
and defined borders, similar to the colonies obtained when using MEFsi as 
substrate (Fig. 4.4 D’). Conversely, ESCs cultured in gelatin and in TCPS plates 
lost the capacity of colony formation, presented an irregular shape and acquired 
undefined borders, a typical characteristic of loss of pluripotency (Fig. 4.4 E, E’, F, 
F’).  
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Figure 4.4: Cell morphology. Representative images of E14GFP8 embryonic stem cells 
during 3 (A-F) and 5 (A’-F’) days in culture. The wells were covered by: A. 100 µg/ml nf, 
B. 50 µg/ml nf, C. 10 µg/ml nf. D. MEFsi E. 0.1% Gelatin, F. TCPS. Magnification is 100x.  
 
After 3 days in culture, the cell growth in 100 and 50 µg/ml of nanofibers was 
16.04- and 15.27-fold respectively, which was significantly higher than the 10.62-
fold observed in TCPS plates. In addition, no significant difference was observed 
in proliferation between 100, 50, 10 µg/ml of nanofibers, gelatin and MEFsi at day 
3 of culture (Fig. 4.5 A). On the other hand, ESC proliferation in nanofibers for 5 
days was higher than not only the cultures in TCPS but also cultures in gelatin. 
Concurrently, 50 µg/ml of nanofibers promoted a 27-fold increase in cell number, 
which is significantly higher than that observed in gelatin (17.63-fold) or TCPS 
         MEFsi                       Gelatin                      TCPS
Day 3 
 
 
 
 
 
 
 
Day 5 
             D                               E                          F 
 
 
 
 
                       D’                              E’                     F’
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(14.53-fold) (Fig. 4.5 A). Therefore, the results obtained for the proliferation of 
ESCs in PEG-PTMSMA-PMAA-GRGDS nanofibers in a short-term culture were 
similar or, in some cases, even better than those in gelatin. This suggests that the 
nanofibers may be used to replace gelatin in supporting ESC growth.  
The viability ratio of ESCs was approximately 1 for all the tested conditions 
indicating that viability maintenance was independent from the culture conditions 
and the time of culture (Fig. 4.5 B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Cell proliferation.  A. Cell proliferation and viability tests (B.) performed 
during 3, 5 of ESC culture. Cell growth (fold) is presented as the ratio between viable cells 
and initial cell number. Viability ratio is the ratio between the number of viable cells and 
total number of cells. (*) Significantly different cell number in nanofibers compared with 
negative control value (TCPS) (p<0.05). (#) Significantly different cell number in 
nanofibers compared with gelatin. Data presented as mean + SD for n=6. 
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4.3.4. Maintenance of Pluripotency  
The pluripotent status of stem cells was detected by ALP test performed in ESCs 
cultured in 100, 50 and 10 µg/ml PEG-PTMSMA-PMAA-GRGDS nanofibers and 
under control conditions. Undifferentiated pluripotent stem cells presented 
elevated levels of ALP, therefore ALP staining was used to distinguish between 
pluripotent and differentiated cells (Tsuji et al., 2008). ESCs were passaged every 
3 days at the same density and the ALP test was performed at passage 1 (day 3) 
and at passage 5 (day 15). ALP staining revealed that, contrarely to ESCs cultured 
in gelatin (Fig. 4.6 E, E’) or TCPS (Fig. 4.6 F, F’), ALP activity is present in all cells 
cultured in nanofibers independently of the time of culture (3 or 15 days) (Fig. 4.6 
A, A’, B, B’, C, C’). Indeed, ESCs cultured on nanofibers (Fig. 4.6, A, A’, B, B’, C, 
C’) resemble more the colonies that form when ESCs are cultured on a monolayer 
of fibroblasts where all cells are ALP-positive and the colonies are dome-shaped 
(Fig. 4.6 D, D’). These results suggest that nanofibers may be used as an 
alternative to conventional gelatin to support the growth of undifferentiated ESC 
cultures. 
Quantitative RT-PCR for stem cell markers was performed using total RNA isolated 
from ESCs at passage 4. After 13 days, ESCs cultured in 10 and 100 µg/ml 
nanofibers presented Oct4 expression levels of 1.37- and 1.24- fold, which were 
significantly higher than ESCs cultured in MEFsi (one-fold), gelatin (1.09-fold) or 
TCPS (0.99-fold) (Fig. 4.7). As Oct4 is one of the major regulators of ESC 
“stemness” (Shi and Jin, 2010), these results suggest that the nanofibers not only 
support but also stimulate further ESC “stemness”. Furthermore, ESCs cultured in 
10 µg/ml nanofibers also presented Nanog expression level similar to that of ESCs 
cultured in MEFsi (Fig. 4.7).  Moreover, the expression levels of Sox2 in ESCs 
cultured in 10 µg/ml nanofibers (0.72-fold) were higher than ESCs cultured in 
gelatin (0.65-fold) or TCPS (0.59-fold) (Fig. 4.7).  
Taken together, these data suggest that mESCs cultures in the nanofibers remain 
self-renewable. 
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Figure 4.6: Maintenance of Pluripotency. Representative images of ESCs stained for 
ALP after 3 (A-F) and 15 days (A’-F’) of culture. The wells were covered by: A. 100 µg/ml 
nf, B. 50 µg/ml nf, C. 10 µg/ml nf D. MEFsi, E. 0.1% Gelatin, F. TCPS. Magnification is 
100x. The red arrows indicate the differentiated cells and the green arrow indicates the 
pluripotent colonies with a regular shape. 
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Figure 4.7: Maintenance of Pluripotency. Expression of the pluripotency markers 
Nanog, Oct4 and Sox2 in cells cultured on PEG-PTMSMA-PMAA-GRGDS nanofibers, and 
under standard conditions, for four subcultures. (*) significantly different expression levels 
in nanofibers compared with gelatin, MEFsi and TCPS (p<0.05); (#) significantly different 
expression levels compared with TCPS (p<0.05).  
 
 
 
4.3.5. Tri-lineage differentiation  
Determination of long-term effects of nanofibers is important in screenning 
nanomaterials for their potential benefits or pathogenic properties. Therefore, we 
tested whether the nanofibers could support ESC differentiation potential over 
multiple passages.  
ESCs were subcultured in nanofibers and under standard conditions for 10 
passages, then induced to form EBs by the hanging drops method and 
differentiated for 10 days. At day 10 of differentiation, some fibroblast-like cells 
had migrated out to form a halo around the EBs and the cultures become dense, 
confluent and multilayered (Fig. 4.8 A). Different structures with diverse types of 
organization and arrangement had formed (e.g. beating foci) suggesting that cells 
cultured for a long term in nanofibers retain their tri-lineage differentiation 
capacity (Fig. 4.8 A). Indeed, these results were confirmed by qRT for markers of 
ectoderm (βIII-Tubulin and Sox1), mesoderm (Hand1 and αSma) and endoderm 
(Afp and Gata4) (Fig. 4.8 B). According to our qRT data, ESCs cultured in 50 and 
#  
Pluripotency
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10 µg/ml nanofibers for 30 days were able to give rise to the three germ layers 
more efficiently than the MEFsi and gelatin (Fig. 4.8 B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 EBs ∆∆ Cq 100 50 10 
µg/ml nf
MEFsi  Gelatin TCPS 
Ectoderm 
 βIII-Tubulin 1.13 1.47 1.54 1.39 1.33 1.88 
Sox 1 0.22 0.40 0.65 1.02 0.58 0.61 
Mesoderm 
Hand 1 0.53 0.65 1.05 0.98 1.53 1.79 
αSma 0.97 1.32 0.50 1.01 0.59 0.73 
Endoderm 
Afp 0.46 0.89 0.42 1.01 0.63 1,76 
Gata 4 0.06 0.44 0.47 1.14 0.47 0.34 
 
 
 
 
 
 
Figure 4.8: Tri-lineage Differentiation. Differentiation potential of ESCs cultured on 
nanofibers for 30 days. A. Morphology of EBs at day 10 of differentiation. B. Levels of gene 
expression of germ layer markers in EBs collected at day 10 of differentiation, βIII-Tubulin 
and Sox1 for ectoderm, Hand1 and αSma for mesoderm and Afp and Gata4 for endoderm 
and mesoderm. The relative gene expression was normalized to Gapdh and Tbp and to 
MEFsi control. Data are from two biological and two technical replicates, performed in 
triplicate (n=8). 
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4.4.  DISCUSSION 
 
The PEG-PTMSMA-PMAA-GRGDS nanofibers were designed taking advantage of 
the ideal and diverse properties of each block. PEG is a flexible, water-soluble well-
established biodegradable polymer with many applications from industrial 
manufacturing to medicine (Duncan, 2003). On the other hand, a combinatorial 
library of biomaterials formed from different acrylate and methacrylate monomers 
has proved to be useful for identifying environments suitable for ESCs 
differentiation (Anderson et al., 2004). Furthermore, methacrylates have been 
used in biomedical applications for many years and have been shown to promote 
adhesion and proliferation of endothelial cells when tethered to adhesive proteins 
(Fussell and Cooper, 2004). Polymers containing methacrylic acid and 
trimethylsilyl methacrylate have also been described to improve adhesion between 
the resist film and the wafer surface, as well as dry etch resistance in 
photolithographic applications (Mormann and Ferbitz, 2002). RGD is a well-known 
cell attachment peptide (Bellis, 2011). Taking this into account, our nanofibers 
have many features that may promote stem cell adhesion and control of cell 
proliferation. In addition to these potential benefits, they represent a good 
substitute for the existing systems, due to the advantages of being cheap and easy 
to produce, presenting chemical and physical properties tailored via molecular 
synthesis. 
We successfully synthetized PEG-PTMSMA-PMAA by RAFT polymerization and the 
polymer self-assembly into nanofibers also succeeded. In the self-assembly 
process, it is expected that the neutral hydrophilic segment of the copolymer (PEG) 
becomes majorly oriented to the core of the particles, and the negatively charged 
one (PMAA) to their surfaces, in order to minimize charge repulsion. Attachment 
of GRGDS to the fibers surface would occur by interaction between the positively 
charged terminal amino group of the former and the negatively charged 
carboxylate groups of the latter, leaving the guanidium group of the arginine 
residue available for cell adhesion. After polymerization, nanofiber assembly and 
bioconjugation with GRGDS, our purpose was to test the authentic effect of the 
nanofibers culture system, not only in supporting high-quality mouse embryonic 
stem cells growth but also in keeping cells undifferentiated and pluripotent. 
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Cell-biomaterial interaction mechanisms are poorly understood and many efforts 
have been made to clarify this matter. Nonetheless, several studies have 
demonstrated that cells do not interact with surfaces directly, but via deposition 
of adhesive proteins secreted by themselves and adsorbed on the adhesive 
surface, forming and remodeling their own ECM (Vladkova, 2010). Therefore, an 
increased expression of ECM and adhesion proteins, such as integrins, is evidence 
that surrounding microenvironment fosters cell adhesion and interaction with the 
support system. Our hypothesis was that the functionalization of the nanofibers 
with GRGDS may promote the expression of integrins, like e.g. β1-Integrin.  
Indeed, culture of ESCs in 100 µg/ml of nanofibers lead to an increase in β1-
Integrin expression and Col1α1 suggesting that integrins mediate the interaction 
between cells and the surrounding engineered bioadhesive motifs (GRGDS) of the 
nanofiber matrix. This indicates that the nanofibers play an important role in the 
regulation of synthesis, secretion and deposit of endogenous ECM proteins. This 
newly developed synthetic system allows the establishment of a more realistic and 
controlled microenvironment for mESC culture, by providing a complex network of 
nanofibers, gaps and pores through which oxygen and nutrients can be delivered 
and metabolites can be filtered away in a scale similar to the native ECM, where 
the functional and biological properties of mESCs could be understand more 
precisely and manipulated.  
The first approach to evaluate the capacity of the nanofibers to sustain ESCs 
culture was to test whether the nanofibers were able to support ESCs’ growth for 
3 and 5 days. According to cell adhesion and proliferation results, the cell 
proliferation in 100 µg/ml nanofibers for a short-term culture was revealed to be 
higher than or similar to that in gelatin or TCPS.  Besides the similarity of 
proliferation results between gelatin and in nanofibers, ESCs cultured in gelatin 
were found to be less pluripotent than in nanofibers, which could be explained by 
a selective process in which nanofibers potentiate the growth of pluripotent cells. 
Indeed, according to our morphological analyses of the ESCs cultures at different 
time points of culture, the ability of nanofibers to support growth of 
undifferentiated ESCs seemed to be better than gelatin as, in the latter, ESCs were 
rearranged in irregular colonies resembling a spontaneous differentiation process. 
Nevertheless, despite the translational effects that cell morphology has on different 
cell functions, a study pointed out that the association of the undifferentiated state 
of the ESCs with their pluripotency might not necessarily be related to a specific 
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cellular morphology (Tsuji et al., 2008). The regulation of pluripotency in ESCs is 
provided by a complex network of transcription factors, cell-ECM interactions, cell-
cell contacts and niche-support cells. Due to the complexity of pluripotency 
maintenance mechanism, we performed an extensive assay using nanofibers and 
standard culture conditions to more accurately verify the effect of the nanofibers 
on ESCs pluripotency. The maintenance of pluripotency was verified through ALP 
activity test, analysis of the quantitative expression of pluripotency marker genes 
(Nanog, Oct4 and Sox2) and, lastly, the differentiation potential of ESCs after long-
term culture in nanofibers. Results of ALP staining showed that, independently of 
the time of culture, ALP activity was higher in ESCs cultured in the nanofibers than 
those in gelatin, in which there seemed to be many more differentiated cells. In 
addition, ESCs long-term cultured in 10 µg/ml nanofibers exhibited Nanog and 
Oct4 expression levels similar to or higher than those in ESCs cultured in MEFsi, 
emphasizing that nanofibers not only support but also promote ESCs to retain their 
“stemness”.  
The differentiation potential of ESCs was tested after 30 days of culture in 
nanofibers via the hanging drop method. EBs formation stimulates disordered and 
heterogeneous patterns of differentiated ESCs into three germ lineages. 
Consequently, in some cases there is a preponderance of specific germ layer-
derived cells, whereas only a small fraction of cells differentiate into the other 
lineages (P. T. W. Kim et al., 2010). Therefore, to clarify the differentiation status 
of EBs, the global gene expression profile of ESCs population differentiated in 
nanofibers was quantitatively analyzed by qPCR (Koike et al., 2007; Sakai et al., 
2011). 
The in vitro differentiation assay showed  that ESCs cultured in 50 and 10 µg/ml 
nanofibers for 10 passages were able to preserve their tri-lineage differentiation 
capacity, which validates the authenticity of ESCs cultured in nanofibers. 
Interestingly, the higher levels of pluripotency markers and differentiation were 
observed in ESC cultures in 10 and 100 µg/ml nanofibers as well as the higher 
levels of β1-Integrin and Col1α1 expression, suggesting that nanotopography may 
play a role in regulation of cell attachment, spreading, proliferation and, most 
importantly, in regulation of self-renewal of undifferentiated ESCs. This 
phenomenon of influence of nanometric-scale surface topography and roughness 
of biomaterials in cell fate was also observed in other studies (Park et al., 2007). 
In summary, this newly developed synthetic system brings an alternative substrate 
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for mESC culture with the advantage of being inexpensive and easy to produce, 
and researchers can really control their chemical and physical properties via 
molecular synthesis. The major advantage of this system is that mESCs cultured 
on PEG-PTMSMA-PMAA-GRGDS nanofibers maintain their pluripotent state and 
present increased expression of Col1α1 and β1-Integrin, which may help 
establishing a microenvironment that supports ESC attachment, proliferation, and 
pluripotency.  
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5.1. ABSTRACT 
 
Ccbe1 or collagen and calcium-binding EGF domains 1, is involved in 
lymphangiogenesis, cardiogenesis and carcinogenesis. However, its function and 
molecular action in biological events is still unknown. Indeed, little is known about 
the Ccbe1 gene and protein, except that the amino acid sequence of the CCBE1 
protein predicts the presence of a signal peptide and collagen and calcium binding 
EGF domains. As these domains are also found in some of the ECM proteins, CCBE1 
might be an ECM protein and the loss of its expression may result in changes in 
cellular characteristics, such as adhesion and motility. 
Experimental data from literature and from experimental work conducted in our 
lab revealed that, even though Ccbe1-/- mice die prenatally, Ccbe1 is highly 
expressed in MEFs. Therefore the aim of this work was to evaluate the effect of 
Ccbe1 in cell adhesion, proliferation and migration using MEFs as a model. 
Here, we show that the proliferation of Ccbe1-/- mouse embryonic fibroblasts 
ceases prematurely. The Ccbe1-/- MEFs presented senescent cellular morphology, 
a reduction in growth fraction, and increased expression of the cell proliferation 
inhibitor Bax. Wound healing migration assay using different protein ECM as a 
coating revealed that Ccbe1-/- MEFs presented high motility and that the migration 
is substrate-dependent. The culture of Ccbe1-/- MEFs culture on top of a CCBE1 
coating rescued the defective proliferation and viability of Ccbe1-/- fibroblasts, and 
the highly migratory behavior was also reduced. 
Even though the underlying mechanism of action of Ccbe1 is still unknown and 
complex, the data presented here suggests that Ccbe1 coordinates cell adhesion, 
migration and proliferation, thus playing a key role in the ECM remodeling. 
 
 
Keywords: Ccbe1, ECM, migration, MEFs, survival 
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5.2. INTRODUCTION 
Collagen and calcium-binding EGF domain 1 (Ccbe1) was identified during a gene 
expression profiling of chick heart/hemangioblast precursors using Affymetrix® 
GeneChip Arrays, in our laboratory (Bento et al., 2011). Data from our laboratory 
indicates that Ccbe1 might be responsible for alterations in cell migration during 
chick heart development. As described in detail, in the General Introduction – 
Ccbe1 State of the art, the absence or presence of Ccbe1 is responsible for several 
phenotypes in vertebrates. In ovary cancer cells and breast cancer, absence of 
CCBE1 has been shown to favor the migration of the cells (Barton et al., 2010; 
Yamamoto and Yamamoto, 2007). In mice, administration of CCBE1 facilitates 
VEGF-C-induced lymphangiogenesis in corneal micropocket assays in mice (Bos et 
al., 2011). Furthermore, Ccbe1 is required for proper lymphangioblast migration 
and lymphatic vessels development in zebrafish (Hogan et al., 2009). Moreover, 
fetal liver erythroid precursors of Ccbe1-/- mice exhibit reduced proliferation and 
increased apoptosis (Zou et al., 2013).  
Many efforts have been made, but the function or molecular action of CCBE1 in 
biological events is poorly understood. Knockout (KO) mice are important animal 
models that represents a powerful tool to study the role of genes which have 
been sequenced but whose functions have not been determined. The existence of 
a Ccbe1-/- mice makes possible to take full advantage of the potential of mice and 
their MEFs to study the effect of Ccbe1 in embryonic development events, such as 
cell proliferation, migration and cell-ECM interactions. Furthermore, analysis of the 
Affymetrix array data generated in Greber et al revealed that Ccbe1 is highly 
expressed in MEFs (Greber et al., 2007). Moreover, as Ccbe1-/- mice died prenatally 
at about E16.5 (Zou et al., 2013) makes possible to isolate the embryonic 
fibroblasts between E13.5 and E14.5, for further studies. 
Ccbe1 has been shown to interact with extracellular matrix (ECM) proteins 
vitronectin, collagen type I and V, indicating that Ccbe1 may be as well an ECM 
component (Bos et al., 2011). Besides conferring support, interaction of ECM 
components with membrane receptors integrins is known to regulate several 
cellular processes, such as proliferation, survival, cellular shape and migration. For 
that reason, the main aim of this work was to characterize Ccbe1-/- MEFs and 
attempt to understand how Ccbe1 affects viability, proliferation and migration 
processes. 
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5.3.  RESULTS 
5.3.1. Genomic organization of mouse Ccbe1 gene 
Collagen and calcium-binding EGF-like domain 1 gene (GeneBank reference 
sequence number NM_178793.4) has 11 exons, 1631 bps and is localized in the 
Mus musculus chromosome 18, oriented in the reverse strand at the genomic 
region between 66,060,967 and 66,291,838 K (Fig. 5.1 A). 
CCBE1 protein is a 408 aminoacid (aa) secreted protein with a predicted molecular 
weight of 44.4 kDa. According to bioinformatic analyses performed using InterPro 
and Vega Genome Browser, CCBE1 contains a predicted signal peptide with a 
cleavage site (1-37 aa), a EGF domain (93-134 aa), a calcium-binding EGF-like 
domain (135-176 aa) presenting an aspartate/asparagine hydroxylation site (151-
162 aa) and two collagen-like domains (248-335 aa; Fig. 5.1 B). Also, CCBE1 has 
a conserved RGD domain (177-179 aa; Fig. 5.1). Mouse CCBE1 protein is 
conserved across vertebrates. Mouse CCBE1 amino acid sequence is 90% identical 
to the human and chimpanzee and 66% identical to zebrafish (Fig. 5.2).  
 
Figure 5.1: Schematic representation of the predicted Ccbe1 gene and protein. A.
The Ccbe1 gene (NM_178793.4) is located in the chromosome 18 of mouse genome and
orientated in the reverse strand. The vertical lines represent the 11 exons and the lines
the introns. The resulting transcript has 1631 bps length. Transcript analysis conducted 
on-line http://www.ensembl.org, in November 2013. B. Predicted functional domains of 
CCBE1. Exons are represented in alternated light and dark green segments. CCBE1 is
composed of a SP – signal peptide, an EGF – epidermal growth factor-like domain, an EGF-
Ca – calcium-binding EGF-like domain, an Asp/Asn hs – aspartic acid and asparagine 
hydroxylation site and two collagen-like domains. Protein sequence analyses was 
conducted on-line using InterPro (http://www.ebi.ac.uk/interpro/) and Vega Genome 
Browser (http://vega.sanger.ac.uk/index.html), in November 2013. 
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     Mus musculus    1 MVPPPlPSRGGAAKRQLGKSLGPL--LLLLALGHTWTYREEPEDRDREVCSENKITTTKYPCLKSSGELTTCFRKKCCKG 78 
     Homo sapiens    1 MVPPP-PSRGGAARGQLGRSLGPL--LLLLALGHTWTYREEPEDGDREICSESKIATTKYPCLKSSGELTTCYRKKCCKG 77 
    Pan troglodytes 1 MVPPP-PSRGGAARGQLGRSLGPL--LLLLALGHTWTYREEPEDGDREICSESKIATTKYPCLKSSGELTTCYRKKCCKG 77 
     Gallus gallus   1 M-------------GRPARSLAPLrlLLLVALGHAWTYREEPQDSDREVCSENKIATTRYPCLKPTGELTTCFRKKCCKG 67 
     X.tropicalis    1 MW------ERGARRGCL--CLGCL--LLLLSLGLAWTYREELE-TDREICSESKITTTKYPCVKPTGELATCFRKKCCKG 69 
     Danio rerio     1 MIYPG-------RGASL--SVAVA--LVLFSSGAPWTFREEKEDVDREVCSESKIATTKYPCVKSTGEVTTCYRKKCCEG 69 
 
     Mus musculus  79 YKFVLGQCIPEDYDICAQAPCEQQCTDNFGRVLCTCYPGYRYDRERHQKRERPYCLDIDECATSNTTLCAHICINTMGSY 158 
     Homo sapiens  78 YKFVLGQCIPEDYDVCAEAPCEQQCTDNFGRVLCTCYPGYRYDRERHRKREKPYCLDIDECASSNGTLCAHICINTLGSY 157 
     P.troglodytes 78 YKFVLGQCIPEDYDVCAEAPCEQQCTDNFGRVLCTCYPGYRYDRERHRKREKPYCLDIDECASSNGTLCAHICINTLGSY 157 
     Gallus gallus 68 YKFVLGQCIPEDYDVCAEAPCEQQCTDNFGRVLCTCYPGYRYDRERHRNREKPYCLDIDECAASNGTLCSHICINTVGSY 147   
     X.tropicalis  70 YKFVLGQCIPEDYDVCSEAPCEQQCTDNFGRVLCTCYPGYLYDRERHRNREKPYCLDIDECASKNETVCSHICINTPGSY 149    
     Danio rerio   70 FKFVLGQCIPEDYDVCAGAPCEQQCTDHFGRVVCTCYDGYRYDRERHRNREKPYCLDIDECANNNETVCSQMCVNTPGSY 149   
 
     Mus musculus 159 HCECREGYILEDDGRTCTRGDKYPNDTGHEeKSENEVKAGTCCATCKEFSQMKQTVLQLKQKMALLPNNAAELGKYVNGD 238 
     Homo sapiens 158 RCECREGYIREDDGKTCTRGDKYPNDTGHE-KSENMVKAGTCCATCKEFYQMKQTVLQLKQKIALLPNNAADLGKYITGD 236 
     P.troglodytes158 RCECREGYIQEDDGKTCTRGDKYPNDTGHE-KSENVVKAGTCCATCKEFYQMKQTVLQLKQKIALLPNNAADLGKYITGD 236 
     G.gallus     148 RCECHEGYTRGEDGRTCTKGDKGMCPGLSE-KSENVAKPGTCCASCKEFHQIKQTVLQLKQKVSLLPNNAADLSKQITGE 226 
     X.tropicalis 150 RCECPEGYSLEEDGKTCTKGSQGD----FE-KSNNVMKAGVCSETCKDFHQIKQTVLQLKQKLAFLPNSVSESSKHITAE 224  
     Danio rerio  150 RCDCHSGFYLEDDGKTCTKGERAP---LFE-KSDNVMKEGTCSATCEDFHQMKMTVLQLKQKMSLLSSN-TEINKQMTNE 224 
 
     Mus musculus 239 KVLASN-AYLPGPPGLPGGQGPPGSPGPKGSPGFPGMPGPPGQPGPRGSMGPMGPSPDLSHIKQGRRGPVGPPGAPGRHG 317 
     Homo sapiens 237 KVLASN-TYLPGPPGLPGGQGPPGSPGPKGSPGFPGMPGPPGQPGPRGSMGPMGPSPDLSHIKQGRRGPVGPPGAPGRDG 315 
     P.troglodytes237 KVLASN-TYLPGPPGLPGGQGPPGSPGPKGSPGFPGMPGPPGQPGPRGSMGPMGPSPDLSHIKQGRRGPVGPPGAPGRDG 315 
     G.gallus     227 KVLASN-AYIPGPPGQPGQQGPPGAPGPKGSQGVPGSPGPPGQPGPRGSMGPMGPSPDISHIKQGRRGPVGPPGAPGRDG 305 
    X.tropicalis 225 KVLAST-TYVQGPPGLPGAQGPPGLPGPKGSAGQSGIPGPPGPPGPRGFMGPVGPSPEISQLKQGRRGPVGPPGAPGKDG 303 
     Danio rerio  225 KMMMTTnSFLPGPPGPPG---PAGTPGAKGSSGSPGQMGPPGLPGPRGDMGPIGPSPDLSHIKQGRRGPVGPPGAPGRDG 301 
 
     Mus musculus 318 SKGERGAPGPPGSPGPPGSFDFLLLVLADIRNDIAELQEKVFGHRTHSSAEDFP-LPQEFSSYPETLDFGSGDDYSRRTE 396 
     Homo sapiens 316 SKGERGAPGPRGSPGPPGSFDFLLLMLADIRNDITELQEKVFGHRTHSSAEEFP-LPQEFPSYPEAMDLGSGDDHPRRTE 394 
     P.troglodytes316 SKGERGAPGPRGSPGPPGSFDFLLLMLADIRNDITELQEKVFGHRTHSSAEEFP-LPQEFPSYPEAMDLGSGDDHPRRTE 394 
     G.gallus     306 SKGERGAPGPKGIPGPPGSFDFLLLMMADIRNDIAELQERVFGRRTHSSTEEFP-LPQEFTNYHDTVDFGSGEDYKPRAA 384 
     X.tropicalis 304 TKGDRGAPGPRGPPGPPGSFDFLLLMMADIRNDIAELQDKVFGRRTHSSAEEFP-LPHEFTNHHESVDLGSGEDYKHRTV 382  
     Danio rerio  302 MKGERGFPGPSGPPGPPGSFDFLLLMMADIRNDIAELQSKVFSRPLHSSFEDFPsAPDSWRDTPENLDFGSGEDYKSQSP 381 
   
     Mus musculus 397 ARDPEAPRNFYP    408 
     Homo sapiens 395 TRDLRAPRDFYP    406 
     P.troglodytes395 TRDLRAPRDFYP    406 
     G.gallus     385 PRDSRIQKAAHP    396 
    X.tropicalis 383 SKNLRTDKNSRH    394 
     Danio rerio  382 PKSSRKRKLPRN[8] 401 
 
 
 
 
 
 
 
Figure 5.2: Predicted Ccbe1 homology among vertebrate species. A. Multiple 
protein sequence alignment was computed using Cobalt Constraint-based Multiple Protein 
Alignment Tool to obtain conserved domains and local sequences similarities. B. Homology 
analysis was further obtained from the NCBI Blast Local Alignment Search Tool database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). GenBank Accession Number of sequences used 
for alignment were: Mus musculus - NP_848908.1, Homo sapiens - NP_597716.1, Pan 
troglodytes - XP_512156.3, Gallus gallus - XP_001233358.1, Xenopus tropicalis - 
XP_002936721.2 and Danio rerio - NP_001157395.1. Red corresponds to highly conserved 
Specie 
Ccbe1 percent homology 
to Mus musculus 
Homo sapiens 90 
Pan troglodytes 90 
Gallus gallus 79 
Xenopus tropicalis 72 
Danio rerio 66 
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residues in the species listed, while black corresponds to moderately conserved residues, 
and blue corresponds to less conserved residues. Delimited zone corresponds to RGD 
domain. Alignment and analysis were conducted on-line 
http://www.ncbi.nlm.nih.gov/tools/cobalt, in September 2013 
 
 
5.3.2. Ccbe1-/- fibroblasts exhibited premature proliferation arrest  
The effect of Ccbe1 in the autonomous proliferative capacity of MEFs was firstly 
explored by analyzing the survival curves of Ccbe1+/+ and Ccbe1-/- MEFs in culture. 
Therefore, taking advantage of the conventional Ccbe1 mutant mice already 
existent in our animal facility, Ccbe1+/+ and Ccbe1−/− MEFs were isolated 
separately from littermate embryos at approximately E13.5 days of gestation. The 
majority of the Ccbe1-/- embryos appeared edematous, which is consistent with 
defective lymphatic vasculature in these mutants (Bos et al., 2011). Ccbe1+/+ and 
Ccbe1-/- primary mouse embryonic fibroblasts were plated at a density of 15 000 
cells/cm2 in a 6-well plate, in technical triplicates, and subcultured or passaged 
every 3 days at the same cell density, in parallel and under identical cell culture 
conditions.  
Analyses of the cumulative population doubling (CDP) of isolated MEFs showed a 
decrease or delay in proliferation of Ccbe1-/- MEFs when compared to the wild-type. 
Several independent assays revealed that Ccbe1-/- MEFs proliferated normally in 
the first two passages but slowed dramatically by passage 3 and then arrested 
permanently (Fig. 5.3 A). Indeed, from passage three forward, Ccbe1-/- MEFs 
cumulative doubling population (CPD) is approximately half (CPD=2.95) of the 
Ccbe1+/+ MEFs (CPD=4.48). In addition, morphological analysis showed that 
cultures of either genotype had indistinguishable spindle-shaped cells at initial 
plating (Fig. 5.3 B: a, d), but after two passages Ccbe1-/- fibroblast cultures started 
to accumulate cells that had a flattened appearance and cytoplasmic enlargement 
(Fig. 5.3 B: e), which is reminiscent of senescent cells. Furthermore, at passage 
six Ccbe1-/- fibroblasts resemble senescent cells and also presented binuclei, in 
contrast to Ccbe1+/+ fibroblasts that exhibited a spindle-shape even after 21 days 
of culture (Fig. 5.3 B: f). Together, these data suggest that Ccbe1 is involved in 
proliferation. 
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Figure 5.3: Proliferation properties and morphology of Ccbe1-/- MEFs.  A. Growth 
curve of primary mouse embryonic fibroblasts from Ccbe1+/+, Ccbe1+/- and Ccbe1-/-
embryos.  Data are representative of eight independent experiments, performed in
technical triplicates, using three littermates at approximately E13.5. Population doubling 
(PD) per passage was calculated as log(nf/n0)/log2, where n0 is the initial and nf the final 
number of cells at each passage. Cumulative population doubling (CPD) at each passage
was calculated by adding population doubling per passage. Data presented as mean ± 
SD. B. Representative contrast phase images of MEFs at day 1, day 6 (passage 2) and 
day 21 (passage 6). Magnification is 100x (a, b, d, e) and 200x (c, f). 
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Figure 5.4: Cell cycle. A. Cell cycle phases (Go/G1, S and G2/M) of Ccbe1+/+ and Ccbe1-
/- MEFs at passage 2. Representative results of two independent experiments performed
in technical triplicates. B. Ratio of the difference in cell cycle phases population between
Ccbe1+/+ and Ccbe1-/- MEFs, in percentage. (*; **) indicates significantly different 
percentage (p<0.05; p<0.01) compared to Ccbe1+/+ MEFs. 
The BrdU labeling assay started with the seeding of Ccbe1+/+ and Ccbe1-/- MEFs at 
passage 2, in technical triplicates, in a 6-well plate. Cells were cultured for 24h, 
incubated with BrdU at the last 14h of culture and supplemented with 7-
aminoactinomycin D (7-AAD) immediately before flow cytometry acquisition. Flow 
cytometry analysis showed that the percentage of Ccbe1−/− MEFs in phase G0/G1 
(31.20%) was approximately the double of Ccbe1+/+ MEFs (13.10%) (Fig. 5.4 A) 
suggesting that  Ccbe1-/- fibroblasts may leave cell cycle and stop dividing, and/or 
the G1 phase in KO MEFs takes longer than WT MEFs (Fig. 5.4 A). The percentage 
of Ccbe1-/- proliferating MEFs (cells in S phase) is approximately 25% less than 
Ccbe1+/+ MEFs (Fig. 5.4 B), which is consistent with the growth curves presented 
above (Fig. 5.3 A). Furthermore, Ccbe1 mutant MEFs presented high percentage 
of cells in G2/M phase (8.50%) than Ccbe1+/+ (1.77%; Fig. 5.4 A). The results 
from the analysis of survival growth curves and cell cycle indicate that the lack of 
Ccbe1 in MEFs promote decrease of proliferating cells (S phase) and G0/G1 or 
G2/M phase arrest leading to cell quiescence.  
 
 
 
 
 
  
% WT KO ∆(KO-WT)
G0/G1 13,10 31,20 +18,10
S 85,13 60,30 -24,83
G2/M 1,77 8,50 +6,73
A         B                  
** 
* 
* 
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To evaluate if the proliferation is arrested in Ccbe1-/- fibroblasts, the proliferative 
properties of Ccbe1+/+ and Ccbe1-/- were also analyzed by a Cell Proliferation Dye 
eFluor® 670 assay. Cell Proliferation Dye eFluor® 670 (eBioscience) is a red 
fluorescent dye that can be used to monitor individual cell divisions. This 
fluorescent dye binds to proteins containing primary amines and as cells divide, 
the dye is distributed equally between daughter cells, which can be measured as 
successive halving of the fluorescence intensity of the dye. Therefore, eFluor® 
670-labeled Ccbe1+/+ and Ccbe1-/- fibroblasts were seeded and the tracking of cell 
division was performed at day 2, 4 and 7 of culture by flow cytometry. In order to 
analyze the loss of fluorescence intensity with more accuracy, the resultant charts 
were divided in 4 levels of fluorescence in which quadrant (Q) 1 corresponds to 
the maximum and 4 to the lower level of fluorescence intensity. Analysis of 
Ccbe1+/+ and Ccbe1-/- MEFs histograms showed that at day 0 all the cells were 
eFluor® 670-labeled and the intensity of fluorescence decreased along the time of 
culture (Fig. 5.5 A), as expected. At day 2, the percentage of undivided cells, i.e. 
the cells that remained with the initial intensity of fluorescence (Q1), was higher 
in Ccbe1-/- (29.01%) than in Ccbe1+/+ (16.70%) fibroblasts population (Fig. 5.5 
B). A similar cell behavior was observed at day 4, where the undivided cells 
(Q1+Q2) in Ccbe1-/- fibroblast population was approximately a half (53.22%) of 
the Ccbe1+/+ fibroblast population (35.55%, Fig. 5.5 B). Subsequently, at day 7, 
while Ccbe1+/+ histogram revealed a pronounced shift to the left, Ccbe1-/- 
presented a peak approximately in the middle of the fluorescence intensity axis 
(Fig. 5.5 A) indicating that Ccbe1 mutant MEFs divided less. Taking together, these 
results indicate that Ccbe1-/- MEFs proliferated less than Ccbe1+/+ MEFs. In 
addition, these results indicate that the proliferation of Ccbe1-/- MEFs is not 
arrested, but instead, severely delayed. 
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Figure 5.5: Cell division tracking assay. A. Histograms of fluorescence decay during 7 
days of culture. The undivided cells maintain their fluorescence intensity. In divided cells
the fluorescence intensity decrease. Y axis – Cell number, X axis - Fluorescence B.
Percentage of fibroblasts per quadrant of fluorescence intensity (Q). Data are resultant of
one experiment performed in technical triplicates. 
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5.3.3. Ccbe1−/− MEFs are susceptible to apoptosis 
The analysis of cell proliferation and cell cycle results was complemented with an 
apoptosis assay to determine whether Ccbe1 has a role in cell viability. The 
apoptosis or viability assay was performed using propidium iodide (PI) which is a 
membrane-impermeant dye generally excluded from viable cells and, therefore, it 
can be used to differentiate necrotic or apoptotic from viable cells and 
consequently to evaluate cell viability. In short, viable Ccbe1+/+ and Ccbe1−/− MEFs 
at passage 2 were cultured for 44h in growth medium (10% FBS) and in starvation 
medium (2% FBS) to induce cell stress, allowing a more clear analysis of cell 
viability. Then, cells were collected and incubated with PI immediately before FACS 
acquisition.  
According to our data, the percentage of apoptotic (PI positive) Ccbe1+/+ MEFs was 
unaffected by starvation conditions (Fig. 5.6 A). However, the percentage of 
apoptotic Ccbe1−/− MEFs was higher (4.14%) than Ccbe1+/+ MEFs (2.45%) in 
standard conditions and the double in starvation conditions (7.93; Fig. 5.6 A). 
Therefore, the differences in apoptosis susceptibility of Ccbe1+/+ and Ccbe1−/− 
MEFs become more evident in starvation conditions. In fact, the percentage of 
apoptotic fibroblasts in standard conditions was 47% higher in Ccbe1−/− than in 
Ccbe1+/+ population, while in starvation conditions the percentage of Ccbe1−/− PI 
positive MEFs increased 150% in comparison to Ccbe1+/+ MEFs (Fig. 5.6 A). The 
viability assay revealed that Ccbe1−/− MEFs seem to be more susceptible to 
apoptosis suggesting that Ccbe1 may be important to maintain cell viability, 
especially in stress conditions.  
In order to confirm that the absence of Ccbe1 increases the susceptibility to 
apoptosis, the mRNA levels of Bax (an apoptosis promoter) and Bcl2 (an apoptosis 
inhibitor) were quantified. The ratio of Bax to Bcl2 acts as a cell autonomous 
rheostat and is considered to be a marker of a cell's susceptibility to apoptotic 
stimuli (Yin et al., 1994). Following a signal for programmed cell death, cells die if 
Bax is in excess, but live if Bcl2 predominates. The evaluation of Bax and Bcl2 
expression levels was performed using mRNA from Ccbe1+/+ and Ccbe1−/− MEFs at 
passage 0 and 3. At passage 0, the Bax/Bcl2 ratio was approximately 1 for 
Ccbe1+/+ and Ccbe1−/− MEFs, suggesting an equilibrium between both apoptosis 
promoter and inhibitor factors (Fig. 5.6 B, C). Nonetheless, when Ccbe1−/− MEFS 
endured three passages, the expression levels of Bax increased and the expression 
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levels of Bcl2 decreased, resulting in an increase of approximately 50% of Bax/Bcl2 
ratio (Fig. 5.6 B, C). This is consistent with the decreased cell viability of Ccbe1 
mutant MEFs. Normally, an increase of Bax/Bcl2 ratio leads to the activation of the 
caspases, especially Caspase3, which are known to act downstream of Bax/Bcl2 
control and play a key role in the execution of apoptosis (Salakou et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Therefore, Ccbe1+/+ and Ccbe1−/− MEFs at passage 3 were seeded in coverslips for 
24h. Then, the activity of Caspase3 was analyzed by immunocytochemistry using 
antibodies against cleaved-Caspase3. Preliminary results (n=1) showed that 
approximately 18% of Ccbe1−/− MEFs exhibited active (cleaved) Caspase3, 
whereas Caspase3 seemed to be inactive in Ccbe1+/+ MEFs (Fig. 5.7), which is 
consistent with the results obtained for Bax/Bcl2 ratios. Altogether, these results 
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Figure 5.6: Viability and apoptosis study. A. Evaluation of viability of Ccbe1+/+ and 
Ccbe1-/- fibroblasts after 44h under standard (10% FBS) or starvation (2% FBS)
conditions. Data are expressed as mean+SD, from two experiments performed in technical 
triplicates. B. Bax and Bcl2 expression levels of Ccbe1+/+ and Ccbe1-/- fibroblasts at 
passage 0 and passage 3. Data are expressed as mean+SEM, from three biological
samples in technical triplicates. C. Bax/Bcl2 ratio of mRNA levels. (*, ***) indicates 
significantly different (p<0.05; p<0.001) compared to Ccbe1+/+ MEFs. 
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indicate that Ccbe1−/− MEFs seem to be less viable and more susceptible to 
apoptotic stimuli. 
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Figure 5.7: Activated caspase3 expression. Representative pictures of Ccbe1+/+ and
Ccbe1-/- MEFs at passage 3 labeled with cleaved caspase3 antibody. Red – CCBE1. Blue
(Dapi) – Nuclei. 
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5.3.4. Rescue of Ccbe1+/+ proliferative phenotype 
 
A rescue assay was performed to verify whether the addition of CCBE1 contributes 
to cell proliferation and prevention of apoptosis. Therefore, 10 µg/ml of mouse 
CCBE1 protein solution and the buffer where CCBE1 was diluted (25 mM Tris, 0.15 
M NaCl pH 7.4, 2 mM CaCl2, 10% Glycerol) as control were incubated o.n. at 4ºC 
in the culture plates to cover entire growth area. Then, the excess of the solution 
was removed and approximately 22 000 MEFs were seeded per well of a 6-well 
plate. Culture of Ccbe1-/- and Ccbe1+/+ fibroblasts in TCPS was used as negative 
control. The culture was monitored by microscopic observation. Cell culture was 
stopped and cells were counted approximately after 48h, when cell density started 
to reach confluency. According to our data, Ccbe1-/- fibroblasts cultured in TCPS or 
in dialysis buffer presented similar values of cell growth (Fig. 5.8 A). In contrast, 
Ccbe1-/- fibroblasts cultured in CCBE1 coating exhibited a significant increase in 
growth, corresponding to a gain of 63% of the cell growth obtained for Ccbe1-/- 
fibroblasts cultured in TCPS (Fig. 5.8 A). In addition, Ccbe1-/- fibroblasts cultured 
in CCBE1 coating appeared to have a small size and spindle-shape morphology, 
similar to fibroblasts found in Ccbe1+/+ MEFs culture and in contrast to the flattened 
appearance with extensive lamellipodia of Ccbe1-/- MEFs cultured in TCPS (Fig. 5.8 
B). Furthermore, preliminary results (n=1) revealed that the viability of Ccbe1-/- 
MEFs in starvation conditions can be improved as well through the use of a CCBE1 
coating (Fig. 5.8 B). Even though Ccbe1-/- MEFs cultured in CCBE1 did not achieve 
the levels of proliferation and viability of Ccbe1+/+ MEFs, rescuing CCBE1 loss-of-
function by providing CCBE1 protein as a coating improves proliferation and 
prevent apoptosis of Ccbe1-/- MEFs.  
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Figure 5.8: Rescue of proliferative phenotype of Ccbe1+/+ MEFs. A. Proliferation 
of Ccbe1-/- MEFs in TCPS, CCBE1 and buffer coatings and Ccbe1+/+ MEFs in TCPS, for 
48h. Data are representative of two independent experiments. ** p<0.01 relative to 
Ccbe1-/- MEFs cultured in TCPS. B. Morphology of Ccbe1-/- and Ccbe1+/+ MEFs after 48h 
of culture. Magnification is 100x. C. Evaluation of viability of Ccbe1-/- fibroblasts cultured 
in TCPS, buffer and CCBE1 coatings and Ccbe1+/+ fibroblasts after 44h under standard 
(10% FBS) or starvation (2% FBS) conditions. Data from one sample per condition.  
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5.3.4. Ccbe1-/- MEFs presented high motility 
 
Data from our lab showed that absence of Ccbe1 leads to alterations in cell 
migration events during chick heart development. Furthermore, absence of Ccbe1 
in ovary cancer cells has been shown to favor the migration of the cells (Barton et 
al., 2010). Moreover, in mice, Ccbe1 seems to be required for proper lymphatic 
cell migration (Bos et al., 2011). In order to evaluate if migration is affected as 
well in Ccbe1−/− MEFs and to determine the possible mechanism whereby Ccbe1 
may modulate cell migration, we performed comparative analysis of Ccbe1+/+ and 
Ccbe1−/− MEFs in wound healing assays. In one of the first approaches to 
characterize the migration of Ccbe1-/- MEFs, 500 000 of Ccbe1+/+ and Ccbe1−/− 
inactivated MEFs were seeded in 6-well plate pre-coated with gelatin, and in the 
following day cell migration was evaluated by a wound-induced migration assay: 
the basic steps involved creation of a "wound"/scratch in the MEFs monolayers 
with the help of a pipette tip, capture of micrographs at the beginning and at 
regular intervals during cell migration to close the wound, and comparing the 
images to quantify the migration rate of the cells. Since Ccbe1 affects proliferation, 
MEFs were mitotically inactivated to isolate the effect of the migration in wound 
closure. Observation of micrographs at 0 and 6h, showed that Ccbe1-/- MEFs are 
able to close the gap faster than Ccbe1+/+ MEFs (Fig. 5.9 A). The delay was 
confirmed by the calculations of migration rate where Ccbe1-/- fibroblasts were 
11.26 % faster than Ccbe1+/+ fibroblasts (Fig. 5.9 B).  
Chapter V – Characterization of Ccbe1 mutant MEFs 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
5.3.5. Migration of Ccbe1-/- MEFs is substrate dependent 
Ccbe1 has been shown to interact with ECM proteins vitronectin, collagen type I 
and V, indicating that Ccbe1 may be as well an ECM component (Bos et al., 2011). 
Besides conferring support, interaction of ECM components with membrane 
receptors integrins is known to regulate several cellular processes, such as 
proliferation, survival, cellular shape and migration (Kim et al., 2011). Whether 
Ccbe1 is a signaling molecule or simply an ECM component remains unclear. The 
in vitro scratch assay is particularly suitable for studies on the effects of cell–matrix 
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Figure 5.9: Motility of Ccbe1-/- and Ccbe1+/+ MEFs. A. Representative pictures of
wound-induced migration assay. Magnification is 100x. B. Quantitative analysis of the
migration rate of the cells into the denuded area over 6h. Data are representative of 3
independent experiments and presented as mean±SD. 
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and cell–cell interactions on cell migration, mimic cell migration during wound 
healing in vivo. So, in order to start to understand the mechanism whereby Ccbe1 
may regulate cell migration, were performed wound healing assays in the presence 
of several of these ECM components, namely vitronectin and fibronectin. 
Therefore, 0.1% of gelatin, 10 µg/ml of fibronectin and vitronectin were incubated 
o.n. at 4ºC in a 6-well plated and then mitotically inactivated Ccbe1-/- and Ccbe1+/+ 
MEFs were seeded at same density, in technical triplicates. As Ccbe1 is involved in 
proliferation process MEFs were mitotically inactivated prior to the migration assay 
to avoid the interference of proliferation events. In the next day, all the cells were 
adhered forming a monolayer and three gaps or scratches per well were done using 
a blue pipette tip. In general, Ccbe1-/- MEFs demonstrated to be faster than 
Ccbe1+/+ MEFs, independently of the coating (Table 5.1). Nevertheless, the 
difference of migration rate between Ccbe1 KO and WT MEFs was matrix 
dependent and more evident for migration in vitronectin (28%) (Table 5.1). 
Migration was favored in vitronectin, a substrate that possibly interacts with 
CCBE1. These results suggest that probably the interaction of CCBE1 with 
vitronectin block migration and, in absence of CCBE1, fibroblasts are able to 
migrate easier. 
 
Table 5.1: Main results of migration in gelatin, fibronectin and vitronectin, over 6h. Ccbe1-
/-/Ccbe1+/+ (%) = (v (Ccbe1-/-/Ccbe1+/+)*100) – 100. Data are representative of 2 
independent experiments as mean±SD 
 
 
 
Ccbe1+/+ 
v (µm/h) 
Ccbe1-/- 
v (µm/h) 
Ccbe1-/-/Ccbe1+/+ 
(%) 
Gelatin 41,40 ± 3,39 45,72 ± 4,01 10,46 
Fibronectin 51,30 ± 2,30 60,05 ± 2,50 17,06 
Vitronectin 48,55 ± 2,69 62,09 ± 1,49 27,90 
 
Migrating cells make new adhesions under the leading edge, have stable adhesions 
under the cell body and break adhesions at the trailing edge (Moissoglu and 
Schwartz, 2006). Furthermore, adhesion is mediated primarily by integrins; 
transmembrane receptors, each containing an α and a β subunit, that bind ECM 
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proteins outside the cell and link to cytoskeletal proteins and signaling pathways 
inside the cell (Moissoglu and Schwartz, 2006). Moreover, the differences in 
adhesion stability during migration give rise to gradients in multiple signaling 
pathways that promote or maintain the directionality of cell movement (Moissoglu 
and Schwartz, 2006). Taking this into account, we performed a wound-healing 
assay including antibodies (ab) to block specific subtypes of integrins. More 
specifically, scratches were performed and Ccbe1-/- MEFs were incubated with 
growth medium supplemented with antibodies against β1-integrin (usually part of 
collagen receptor; Santa Cruz; 1:100) and β4-integrin (usually part of laminin 
receptor; Abcam; 1:100) (Srichai and Zent, 2010). In addition, Ccbe1+/+ and 
Ccbe1-/- MEFs incubated with growth medium were used as control. A rescue 
condition was also tested by incubating Ccbe1-/- MEFs with growth medium 
supplemented with 10 µg/ml of CCBE1 protein. Ccbe1-/- MEFs migrated 8.17% 
faster than Ccbe1+/+ MEFs, as expected (Table 5.2). The incubation of Ccbe1-/- 
MEFs with antibodies against both β1 and β4-integrins induced a decrease of 
migration rate, however the blocking of migration was not selective and cells 
responded similarly to the blocking of interaction via collagen or via laminin-
dependent pathway (Table 5.2). So this experiment was not sufficiently elucidative 
about the specific β-integrin signaling pathway where Ccbe1 is involved. On the 
other hand, the supplementation of Ccbe1-/- MEFs with CCBE1 protein rescued the 
migration phenotype of Ccbe1+/+ MEFs. Ccbe1-/- MEFs supplemented with CCBE1 
migrated 16.15% slower than Ccbe1-/- MEFs in growth medium and 9.30% slower 
than Ccbe1+/+ MEFs (Table 5.2). 
 
Table 5.2: Main results of migration in gelatin over 7h. Growth medium was supplemented 
with antibodies against β1 and β4 integrin and with CCBE1, in gelatin coating. 
Ccbe1/Ccbe1-/- control (%) = (v (Ccbe1/Ccbe1-/- control)*100) – 100, Ccbe1-/-/Ccbe1+/+ 
(%) = (v (Ccbe1-/-/Ccbe1+/+)*100) – 100. Data are from one experiment performed in 
technical duplicates and presented as mean±SD. 
 
  v 
(µm/h) 
Ccbe1/Ccbe1-/- 
control (%) 
Ccbe1-/-/Ccbe1+/+ 
(%) 
Ccbe1+/+ control 36,84 ± 0,86 -7,55 - 
Ccbe1-/- 
control 39,85 ± 0,92 - 8,17 
β1-integrin ab 35,59 ± 0,89 -10,69 -3,40 
β4-integrin ab 34,37 ± 1,12 -13,75 -6,71 
CCBE1 33,41 ± 0,02 -16,15 -9,30 
Chapter V – Characterization of Ccbe1 mutant MEFs 
137 
Collectively, these experiments confirmed that the absence of Ccbe1 in MEFs 
favors migration and the addition of CCBE1 blocks migration, in vitro. The 
migration rate of MEFs was modulated by both ECM and β-integrin signaling 
pathways. 
 
5.3.6. Disruption in Ccbe1 gene changes cell adhesion  
The differences in migration rate between Ccbe1+/+ and Ccbe1−/− MEFs might be a 
consequence of alterations in cell adhesion and spreading. To test this, 100 000 
Ccbe1+/+ and Ccbe1-/- MEFs were seeded sparsely and cell adhesion was evaluated 
at 0, 40, 80 and 240 min by microscopy and photography. At last time point, the 
non-adherent cells were washed and the adherent cells were collected and 
counted. After 80 and 240 min of culture, we observed more adherent Ccbe1+/+ 
than Ccbe1-/- MEFs (Fig. 5.10 A). This result was confirmed by counting the 
adherent cells, where from the 100 000 seeded cells only 43 000 Ccbe1-/- MEFs 
had adhered in contrast to 79 000 adherent Ccbe1+/+ MEFs. Next, to test the 
adhesive capacity of Ccbe1-/- MEFs, 130 000 Ccbe1+/+ and Ccbe1-/- MEFs were 
plated and cultured for 48h to reach confluency. Then, plates were washed and 
the adhesive capacity was determined by incubating the cells with 0.01% of trypsin 
for 0, 1, 5 and 8 min and monitored by microscopy and photography (Fig. 5.10 B). 
Ccbe1+/+ fibroblast culture presented adherent and not completely individualized 
cells even after 8 min of trypsin incubation. In contrast, all the Ccbe1-/- MEFs were 
detached from the substrate and individualized after 5 min of trypsin incubation 
(Fig. 5.10 B). These data suggest that absence of Ccbe1 weakens the adhesive 
ability of cells, which may be related to the enhanced motility of Ccbe1-/- MEFs. 
Localized degradation of the ECM is necessary for cells to migrate and involves 
many proteolytic enzymes (Lu et al., 2011). Most of these enzymes are either 
serine proteases or matrix metalloproteinases (MMPs; Ennis and Matrisian, 1994). 
To understand if any of these enzymes was upregulated in Ccbe1 mutants MEFs, 
we analyzed the profile of urokinase-type plasminogen activator (uPa) and Mmp2 
expression in Ccbe1+/+ and Ccbe1−/− MEFs. uPA is a serine protease that can 
initiate proteolytic cascades, resulting in remodeling of extracellular matrix and 
basement membrane, allowing cells to move across and through these barriers 
(Pepper and Vassalli, 1987).  
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Figure 5.10: Adhesive properties of Ccbe1+/+ and Ccbe1-/- MEFs. A. Evaluation of 
cell adhesion during 4h. B. Confluent monolayers of MEFs were incubated with 0.01% of
trypsin and cell detachment was monitored during 8 min. All these pictures are
representative of two independent experiments. C. Expression levels of uPa and Mmp2
from two biological replicates, presented as mean + standard error of mean. 
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On the other hand, MMPs are a family of matrix-degrading enzymes, which include 
collagenases, stromelysins and gelatinases. MMP2 is a gelatinase which degrades 
collagen type IV, the major structural component of basement membranes and 
the first barrier for migrating cells (Monaco et al., 2006).  
According to our qRT analysis, Ccbe1−/− fibroblasts expressed higher levels of uPA 
and of Mmp2 comparatively to Ccbe1+/+ fibroblasts (Fig. 5.10 C), which is 
consistent with the higher migratory behavior of Ccbe1 mutant MEFs. In sum, 
these data indicate that absence of Ccbe1 in MEFs leads to increased migration, 
suggesting that Ccbe1 interferes with cell migration in wild-type cells. 
 
 
5.3.7. Ccbe1-/- MEFs do not support cardiac ESC differentiation 
According to the data presented above, Ccbe1 seems to act as ECM modulator. In 
the absence of Ccbe1 in MEFs, the expression of Mmp2 increased, which probably 
leads to changes in ECM structure making it more suitable for cell motility. On the 
other hand, the developmental fate of differentiating ESCs depends on the complex 
combination of growth factors, signaling molecules, and ECM proteins constituting 
the developmental niche in which the cells exist (Czyz and Wobus, 2001; Oyamada 
et al., 1996). In addition, it is known that ESC differentiation require specific 
signals dependent on cell-matrix and cell-cell interactions via gap-junctions 
(Oyamada et al., 1996). Therefore, in agreement with the scope of the present 
thesis, we co-cultured ESCs during differentiation with Ccbe1-/- MEFsi as their niche 
to evaluate whether there would be an effect of cardiac differentiation. This was 
determined by evaluating the expression of cardiac-specific markers upon ESC 
differentiation. To do so, undifferentiated ESCs were resuspended in differentiation 
medium and hanging drops were plated onto the base of a bacteriological Petri 
dish to form EBs. At day 5 of differentiation, EBs were collected and seeded in 
gelatin, wild-type and mutant Ccbe1 MEFs. Subsequently, at day 10 of 
differentiation, cellular aggregates were collected out from the plates and RNA 
isolated for further analyses of cardiac differentiation markers. During EB 
differentiation, there is a characteristic pattern of the expression of cardiac-specific 
genes. Accordingly, ESC differentiation to cardiac fate starts with mesoderm 
differentiation followed by cardiac mesoderm specification in which cell 
transcription factors, such as Mesp1 and 2, are involved. At the terminal 
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differentiation stage, maturing cardiomyocytes can be identified by the expression 
of cardiac structural proteins such as α-actinin, α-myosin heavy chain (αMhc), or 
the cardiac isoform of Troponin-T (cTnT) (Rajala et al., 2011). Therefore, in this 
preliminary study, we analyzed the expression of early cardiac progenitor markers 
(Isl1 and Nkx2.5) and terminally differentiated cardiomyocyte markers (αMhc and 
cTnT). The expression of these markers were also analyzed in Ccbe1-/- and 
Ccbe1+/+ MEFs to establish baseline expression in the MEFs and were used as 
negative controls. 
According to our data, with the exception of cTnT, the expression of the early and 
terminal cardiac differentiation markers in EBs seeded in Ccbe1+/+ MEFsi was 
identical to EBs differentiated in gelatin (Fig. 5.11). In contrast, the expression of 
the early and terminal cardiac differentiation markers in EBs seeded in Ccbe1-/- 
MEFsi was significantly lower than in EBs seeded in gelatin or in Ccbe1+/+ MEFsi 
(Fig. 5.11). These results, even if only preliminary, suggest that the presence of 
Ccbe1-/- MEFsi hampers the differentiation of ESCs to cardiac lineages. 
 
 
 
 
 
Figure 5.11: Cardiac ESC differentiation. Cardiac differentiation potential of EBs seeded 
in gelatin, Ccbe1+/+ and Ccbe1-/- MEFsi. Levels of gene expression of early (A.) and terminal 
(B.) cardiac markers, in EBs collected at day 10 of differentiation. The relative gene 
expression was normalized to Gapdh and Pgk1 and to gelatin control. (*) significantly 
different expression levels compared to EBs in gelatin. (#) significantly different expression 
levels compared to EBs in Ccbe1+/+ MEFsi. Data are from one biological replicate, 
performed in technical triplicates.  
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5.4.  DISCUSSION 
Several independent experiments revealed Ccbe1-/- MEFs proliferated normally 
until passage 2 but then proliferation decreased a half, probably due an increase 
of approximately 50% of Bax/Bcl2 ratio. The decreased CPD Ccbe1-/- MEFs is 
consistent with the reduced cell proliferation exhibited by mouse Ccbe1-/- fetal 
livers in Zou’s work (Zou et al., 2013).  In addition, the analysis of cell cycle 
propose that the absence of Ccbe1 in culture of MEFs promote an increase of cells 
in G0/G1 or G2/M phase and, consequently, a decrease of cells in proliferating 
phase (S). Cell cycle delay in G0/G1 or G2/M phase indicates that G0/G1 phase of 
Ccbe1-/- fibroblasts is longer or they tend to left cell cycle and stop dividing or to 
enter in quiescence. A delay in proliferation was also found by tracking cell division 
through Cell Proliferation Dye eFluor® 670 assay. Furthermore, viability assays 
revealed that Ccbe1−/− MEFs seemed to be more susceptible to apoptosis 
suggesting that Ccbe1 is important to prevent cell apoptosis or protect cell viability 
under challenging conditions or apoptotic stimuli. Moreover, the addition of CCBE1 
to the culture system reversed morphological changes in Ccbe1-/- MEFs, improved 
proliferation and prevented apoptosis of Ccbe1-/- MEFs. 
Ccbe1 is thought to function in extracellular matrix remodeling and migration. In 
the present work, the possible use of Ccbe1-/- MEFs matrix to support ESC 
differentiation and the effect of Ccbe1 in ECM structure was evaluated by 
differentiating ESCs in Ccbe1-/- MEFs and under control conditions. According to 
our data, the Ccbe1-/- MEFs matrix did not able support ESC differentiation. Taking 
into account that the cell-cell and cell-ECM interactions within the 3D structure of 
the EBs are important for differentiation (Bratt-Leal et al., 2009; White et al., 
2013), these results are consistent with the hypothesis that Ccbe1 acts as 
modulator of ECM by changing ECM structural integrity. Furthermore, according to 
our data, absence of Ccbe1 in MEFs favors migration and the addition of CCBE1 
blocks migration. In literature, namely in a study of the migration of carcinoma 
cells using the transwell system coated with collagen I, the knockdown of Ccbe1 
expression increased cell migration and overexpression Ccbe1 decreased cell 
migration to collagen I (Barton et al., 2010). In addition, two important factors in 
cell motility and in invasion, namely uPa and Mmp2 (Mi et al., 2006) presented 
increased expression in absence of Ccbe1 in MEFs. uPa either acts directly on ECM 
proteins or converts inert plasminogen into widely acting plasmin or activate pro 
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MMPs to active MMPs. Therefore, the high expression of uPa and Mmp2 Ccbe1−/− 
MEFs suggests that cells are less adherent and more motile, which could leads to 
the rise of migration rates. Furthermore, Ccbe1-/- MEFs seemed to exhibited weak 
adhesive bonds and, morphologically displayed extensive lamellipodia, that might 
be also correlated with and enhanced motility of Ccbe1-/- MEFs.  The wound-healing 
assay performed using antibodies against β-integrins showed that migration 
events are negatively regulated by the blocking of β-integrins, as they act as 
primary migration mediators (Barczyk et al., 2010). However, the blocking was 
not sufficiently preferential, so that experiment was not elucidative of the possible 
mechanism whereby Ccbe1 may modulate cell migration. Nonetheless, we decided 
to perform a migration assay using different matrices that may interact with 
CCBE1. As expected, the migration of Ccbe1+/+ MEFs was favored in fibronectin, 
because fibronectin is the proper ECM substrate to study migration of fibroblasts 
(Liang et al., 2007). Furthermore, in vivo, fibronectin provides a crucial substrate 
for many forms of fibroblast migration, such as in embryonic migratory pathways 
and in the provisional matrix of healing wounds (Clark et al., 2003; Knox et al., 
1986; Yamada, 2000). Besides acting as a substrate, fibronectin also has certain 
proteolytic fragments that can promote chemotactic migration (Clark et al., 1988). 
The differences of migration rate between Ccbe1+/+ and Ccbe1−/− MEFs was matrix 
dependent and more evident for migration in vitronectin.  Migration was favored 
in vitronectin, a substrate that possibly interacts with CCBE1. These results 
suggest that a possible complex vitronectin-CCBE1 could block migration and, in 
absence of  CCBE1, fibroblasts are “released” and migrate easier.  
The function of Ccbe1 in migration is however still contradictory and poorly 
understood. On the one hand, Bos et al reported that Ccbe1 deficiency results in 
failure of specified LECs to migrate, but also observed that LEC numbers are 
reduced in mutants and resulting in a primary defect before the migration and 
further formation of lymph sacs (Bos et al. 2011). Hägerling et al work’s also 
confirmed that CCBE1 deficiency results in a failure of nascent LECs to leave the 
veins, formation of aberrant venous sprouts and a lack of developing lymphatic 
vessels (Hägerling et al., 2013). On the other hand, CCBE1 has been reported to 
be highly down-regulated in primary breast carcinomas as compared with matched 
normal breast tissue (Yamamoto and Yamamoto, 2007) and modulated cell 
migration and survival in human ovarian cancer cells (Barton et al., 2010). In the 
study reported by Barton et al, CCBE1 overexpression in breast cancer cells 
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inhibited cell migration and, in opposite, loss-of-function of CCBE1 in ovarian 
cancer context conferred migratory advantage to cancer cells (Barton et al., 2010). 
In the present manuscript, we were able to study the role of Ccbe1 in cell migration 
outside the context of cancer. According to our in vitro model using Ccbe1+/+ 
versus Ccbe1-/- MEFs, Ccbe1 revealed to be an important migration blocker. 
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GENERAL DISCUSSION 
The first years of cell research were essentially devoted to the maintenance of 
pieces of tissue in natural media such as plasma clots. Even though the methods 
and results were remarkable, animal cell culture only became a practical science 
with development of cell lines, cloning of cells, development of both monolayer 
and suspension culture methods by Eagle, and the replacement of totally natural 
media by the complex but defined media (Freshney, 2006). Over the last decades, 
embryonic stem cells have gathered a lot of attention owing to their inherent self-
renewal and pluripotent capacities. Basic and clinical research carried out during 
the last few years on embryonic, fetal, amniotic, umbilical cord blood, and adult 
stem cells have constituted a revolution in regenerative medicine and cancer 
therapies by providing the possibility of generating multiple therapeutically useful 
cell types (Mimeault et al., 2007). In order to meet specific needs of stem cell-
based therapies, development of bioprocessing strategies for propagation of 
pluripotent stem cells involves the development of medium formulations and 
biomaterials as substrates. Although modern tissue culture methods are widely 
used every day at the laboratory level, currently many stem cell culture 
propagation and differentiation systems incorporate animal-derived components 
for promoting self-renewal and differentiation (Greenlee et al., 2005; Li et al., 
2009; McElroy and Pera, 2008; Zhou et al., 2013). Mouse embryonic stem cells 
were one of the first ESC types derived from the inner cell mass of pre-implantation 
blastocysts, and cultured in direct co-culture conditions on MEFsi feeder layers 
(Martin and Evans, 1975; Martin, 1981). For mouse ESCs, fibroblast feeder layers 
are often used at some phase during the culture protocol. This methodology was 
primarily adopted as it provides the cells with the appropriate conditions conducive 
to increase of plating efficiency, facilitates both the survival and the growth of stem 
cells, helps maintaining self-renewal rather than differentiation (Hu et al., 2012; 
Khademhosseini et al., 2006a). On the other hand, from a cell-based regenerative 
therapy perspective, the use of MEFsi for the propagation of ESCs is seen as a 
potential obstacle by many researchers. Even though the risk of transmitting 
murine viruses seems low (Amit et al., 2005), the potential immune rejection of 
xeno-proteins in hESCs, as demonstrated by Martin et al (Martin et al., 2005), 
shows the need for a complete xeno-free cell culture system in order to achieve 
the full clinical potential of ESCs. In addition, the use of feeder layers is labor 
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intensive and could compromise experimental data that are sometimes difficult to 
validate. Numerous protocols for culturing embryonic stem cells were tested, but 
the trend now is towards feeder-free cultures. In alternative to the use of MEFsi 
as feeder layer for ESC culture, several authors have explored the role of natural 
biopolymers, such as complex protein gels like gelatin and Matrigel™. However, 
gelatin is thermally denatured collagen derived from animal skin and bones and 
thus not xeno-free (Gorgieva and Kokol, 2011), and Matrigel is derived from the 
basement membrane of Enelberth-Holm-Swarm mouse sarcoma and, hence, still 
animal-derived (Hughes et al., 2010). Furthermore, several authors alert to the 
fact that when ESCs are cultured in gelatin, even when supplemented with LIF, 
part of the population is differentiated during the culture, indicating that the 
maintenance of pluripotency is compromised (Ramírez et al., 2011; Yue et al., 
2012). From a biomaterials perspective, the generation of an animal- and cell-free 
biomimetic microenvironment that provides the appropriate physical and chemical 
cues for stem cell self-renewal or differentiation into specialized cell types would 
be ideal.  
The advances of biomaterials as a scientific field dates back to approximately 50 
years. Biomaterials have been investigated extensively as substrates for cell 
propagation, scaffolds for various organs and as delivery vehicles for drugs, growth 
factors and cells in many regenerative biomedical paradigms (Abraham et al., 
2009). One of the potential benefits of using biomaterials for pluripotent stem cell 
propagation is the elimination of direct co-culture with a supportive feeder layer 
that has been an integral component of pluripotent stem cell culture. This removes 
the risk of contamination with xenogeneic pathogens and reduces variability in 
experimental outcomes due to feeder layer contribution. In addition, specialized 
biomaterials that include appropriate chemical and physical (topographic features) 
modifications, have contributed to successful differentiation of ESCs to multiple 
cell types. The use of a polymer-based substrates that can be synthesized with 
‘off-the shelf’ constituents for ESC culture has several advantages, including: 
economic feasibility; reduction in the labor involved to maintain an additional cell 
line as feeders; elimination of the source of potential xenogeneic contamination; 
manipulation of chemical or physical and properties such as porosity, stiffness, and 
degradation to increase spatial complexity. 
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Locust Bean Gum as an alternative polymeric coating for embryonic stem 
cell culture 
Biopolymers have received attention as tissue engineering substrates with several 
studies examining materials, such as alginate, chitosan, and gelatin as cell 
scaffolds for both 2D and 3D cell culture. Among biopolymers, LBG is a versatile 
polymer; it has been used in the past in numerous areas, such as food and 
cosmetic industry. Curiously, LBG has been used by ancient Egyptians to bind the 
wrapping of mummies. At present, the chemical stability and biocompatibility of 
natural products, such as LBG, in the body greatly accounts for their utilization. 
The adhesive properties of LBG make it an adequate polymer to use for example 
in drug delivery systems and in biopharmaceuticals applications (Dionísio and 
Grenha, 2012; Manjanna et al., 2013). The potential application of the LBG is vast 
but it had however not been fully explored. In the present thesis, we tested the 
potential use of the commercially available LBG polysaccharide as a novel coating 
to support pluripotent ESC in culture. Polymeric coatings of LBG were characterized 
by SEM and exhibited a rough topography, in opposition to the smooth gelatin 
coating. There is a general consensus that the topography of ECM can control cell 
spreading, which could determine whether the cell undergoes apoptosis or cell 
growth, maintenance of pluripotency or differentiation. In the present study, the 
topography of LBG coatings in combination with the chemical and biological 
properties of LBG, seem to be to be a great asset to support mouse ESC culture.  
Although the natural polymers present high levels of biocompatibility, they should 
be used carefully due to the possible batch-to-batch and producer-to-producer 
variation. Furthermore, concerning the producer, batch or harvest time, the 
composition in galactomannan, protein and ash can vary, motivating several 
authors to perform purification of the polymer prior to use. Therefore, the study 
of the applicability of LBG as coating for stem cell culture was complemented with 
a comparative test performed using LBG from two manufacturers and using 
purified LBG. In general, when ESCs were cultured in LBG coatings, they were able 
to grow and retain their pluripotency regardless of the producer and purification 
step. In the present comparative study, one of the main aims was to test whether 
the ash and protein content affects ESC culture results or if the ESCs respond 
mainly to galactomannan, the major component of LBG. Taken together, the data 
presented here suggests that the possible protein and ash impurities did not cause 
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biological intolerance or benefit ESC culture system. Furthermore, ESC response 
among the different LBG coatings was equivalent, suggesting that maintenance of 
pluripotent ESCs is likely mainly due to the galactomannan.  
In conclusion, the results suggest that LBG coating not only allows ESC survival in 
culture, but also promotes long-term ESC proliferation in the pluripotent state, 
while preserving their tri-lineage differentiation capacity. Therefore, LBG coating 
seems to be a suitable matrix to support pluripotent ESC cultures and an excelent 
alternative to the conventional gelatin-based ESC culture system. 
 
 
Novel triblock copolymer nanofiber system as an alternative support for 
embryonic stem cells growth and pluripotency 
Much of the knowledge of the biological mechanisms that underlie cellular 
functions, such as migration, differentiation and force-sensing has been garnered 
from studying cells cultured on glass or plastic surfaces (Freshney, 2005). 
However, more recently the cell biology field has come to appreciate the 
dissimilarity between these flat surfaces and the physical, chemical, mechanical 
cues of complex three-dimensional extracellular environments in which cells 
routinely operate in vivo (Baker and Chen, 2012). This has encouraged substantial 
efforts towards the development of in vitro biomimetic environments and has 
encouraged much cross-disciplinary work among biologists, material scientists and 
tissue engineers. Therapeutics is limited in part by in vitro cell expansion as well 
as materials issues that include the design of biocompatible scaffolds for further 
co-transplantation (Willerth et al., 2008). Recapitulating the various stem cell 
niches ex vivo is extremely challenging as it likely involves spatiotemporal 
regulation of biostimuli that extend to extracellular matrix architecture. 
Nonetheless, understanding the niche in vitro might help in translation to in vivo. 
The use of biomaterials properties to guide cell behavior is an attractive option for 
regenerative medicine, where controlling stem cell behavior is important for the 
establishment of a functioning cell population. A wide range of materials properties 
have been shown to influence many types of cells, inclusive the effects of 
topography on embryonic stem cells (Ji et al., 2012). It is recognized that 
topographical features such as ridges and grooves can dramatically influence cell 
phenotype (Park et al., 2007), which increase the need of developing substrates 
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with precisely biomimetic topography.  Natural and synthetic polymers have 
emerged as a tool to develop and mimic stem cell niche. However, the use of 
synthetic polymers easily allows the control of modifications. The adhesion, growth 
and differentiation of stem cells are likely controlled by the surrounding 
microenvironment. Physical cues in the microenvironment, e.g. nanotopography, 
were shown to play important roles in stem cell fate decisions, mainly in 
maintaining pluripotency (Ji et al., 2012). Thus, controlling stem cell behavior by 
nanoscale topography has become an important issue in stem cell biology. 
Nanotechnology has emerged as a new exciting field and research from this field 
has greatly advanced. Nanotechnology allows the manipulation of sophisticated 
surfaces/scaffolds which theoretically can mimic the cellular environment and 
regulate cellular behaviors. As ESCs are adherent cells that respond to a wide 
range of substrate cues, including topography, the cell-substrate interface is 
therefore an important design parameter in regenerative medicine and tissue 
engineering applications. In an attempt to mimic the fibrous structure of in vivo 
ECM, we developed a new artificial support that is constituted of PEG-PTMSMA-
PMAA-GRGDS nanofibers which main advantages are the elimination of animal-
derived matrices and to make available a complex, synthetic and defined network 
of nanofibers in a scale similar to the native ECM. In the present work, we 
developed a new artificial support that can be used to grow pluripotent stem cells 
by converting an amphiphilic biocompatible peptide-copolymer into a nanofiber 
mesh, through a molecular self-assembly process. The developed nanofibers 
structure was shown to support mESC proliferation in an undifferentiated state 
after short- and long-term culture, indicating that this system is an alternative 
substrate and possible candidate to substitute gelatin coating in mESC culture. The 
nanofibers promoted self-renewal of mESCs without the requirement of a matrix 
coating with high levels of proteins and polymers, which not only provides a route 
for easier and economical stem cell culturing, but also promotes production of 
higher quality undifferentiated pluripotent stem cells with better control of cell 
proliferation and differentiation in a chemically defined matrix, especially when 
compared to gelatin coating. 
It is common knowledge that within the stem cell niche, cell fate is controlled both 
spatially and temporally, as well as through cell-cell and cell-matrix interactions 
(Kim et al., 2012). The cell-substrate interface is therefore an important design 
parameter in tissue engineering applications, where substrate cues are used to 
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influence cell behavior. In the present work, the bioconjugation of nanofibers with 
GRGDS lead to a higher expression of β1-Integrin and Collagen type I suggesting 
that cell-matrix interactions were mediated via integrins. Furthermore, this results 
could indicate that PEG-PTMSMA-PMAA-GRGDS improve cell adhesion by inducing 
the expression of adhesion molecules that will allow the reorganization of the 
microenvironment and incorporation in a fiber-based matrix. Also, the interaction 
nanofiber-cells revealed to be beneficial for the maintenance of pluripotency in the 
culture system. 
 
The culture of pluripotent stem cells on polymeric surfaces opens up avenues for 
the identification of synthetic microenvironments that can be easily synthesized 
and modified to form scaffolds to support the differentiation of ESCs into highly 
ordered structures. In ESC studies, biomaterials have been frequently used to 
direct differentiation to specific lineages in the presence of appropriate growth 
factors. However, maintenance of its undifferentiated state has proven to be a 
challenge. The use of natural and synthetic polymers in promoting ESC self-
renewal is still in its nascent phase and has great potential. Much work remains to 
be done in the laboratory and in the clinic to understand how to use ESCs in stem 
cell-based therapies to treat disease. Furthermore, the use of appropriate matrices 
in cell culture is still an issue. The major challenge is to find a cheap, defined, user-
friendly and feeder-free condition that properly mimics the ESC niche, in order to 
obtain high-quality undifferentiated ESCs. Many efforts have been made to closely 
mimic the real microenvironment of cells. It is expected that advances in 
biomaterial-based approaches will contribute immensely to the standardization of 
culture methodologies, leading to development of bioprocesses for ESC 
propagation and differentiation. Moving towards an animal-free matrix for 
culturing ESCs require the identification of polymeric substrates that support long-
term proliferation and self-renewal. In the present thesis, the use of LBG coating 
and PEG-PTMSMA-PMAA-GRGDS nanofibers was validated as a support for 
proliferation, pluripotency and differentiation of mouse embryonic stem cell 
culture. 
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Characterization of Ccbe1 mutant MEFs. Ccbe1 and its effect in 
proliferation and migration 
In vitro experiments using wild-type versus mutant MEFS is a suitable system to 
study the function of a gene thought to act in extracellular matrix remodeling and 
in migration because the function of fibroblasts is not only the maintenance of the 
structural integrity of connective tissues, but also the continuous secretion of the 
precursors of all the components of the extracellular matrix, primarily the ground 
substance and a variety of fibers. 
The culture of primary mouse embryonic fibroblasts have been widely used by 
several researchers as a model to perform functional analyses  (Chen et al., 2006; 
Kireeva et al., 1996; Kranc and Bamforth, 2003). The Ccbe1 functional studies 
presented in this dissertation clearly suggest that Ccbe1 plays a role in cell 
proliferation. In vitro analyses of survival growth curves showed a cell growth 
decreased in Ccbe1-/- MEFs. Furthermore, failure of proliferation in Ccbe1-/- MEFs 
was supported with cell cycle delay at G0/G1 and G2/M phase. Moreover, FBS 
starvation of Ccbe1-/- MEFs resulted in an increase of apoptotic cells suggesting 
that Ccbe1 is important to protect cell viability. In addition, rescue of proliferation 
and viability was obtained by introduction of CCBE1 back to the culture system. 
The balance of cell proliferation and apoptosis is important for both development 
and normal tissue homeostasis. As fibroblasts have structural support and tissue 
remodeling functions, the low proliferation in Ccbe1-/- MEFs could maybe not be 
enough to maintain the integrity of tissues contributing for the development of 
extensive edema in mice. Furthermore, our preliminary results also show that EBs 
cultured on top of Ccbe1-/- MEFsi feeder layers were not able to properly 
differentiate namely into the cardiac lineage, as verified by the low expression of 
cardiac markers. This result suggests that, contrarily to LBG coating, PEG-
PTMSMA-PMAA-GRGDS nanofibers and wild-type MEFs, Ccbe1-/- MEFsi have not 
the suitable properties to be used as support for mouse cardiac ESC differentiation. 
Moreover, the inability of Ccbe1-/- MEFsi to support differentiation is consistent with 
the requirement of Ccbe1 for proper differentiation of ESCs towards cardiac 
lineages. 
In cancer, it is known that senescent fibroblasts promote tumor growth and 
metastasis (Capparelli and Guido, 2012). Considering the fact that CCBE1 is 
downregulated in several cancer clinical cases and that Ccbe1 mutant MEFs tends 
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to present the morphology of senescent cells, it is possible that the absence of 
Ccbe1 in fibroblasts-like cells in tumors promote their senescence and 
consequently the growth and metastasis of tumors.  
Bioinformatic analyses revealed that CCBE1 contains putative collagen and calcium 
binding EGF-like domains, and might have a function in extracellular matrix 
remodeling and migration (Barton et al., 2010). Indeed, Ccbe1 mutant MEFs 
presented increased motility and seemed to exhibited weak adhesive bonds. In 
absence of Ccbe1, fibroblasts migrated faster and the expression of uPA and Mmp2 
was increased. Migration studies using human cell lines, also revealed an 
enhancement of cell migration upon downregulation of CCBE1 (Barton et al., 
2010). Fibroblast migration was further increased in the presence of vitronectin 
and blocked in the presence of β-integrin blocking antibodies and even more 
evidently in the presence CCBE1. The collagen-like domain present in CCBE1 is a 
possible mediator of migration as collagen is an important regulator of ECM 
assembly and maintenance. Collagen has been shown to transduce signals via 
integrins or VEGFR3 to control cell spreading and migration (Alitalo, 2011). On the 
other hand, bioinformatic analyses performed in our laboratory has shown that 
CCBE1 has a conserved RGD domain which could allow further interactions with 
vitronectin or via RGD-recognizing integrins. 
In the present work, we demonstrated that CCBE1 is involved in the following 
activities: (i) promotion of cell attachment and spreading; (ii) maintenance of cell 
viability; (iii) increase of proliferation rate and (iv) delay of cell migration. Taken 
together, these data indicate that Ccbe1 is likely to function as an extracellular 
matrix signaling molecule and may regulate processes of cell proliferation, 
migration and adhesion during embryo development. 
 
 
Future perspectives 
Embryonic stem cells have a potential of application in drug discovery, 
developmental biology and disease studies due to their unique characteristics. 
Nevertheless, there are some concerns about conventional methods to maintain 
self-renewal of ESCs, since these methods include the use of feeder cells, as well 
as serum. Good manufacturing practice (GMP) quality, defined by both the 
European Medicines Agency and the Food and Drug Administration, is a 
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requirement for clinical-grade cells, offering optimal defined quality and safety in 
cell transplantation (Unger et al., 2008). Immune reactions against animal proteins 
in the cells and infection risk caused by animal microbes can be avoided using 
animal substance-free culture media, feeder cells or feeder-free matrix in 
derivation, passaging, expansion and cryopreservation procedures. In the present 
work, we replaced the animal-derived substrate by natural polymer from plant 
origin and by synthetic polymers, however ESCs were cultured in medium 
supplemented with FBS ESC screened. To support fetal growth and development, 
FBS contains mixed combinations of cell replication stimulators and cell 
differentiation inducers. Owing to the facts that serum is a biological complex 
mixture containing unknown compounds and that serum batches vary in their 
capability of maintaining ESCs at an undifferentiated stage, the replacement of 
serum with defined components would be optimal for GMP production of ESCs 
(Unger et al., 2008). Therefore, to overcome serum-related problems, several 
groups have optimized serum-free culture conditions for ESC lines using chemically 
defined KnockOut™ Serum Replacement (KSR), a defined, serum-free formulation 
optimized to grow and maintain undifferentiated ESCs in culture (Cheng et al., 
2004), to replace FBS. In future work, as the next step towards optimization and 
standardization of ESC culture protocols and to obtain entirely xeno-free 
maintenance of ESCs, it would be interesting to combine the use of LBG or 
nanofibers in xeno-free defined culture medium, such as DMEM supplemented with 
serum alternatives (KSR) or in a chemically defined ESC medium containing 
differentiation inhibitors (2i medium). With this experiment we expect to elucidate 
if our system is also efficient in the maintenance of pluripotency even in culture 
conditions with reduced or zero animal-derived products. 
 
The use of LBG and nanofibers coatings for mouse ESC culture was validated in 
the present thesis, however, it would be interesting to validate the use of these 
supports for culture and differentiation of human ESC and iPS. In the possibility 
that these coatings are able to support not only mESC, but also hESC and iPS, LBG 
and nanofiber based-coatings can be used, for instance, to culture hESC for further 
drug testing and disease studies. Furthermore, the coatings used in this work, LBG 
and nanofibers, were characterized by SEM and TEM. Nevertheless, it may be also 
important to study the stability of the nanofibers and LBG solutions along the time 
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and at different temperatures (i.e. room temperature, 37 and 4ºC) by SEM or TEM 
to verify if their morphological structure is preserved.  
Surface charge, apart from other factors, is a crucial parameter for cell adhesion 
(Lee et al., 1994; Vancha et al., 2004). According to published data, several cell 
lines and primary cultures benefit from the use of positively charged extracellular 
matrix proteins or polymers that enhance their ability to attach to culture plates 
(Berchtold et al., 2005; B. Liu et al., 2008). LBG is a non-ionic or neutral 
polysaccharide. One of the future tasks could be to test cell growth and 
pluripotency of ESCs cultured in aminated LBG (positively charged), sulfated LBG 
(negatively charged) or in blending of both LBG derivatives. 
 
Ccbe1 seems to be involved in both proliferation and apoptosis process. The 
proliferation experiments and the studies concerning the role of Ccbe1 in 
preventing cell apoptosis will be complemented to include more biologial replicates 
in the experiments of cell proliferation dye assay (eFluor®670) and expression of 
genes related to apoptosis process, such as Caspase3.  
Since the analysis of the Affymetrix array data generated in Ieda et al revealed 
that Ccbe1 is highly expressed in mouse cardiac fibroblasts (embryonic and adult) 
(Ieda et al., 2009) and that co-culture of differentiating ESCs with Ccbe1-/- MEFsi 
feeder layers lead to inhibition of cardiac differentiation, we would test the effect 
of Ccbe1-/- and Ccbe1+/+  embryonic cardiac fibroblasts in proliferation and gene 
expression profile of cardiomyocytes. In addition, we would test endoderm and 
ectoderm differentiation markers to verify whether the defect in differentiation is 
related only with the mesoderm and cardiac differentiation or related to a general 
defect in differentiation.  
Ccbe1 is a secreted protein with two putative distinct functional domains: an EGF-
like domain, and a collagen-like domain. EGF-containing molecules signal via EGF-
receptors but also through other receptors, such as integrins. EGF signaling is 
involved in the morphogenesis and homeostasis of several tissues, controlling cell 
migration, proliferation, survival or differentiation. Collagens are important 
regulators of ECM assembly and maintenance, and have been shown to signal via 
integrins and more recently through VEGFR3 to control cell spreading and 
migration (Alitalo, 2011). Furthermore, Ccbe1 has been shown to interact with 
vitronectin, collagen type I and V (Bos et al., 2011). In addition, our results showed 
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that Ccbe1 may modulate cell migration. Therefore, concerning the possibility that 
Ccbe1 may have a role as a modulator migration through integrin signaling or the 
regulation of ECM-integrin signaling, Ccbe1+/+ and Ccbe1−/− MEFs could be tested 
in a Mouse Extracellular Matrix & Adhesion Molecules RT profiler PCR Array 
(Quiagen) to assess the expression of cell adhesion molecules such as 
transmembrane molecules, cell-cell and cell-matrix adhesion molecules, and ECM 
proteins like basement membrane constituents, collagens and ECM structural 
constituents, ECM proteases and ECM protease inhibitors. The use of qPCR would 
allow an easily and reliably analysis of the expression of a focused panel of genes 
related to cell adhesion and the effect of Ccbe1 in their expression, thus giving 
clues about possible pathways or mechanisms of action and about potential 
partners of CCBE1. In addition, in an effort to find the mechanism of action of 
Ccbe1, a RT profiler PCR Array (Quiagen) could be performed using Ccbe1+/+ 
and versus Ccbe1−/− MEFs to assess the expression of target genes that make part 
of extracellular signal-regulated kinase (ERK) signaling, phosphatidylinositde-3-
Kinase (PI3K) signaling, signaling through focal adhesion kinase (FAK) or 
expression of target genes of integrin pathway.  
To characterize which is the region of Ccbe1 responsible for the binding to ECM 
proteins, ECM produced by Ccbe1+/+ MEFs would be incubated separately with each 
CCBE1 protein: the full-length and putative N-terminal (EFG-like domain 
containing region) and C-terminal (collagen domain containing region) fragments 
and immunofluorescence analysis would be performed using antibodies to detect 
Ccbe1 and ECM components. This experiment would be elucidative about the 
localization of Ccbe1 in the ECM, and would allow identification of which ECM 
components interact with each portion of CCBE1 protein. 
The wound-healing assay used to explore the interaction between β-integrins and 
CCBE1 may be re-designed to increase the resolution of the experiment. To do so, 
both Ccbe1+/+ and Ccbe1−/− MEFs can be incubated with antibodies against β1-
integrin (collagen receptor), β3-integrin (vitronectin receptor) and β4-integrin 
(laminin receptor). The results obtained for Ccbe1+/+ MEFs incubated with anti-β-
integrin antibodies would be used to establish a baseline of the ability of each 
antibody to block the corresponding receptor. The possible β-integrin-dependent 
pathway by which CCBE1 interacts with ECM in migration events should be 
identified by considering the antibody that gives rise to a higher block of migration 
of Ccbe1−/− MEFs after normalization to the blockade observed in the Ccbe1+/+ 
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MEFs by the same antibody. The β3-integrin, in particular αvβ3 integrin, is a 
potential candidate to interact with CCBE1 since CCBE1 has an RGD domain and 
αvβ3-integrin usually the receptor of proteins with exposed RGD peptide, including 
vitronectin, fibronectin, and collagen (Srichai and Zent, 2010). On the other hand, 
the most evident differences in migration between Ccbe1−/− and Ccbe1+/+ MEFs 
were obtained in vitronectin coating and it is known that vitronectin, a substrate 
for αvβ3 integrin receptor, promotes cellular spreading and migration following 
αvβ3 integrin ligation to the RGD sequence found in the connecting sequence. Also, 
a shift in the expression of uPa, which is involved in proteolytic activity on the cell 
membrane, or in the expression of αvβ3 can result in aggressive migration, as 
seen in cancer invasion, which is consistent with the increased expression of uPa 
in Ccbe1−/− MEFs. In fact, it is known that the effects of vitronectin and uPa on cell 
migration are additive, both induce cytoskeleton and microtubule reorganization 
and focal contact redistribution (Degryse et al., 2001). Furthermore, vitronectin 
can connect the uPa and the integrin systems as it can bind to both uPa receptor 
and the integrins (Degryse et al., 2001). Therefore, it may be interesting to 
analyze the role of Ccbe1 in the regulation of Integrin signaling. 
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